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B-Raf is an Essential Component of the Mitotic Machinery Critical for Activation of 
MAPK Signaling During Mitosis in Xenopus Egg Extracts 
 
 
Sergiy I. Borysov 
 
 
ABSTRACT 
 
Activation of the MAPK cascade during mitosis is critical for spindle assembly 
and normal mitotic progression.  The underlying regulatory mechanisms that control 
activation of the MEK/MAPK cascade during mitosis are poorly understood.   The goal 
of my dissertation research is to identify the MEK kinase responsible for activation of the 
MAPK cascade during mitosis and to elucidate the biochemical mechanisms that regulate 
its activity.  In the described herein work I purified and characterized the MEK kinase 
activity present in M-phase arrested Xenopus egg extracts.  I demonstrate that B-Raf is 
the critical MEK kinase required for activation of the MAPK pathway at mitosis.  
Consistent with this, I show that B-Raf is activated in an M-phase dependent manner.  
Further, I provide data linking Cdk1/cyclin B to mitotic activation of B-Raf.  Cdk1/cyclin 
xx 
 
B associates with and phosphorylates B-Raf in M-phase arrested extracts and directly 
targets Xenopus B-Raf in vitro at a conserved Ser-144 residue.  Phosphorylation at Ser-
144 is critical for M-phase dependent activation of B-Raf and for B-Raf’s ability to 
trigger activation of the MAPK cascade at mitosis.  Finally, I demonstrate that mitotic B-
Raf undergoes feedback phosphorylation by MAPK at its conserved C-terminal SPKTP 
motif.  Mutation of both phosphorylation sites within the SPKTP sequence to alanines 
increases activity of mitotic B-Raf.  Further, inhibition or over-activation of MAPK 
during mitosis enhances or diminishes B-Raf activity, respectively.  These results 
indicate that MAPK-mediated feedback phosphorylation negatively regulates B-Raf 
activity.  Additionally, I show that active mitotic B-Raf exists in large multi-protein 
complex(s).  By utilizing a proteomics approach I identify a set of proteins, which 
potentially associate with B-Raf at M-phase.  Future studies are necessary to elucidate the 
involvement of these proteins in regulating B-Raf mitotic functions.  In summary, my 
dissertation studies demonstrate that B-Raf activates MAPK signaling at mitosis and 
undergoes an M-phase dependent regulation.  I propose that B-Raf has important 
functions at mitosis that contributes to its overall role in promoting cell proliferation. 
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Chapter One 
General Introduction 
 
General understanding of mitosis 
 
The purpose of the cell cycle is to produce two daughter cells identical to the 
mother cell.  This is achieved through a temporal coordination and execution of the cell 
cycle events.  During G1-S-G2 phases of the cell cycle a cell commits to and prepares for 
cell division, whereas at M-phase the cell division is finally executed (Murray, 1992).  
M-phase is traditionally divided into two stages: mitosis (segregation of the 
chromosomes) and cytokinesis (division of the cytoplasm) (Satterwhite and Pollard, 
1992).  Therefore, mitosis is the culminating stage of the cell cycle, when the duplicated 
genome of the mother cell becomes redistributed into two daughter cells.  
Mitosis is traditionally described as a series of intracellular morphological 
changes involving dynamic rearrangements of chromatin and cytoskeleton structures 
(Karsenti, 1991; McIntosh and Koonce, 1989; Wadsworth, 1993).  The first signs of 
chromatin condensation within an intact nucleus mark the initial progression toward 
mitosis, recognized as prophase (Khodjakov and Rieder, 1999; Swedlow and Hirano, 
2003).  During prophase, a pair of centrosomes (Fukasawa, 2002), duplicated in S-phase, 
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undergoes separation defining the poles of the forming mitotic spindle (Raff and Glover, 
1989).  Recruitment of additional gamma-tubulin ring complexes into centrosomal matrix 
(Khodjakov and Rieder, 1999) provokes a dramatic increase in microtubule nucleation 
activity necessary for dynamic spindle assembly (Kuriyama and Borisy, 1981).  The 
following nuclear envelope breakdown represents the first irreversible point of mitosis, 
prometaphase (Fields and Thompson, 1995; Rieder and Khodjakov, 1997).  The 
dismantling of the nuclear envelope allows physical interaction between growing tubulin 
fibers of the mitotic spindle and the kinetochores of the chromosomes.  Pushing and 
pulling forces of the kinetochore microtubules emitting from opposite poles and bound to 
the same chromosomal kinetochores position chromosomes halfway between the spindle 
poles, along the equator of a cell, called a metaphase plate (Sonoda et al., 2001; Tanaka et 
al., 2000).  Until this stage of mitosis, sister chromatids are held together by cohesin 
(Nasmyth, 2001) selectively enriched in the neighborhood of the centromeres 
(Waizenegger et al., 2000).  The metaphase alignment and proper attachment of 
chromosomes to the mitotic spindle triggers an abrupt and synchronous cleavage of the 
centromeric cohesin complexes (Hauf et al., 2001; Uhlmann et al., 2000).  This provokes 
the sudden separation of sister chromatids and represents the second irreversible stage of 
mitosis, anaphase.  Following the cleavage, chromosomes are separated first due to 
shortening of the kinetochore microtubules (anaphase A) (Mitchison and Salmon, 1992) 
and later due to growing of the polar microtubules and elongation of the whole spindle 
(anaphase B) (Aist et al., 1991).  Mitosis is finished at the telophase when the kinetochore 
microtubules disappear (Wilson et al., 1994), a new nuclear envelope reforms around 
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each set of adjacent decondensing chromosomes (Gerace and Blobel, 1980; Newport, 
1987) and the nucleoli are reformed (Dimario, 2004).  The following cytokinesis is 
temporally and spatially coordinated to the completion of mitosis (Satterwhite and 
Pollard, 1992).  The midbody, a microtubule-based structure assembled at telophase 
around the original spindle equator, directs proper cleavage of the cytoplasm during 
cytokinesis (Otegui et al., 2005).   
An intricate biochemical network governs orderly execution and precision of 
mitotic events.  Protein phosphorylation (Nigg, 2001) and dephosphorylation (Kumagai 
and Dunphy, 1996), protein-protein association (Hardwick, 2005; Kramer et al., 2000; 
Morgan, 1995; Musacchio and Hardwick, 2002; Visintin et al., 1997) and protein 
degradation (Bashir and Pagano, 2004; Holloway et al., 1993; Sudo et al., 2004) are the 
main mechanisms of the mitotic regulatory machinery.   
Proper order and completion of the mitotic stages are accomplished by 
incorporating positive and negative feedback loops into the regulation of mitosis and 
creating two “points of no return” in mitotic progression (Murray, 1992; Murray and 
Kirschner, 1989b).  The first “point of no return” overlaps with the prophase-
prometaphase transition and is associated with a robust activation of Cdk1/cyclin B, the 
master regulator of mitotic entry (Dunphy et al., 1988).    The irreversibility of 
Cdk1/cyclin B activation is ensured by the positive feedback loop existing between 
Cdk1/cyclin B and its upstream activator, Cdc25C phosphatase (Strausfeld et al., 1994), 
which removes the inhibitory phosphorylations from Thr-14 and Tyr-15 residues 
(Atherton-Fessler et al., 1993; Kumagai and Dunphy, 1996).  This positive regulatory 
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circuit ensures an abrupt and robust accumulation of active Cdk1/cyclin B and enables 
Cdk1/cyclin B activation and progression toward mitosis to be independent from any 
further upstream inputs.   
Cdk1/cyclin B activation sets up conditions for the next irreversible point in 
mitosis, activation of the anaphase-promoting complex (APC), a mitosis-specific 
ubiquitin-ligase, which targets mitotic proteins for degradation promoting exit from 
mitosis (Castro et al., 2005).  Indeed, activation of Cdk1/cyclin B via direct and indirect 
mechanisms triggers formation of the mitotic spindle and its association with 
chromosomal kinetochores.  Completion of this spindle-chromosome assembly during 
metaphase leads to activation of APC, which in turn ubiquitinates and targets securin and 
cyclin B for degradation.  Securin proteolysis promotes the disjoining of sister 
chromatids and represents the main condition for anaphase initiation (Holloway et al., 
1993).  Degradation of cyclin B leads to inactivation of Cdk1/cyclin B complexes 
(Wheatley et al., 1997).  Thus, activation of Cdk1/cyclin B triggers a series of events, 
which eventually leads to elimination of Cdk1/cyclin B signaling.     
The spindle assembly checkpoint ensures that progression toward anaphase does 
not happen prematurely.  It is thought that throughout spindle formation and 
establishment of kinetochore-microtubule interactions, the status of the kinetochore-
microtubule attachments can be sensed and reflected in the levels of soluble “wait-
anaphase” signaling complexes (Rieder and Salmon, 1998; Wassmann and Benezra, 
2001), the presence of which delays activation of APC.  Indeed, unattached kinetochores 
or low-tension kinetochores undergo phosphorylation and act as sites where spindle 
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checkpoint Mad2-Cdc20 protein complexes are assembled and released to abrogate APC 
activation (Chan and Yen, 2003; Hardwick, 2005; Yu, 2002). 
In conclusion, mitosis is the final stage of the cell cycle, when segregation of 
replicated chromosomes occurs.  To accommodate separation of the duplicated genomic 
DNA, the chromatin undergoes condensation and the cytoskeleton transforms into the 
mitotic spindle.  These processes of mitosis are tightly regulated by mitotic biochemical 
machinery, which ensures proper timing, completeness and fidelity of mitotic stages. 
 
Protein kinases in regulation of mitosis 
 
Protein phosphorylation comprises one of the major modes of mitotic regulation 
(Nigg, 2001).  Many kinases have been implicated in mitosis.  These include Cdk1/cyclin 
B, members of Polo-like and Aurora kinase families, NIMA, mitotic checkpoint kinases 
(Bub1, BubR1 and Mps1), MAPK and others. 
Cdk1/cyclin B is the main kinase involved in the regulation of mitotic onset 
(Arion et al., 1988; Gautier et al., 1988; Labbe et al., 1989; Lohka et al., 1988; Masui and 
Markert, 1971; Nurse, 1975).  The contemporary dogma of the cell cycle regulation 
represents cyclin-dependent kinase activities, which fluctuate throughout the cell cycle, 
as a regulatory core of the cell cycle (Morgan, 1995).  The identification of Cdk1/cyclin 
B as an initiator of M-phase and a prototype of Cdk/cyclin complexes was a discovery of 
Nobel Prize caliber (Paul Nurse, Leland Harwell and Tim Hunt, Nobel Priz in Medicine, 
2001).   
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Cdk1/cyclin B initiates and establishes mitosis via phosphorylation of multiple 
substrates.  For instance, active Cdk1/cyclin B directly phosphorylates lamins to induce 
dismantling of the nuclear envelope (Peter et al., 1991), condensins to contribute to 
further chromosome condensation (Kimura et al., 1998), and microtubule-associated 
proteins and kinesin-related motor proteins to affect centrosome separation and mitotic 
spindle assembly, respectively (Blangy et al., 1995).  Besides this, Cdk1/cyclin B directly 
regulates APC and other components of the mitotic regulatory network (Patra and 
Dunphy, 1998; Zachariae et al., 1998).  Inactivation of Cdk1/cyclin B occurs during the 
anaphase transition and is required for proper mitotic exit (Noton and Diffley, 2000).  It 
is achieved through an APC-directed degradation of cyclin B, a regulatory partner of 
Cdk1 (Glotzer et al., 1991; Wheatley et al., 1997). 
Polo-like kinases are a new emerging class of mitotic regulators.  Originally, 
Polo-like kinases were identified in Drosophila (Sunkel and Glover, 1988) and yeast 
(Kitada et al., 1993) genomes and linked to mitotic regulation.  There are at least three 
Polo-like kinase members in vertebrates (Lowery et al., 2005), one of which, Polo-like 
kinase 1 (Plk1), has been implicated in mitosis.  It has been shown that Plk1 localizes to 
the mitotic apparatus (Arnaud et al., 1998; Golsteyn et al., 1995; Wianny et al., 1998), 
undergoes an M-phase dependent regulation (Charles et al., 1998; Golsteyn et al., 1995; 
Hamanaka et al., 1995) and has multifaceted roles during M-phase.  It has been proposed 
that Plk1 triggers the Cdc25C-Cdk1/cyclin B positive feedback loop during the mitotic 
entry (Nakajima et al., 2003; Roshak et al., 2000; Toyoshima-Morimoto et al., 2002), 
controls mitotic spindle formation and functions (Ahonen et al., 2005; Casenghi et al., 
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2005; Feng et al., 1999; Lane and Nigg, 1996; van Vugt et al., 2004; Yarm, 2002) and is 
involved in the regulation of mitotic exit and cytokinesis (Zhou et al., 2003). 
The family of Aurora kinases is another important group of mitotic regulators.  
Aurora kinases were originally identified in Drosophila as being involved in the 
regulation of centrosome functions during mitosis (Glover et al., 1995) and in budding 
yeasts as being involved in coordination of mitosis (Chan and Botstein, 1993).  The 
metazoan genome encodes at least three Aurora kinases, Aurora A, B and C (Andrews et 
al., 2003).  Thus far only Auroras A and B are directly linked to mitosis.   
Auroras A and B differ from each other in timing of activation, intracellular 
localizations and functions during mitosis. Aurora A protein levels and activity peak at 
G2/M, whereas Aurora B is up-regulated and activated during late mitosis after 
Cdk1/cyclin B inactivation (Bischoff et al., 1998).  Both kinases undergo proteasome-
mediated degradation at the end of mitosis/G1 (Shu et al., 2003; Taguchi et al., 2002).  
Aurora A localizes to the centrosomes throughout mitosis (Stenoien et al., 2003) and is 
implicated mainly in centrosomal functions (Andrews et al., 2003; Giet et al., 1999).  
Additionally, Aurora A may be an important component of the M-phase onset signaling 
(Katayama et al., 2004; Krystyniak et al., 2006). 
Aurora B localizes to the kinetochore regions from prophase until the metaphase-
anaphase transition and to the midzone and midbody during telophase and cytokinesis, 
respectively (Andrews et al., 2003).  It is thought that Aurora B’s association with 
INCENP (inner centromere protein) and survivin (Adams et al., 2000; Yasui et al., 2004) 
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is important for its roles in spindle formation (Moore and Wordeman, 2004) and the 
mitotic spindle checkpoint (Ditchfield et al., 2003; Hauf et al., 2003).  
Genetic studies in the filamentous fungus Aspergillus nidulans identified a new 
mitotic kinase, NIMA (never in mitosis A) (Osmani et al., 1988).  Functional studies 
characterized NIMA as one of the key regulators of mitotic onset (Osmani et al., 1991; 
Osmani et al., 1988; Osmani and Ye, 1996).  However, the closest mammalian 
homologue of fungal NIMA, Nek2 (Fry, 2002), does not display a global effect on M-
phase progression.  It was shown that Nek2 is a centrosomal resident protein involved in 
centrosome separation (Fry et al., 1998a; Fry et al., 1998b).   
Another important group of kinases involved in the regulation of mitosis is a set 
of kinases directly implicated in the generation of spindle checkpoint signaling.  This 
includes kinases of Mad/Bub families (namely, Bub1 and BubR1/Mad3) and Mps1 
kinase.  It is proposed that Bub1 (Roberts et al., 1994) and BubR1 (Taylor et al., 1998) 
facilitate kinetochore recruitment of other members of the Mad and Bub families (Chen, 
2002; Sharp-Baker and Chen, 2001) and participate in their rearrangements leading to the 
formation of spindle checkpoint protein complexes, which inhibit APC and postpone 
anaphase onset (Brady and Hardwick, 2000; Sudakin et al., 2001).  Checkpoint kinase 
Mps1 (Weiss and Winey, 1996), similar to Bub1 and BubR1, facilitates kinetocore 
localization of the Mad proteins (Abrieu et al., 2001).  However, unlike Bub1 and 
BubR1, Mps1 has not been shown to be a component of the “wait anaphase” complexes 
(Hoyt, 2001).   
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In conclusion, many kinases are involved in the regulation of mitosis.  
Cdk1/cyclin B is the major among them.  Its activation and inactivation mark two of the 
most important transitional points in mitotic progression, commitment and exit from 
mitosis, and ensure the irreversibility of the process.  The involvement of many other 
kinases in the mitotic regulatory network reflects the necessity of multilayered and 
branched control over the fidelity and integrity of cell division.  
 
Three-kinase module of the MAPK pathway 
 
The MAPK cascade is one of the most well characterized kinase pathways 
implicated in cellular signaling.  It governs cellular responses to a variety of stimuli 
including cytokines, growth factors and hormones, and conditions, such as cellular 
stresses, cell adhesion and others (Widmann et al., 1999).  The MAPK signaling module 
consists of three kinases that sequentially phosphorylate and activate one another.  The 
up-stream kinase, MAPK kinase kinase (MEK kinase), phosphorylates and activates 
MAPK kinase (MEK), which in turn phosphorylates and activates MAPK (Fig. 1A) 
(English et al., 1999; Widmann et al., 1999).  The MAPK cascade is unique for 
eukaryotes and conserved from yeast to humans (English et al., 1999; Widmann et al., 
1999). 
Mammalian cells express at least twenty members of the MAPK family (Pearson 
et al., 2001b).  The most studied among them are classified into four distinct subfamilies 
(Widmann et al., 1999).  These include extracellular signal-regulated kinases 1 and 2 
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 Figure 1. Regulation of MAPK signaling by MEK kinases 
A.  General representation of the MEKK/MEK/MAPK signaling module.  B.  MEK kinase network in the regulation of MAPK 
pathway functions   
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 (ERK1/2), Jun amino-terminal kinases 1, 2 and 3 (JNK 1/2/3), p38 proteins alpha, beta, 
gamma and delta (p38α/β/γ/δ) and extracellular signal-regulated kinase 5 (ERK5) 
(Widmann et al., 1999).  Each MAPK subfamily is distinctly regulated and carries out 
distinct biological functions (Fig. 1B).  ERK1/2 are predominantly implicated in the 
regulation of cell proliferation, growth, differentiation and survival.  JNK and p38 are 
stress-response MAPKs, involved in apoptosis, stress responses to different cellular 
conditions or agents as well as cellular differentiation and some immune functions 
(Widmann et al., 1999).  ERK5 is proposed to regulate cell survival and proliferation 
(Dong et al., 2001; Kato et al., 1998; Pearson et al., 2001a). 
To ensure the integrity of intracellular processes, activation of a given MAPK 
cascade within a certain biological context must be precisely regulated (Pearson et al., 
2001b; Widmann et al., 1999).  Several biochemical mechanisms within a MAPK module 
ensure the specificity of MAPK signaling.  First of all, the preferential phosphorylation of 
a certain set of intracellular targets by a given MAPK is conditioned by the intrinsic 
structural properties of a particular MAPK subfamily and its substrates.  Despite the fact 
that all MAPKs phosphorylate their substrates at a similar consensus Ser/Thr-Pro 
sequence (Davis, 1993), substrate recognition by particular MAPKs varies depending 
upon the availability of appropriate docking sites (Fantz et al., 2001; Gonzalez et al., 
1991; Gupta et al., 1996; Tanoue and Nishida, 2003). 
The specificity of MAPK signaling is controlled as well on the level of MEK.  
Very specific combinations of MEK and MAPK are formed within the MAPK modules.  
MEK 1/2 activates ERK1/2, MEK 4/7 activates JNKs, MEK 3/6 activates p38s and 
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MEK5 activates ERK5 (Fig. 1B) (Pearson et al., 2001b; Widmann et al., 1999).  This 
remarkable feature of the MAPK cascade organization prohibits cross-signaling on the 
level of MAPK kinases, thereby contributing to selective activation of a particular 
MAPK.  It is well established that MAPK needs to be phosphorylated at both tyrosine 
and threonine residues within the TEY activation loop for its full activation (Payne et al., 
1991).  This phosphorylation is exerted by MEKs, dual specific kinases, which 
phosphorylate hydroxyl side chains of serine/threonine and tyrosine residues (Nakielny et 
al., 1992; Zheng and Guan, 1993).  Interestingly, this dual phosphorylation of MAPK is 
exerted in two phases (Ferrell and Bhatt, 1997) and, thus, serves as a threshold 
mechanism in activation of MAPK signaling (Ferrell, 1999).   
The specificity of MAPK signaling regulation on the level of MEK kinases 
appears to be much more complex.  There is a vast variety of MEK kinases, which are 
defined as enzymes that catalyze transfer of phosphate from ATP to hydroxyl side-chains 
of serine and threonine residues within MEK’s activation segment, inducing their 
activation (Zheng and Guan, 1994).  Cumulative evidence demonstrates that some MEK 
kinases can activate more than one MEK as well as a certain MEK/MAPK cascade can 
respond to more that one MEK kinase (Fanger et al., 1997; Widmann et al., 1999; Xia et 
al., 2000; Yujiri et al., 1998) (Fig. 1B).  Therefore, it is thought that MEK kinases create 
a signaling network that allows diversity of signaling inputs to trigger specific MAPK 
pathways (Widmann et al., 1999).   
In summary, the MAPK pathway represents an evolutionary conserved signaling 
module implicated in the regulation of a variety of cellular processes.  The core module 
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of the MAPK pathway consists of three kinases (MEK kinase, MEK and MAPK) that are 
sequentially activated via phosphorylation.  The MAPK family is divided into four 
subfamilies, which are distinctly regulated and serve distinctive functions.  Several 
intramodular layers of biochemical regulation ensure signaling specificity of MAPK 
pathways.  These include selectivity of the MAPK-substrate reaction, activation of 
MAPK by a specific MEK and the capacity of the MAPK pathways to be linked to 
diversity of up-stream signals via a variety of MEK kinases. 
 
ERK1/2 cascade and mitosis 
 
ERK1/2 signaling has traditionally been implicated in the regulation of cell cycle 
initiation and G1/S transition following mitogenic stimulation (Kolch, 2000; Pearson et 
al., 2001b).  However, evidence from different experimental systems demonstrates that 
the ERK1/2 pathway is an important regulator of the later stage of the cell cycle, mitosis.  
It is proposed that the ERK1/2 cascade regulates G2/M transition, formation of the 
mitotic spindle, the mitotic spindle checkpoint, exit from mitosis, Golgi fragmentation 
and the duration of mitosis (Fig. 2).   
The first evidence implicating ERK1/2 in M-phase came from studies in Xenopus 
egg extracts.  It has been shown that activation of the Xenopus homologue of ERK2, p42 
MAPK, occurs during M-phase of the cell cycle (Gotoh et al., 1991a; Gotoh et al., 1991b; 
Minshull et al., 1994; Takenaka et al., 1997).  Later works have demonstrated that the  
 
  
Spindle 
Assembly 
Metaphase  
Checkpoint  
 
 
 
 
 
 
 
 
 
 
 
G2 
Golgi Fragmentation
ERK1/2 at 
Midbody Centrosomes 
regulates 
localizes to  
Mitotic
Onset
Anaphase/ Telophase Metaphase 
G1
Prometaphase
Cytokinesis 
Spindle poles, 
kinetochores 
Spindle poles, 
midzone 
 Figure 2.  ERK1/2 functions and localization during mitosis ERK activity is necessary for proper spindle formation, metaphase/anaphase transition and overall mitotic timing.  
Localization of active (phosphorylated) MAPK to mitotic structures is shown schematically in red.  Note that localization of 
monophospho-Y-ERK to Golgi is not shown.    
 
 
14
 
 
15
ERK1/2 cascade is activated as well during mitosis in somatic cells (Harding et al., 2003; 
Roberts et al., 2002; Shapiro et al., 1998; Willard and Crouch, 2001; Zecevic et al., 
1998).   
Functional studies in somatic cell systems provided evidence that ERK1/2 
signaling is important for proper transition to mitosis.  Three different experimental 
settings have been used to study mitotic entry under the MEK/ERK1/2 loss-of-function 
conditions.  Specifically, it was shown that expression of dominant-negative MEK 
(Wright et al., 1999), treatment of synchronized cell populations with PD98059 or 
U0126, MEK specific inhibitors, (Roberts et al., 2002; Wright et al., 1999) and depletion 
of MEK1/2 or ERK1/2 from synchronized cells by RNA interference (RNAi) technique 
(Liu et al., 2004) induced a G2/M arrest (Liu et al., 2004; Roberts et al., 2002; Wright et 
al., 1999), delayed and reduced activation of Cdk1/cyclin B (Liu et al., 2004; Wright et 
al., 1999), decreased nuclear translocation of cyclin B (Roberts et al., 2002), decreased 
reactivity with MPM-2 antibodies that recognize non-specific mitotic phosphoproteins 
(Wright et al., 1999) and reduced phosphorylation of histone H3 (Liu et al., 2004; 
Roberts et al., 2002).  Thus, it was proposed that MEK/ERK signaling is important for 
Cdk1 activation and mitotic initiation.  
Contrary to this, studies in Xenopus egg extracts showed that activation of 
Cdk1/cyclin B is not affected in p42 MAPK depleted extracts (Guadagno and Ferrell, 
1998; Takenaka et al., 1997).  Furthermore, constitutive activation of p42 MAPK in 
Xenopus egg extracts prior to mitosis inhibits Cdk1/cyclin B and delays M-phase onset 
(Bitangcol et al., 1998; Walter et al., 1997).  Additionally, it was demonstrated that p42 
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MAPK can directly phosphorylate and activate Wee1, a kinase that inactivates 
Cdk1/cyclin B (Walter et al., 2000).  Thus, involvement of ERK1/2 in regulation of 
Cdk1/cyclin B activity and mitotic onset remains disputable.    
Early works have characterized ERK1/2 as a potential regulator of cytoskeleton 
functions.  It was shown that active ERK1/2 phosphorylates components of the 
cytoskeleton (Hoshi et al., 1992; Ray and Sturgill, 1987; Verlhac et al., 1993) and largely 
associates with microtubule cytoskeleton in vivo (Reszka et al., 1995).  Functional studies 
demonstrated that an increase in microtubule dynamics, typical for M-phase, depends on 
the presence of active ERK1/2.  Specifically, it was shown that introduction of active p42 
MAPK from M-phase to S-phase Xenopus egg extracts dramatically increases tubulin de-
polymerization (Gotoh et al., 1991b).  Consistently, the abrogation of p42 MAPK 
signaling in M-phase extracts via inhibition of MEK, immunodepletion of MEK or p42 
MAPK dramatically decreases tubulin de-polymerization (Guadagno and Ferrell, 1998; 
Horne and Guadagno, 2003). 
Fluorescent studies further supported implication of ERK signaling in the 
regulation of the mitotic apparatus.  In 3T3 and Ptk1 cells, it was shown that active forms 
of ERK1/2 and MEK localize to the kinetochores from early prometaphase through mid-
anaphase, to the spindle and spindle poles throughout mitosis, and the midbody during 
anaphase (Shapiro et al., 1998; Willard and Crouch, 2001; Zecevic et al., 1998) (Fig. 2).  
A similar pattern of intracellular p42 MAPK distribution was observed on mitotic 
spindles formed in Xenopus egg extracts (Horne and Guadagno, 2003) as well as in 
fertilized sea urchin eggs (Zhang et al., 2005).   
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The involvement of ERK1/2 signaling in formation of the mitotic spindle was 
directly shown by loss-of-function studies.  Specifically, it was demonstrated that 
immunodepleting of p42 MAPK or blocking its activation during mitosis with a MEK 
inhibitor, U0126, induces abnormal spindle formations in mitotic Xenopus egg extracts 
and compromises stability of already formed spindles (Horne and Guadagno, 2003).  
Further, abrogation of mitotic spindle formation was observed as well in somatic cells 
pre-treated with U0126 at the late G2 (Horne and Guadagno, 2003).  Recently, an altered 
formation of mitotic spindles and chromosome attachment was reported as well in sea 
urchin fertilized eggs treated with dominant-negative MEK 1/2 or U0126 (Zhang et al., 
2005).   
It was suggested that one of the substrates through which p42 MAPK may exert 
its spindle formation function is a kinetochore motor protein CENP-E (Zecevic et al., 
1998).  CENP-E is essential for bi-polar attachment of chromosome to microtubules (Yao 
et al., 1997).  During mitosis p42 MAPK directly associates with and phosphorylates 
CENP-E at sites important for its association with microtubules (Zecevic et al., 1998).   
More than a decade ago it was shown that an injection of thiophosphorylated 
ERK1/2 (Haccard et al., 1995) or c-Mos (Sagata et al., 1989) into Xenopus embryos 
induces metaphase arrest.  Further, the addition of constitutively active MEK (Takenaka 
et al., 1997) or c-Mos (Chau and Shibuya, 1998; Guadagno and Ferrell, 1998) into 
mitotic Xenopus egg extracts maintains an M-phase-like state even following cyclin B 
degradation and inactivation of Cdk1/cyclin B.  Consistently, blocking mitotic p42 
MAPK activation by MEK immunodepletion or MEK inhibition shortens the duration of 
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M-phase in cycling Xenopus egg extracts (Guadagno and Ferrell, 1998).  Thus, ERK1/2 
signaling can induce a state similar to mitotic arrest and control the timing of mitosis. 
Xenopus egg extracts have been utilized to address the involvement of p42 MAPK 
in the mitotic checkpoint.  Two different experimental settings e used to mimic the 
mitotic spindle arrest.  First, Xenopus egg extracts were supplemented with high 
concentrations of sperm nuclei and treated with nocodazole (Minshull et al., 1994).  
Second, UV-irradiated nuclei were added to extracts, which then were driven into mitosis 
by the addition of constitutively active Cdc25C phosphatase (Chau and Shibuya, 1999).  
These manipulations arrested extracts in an M-phase like state with high levels of 
Cdk1/cyclin B and ERK1/2 activities.  Importantly, in both experimental systems p42 
MAPK activity was critical for the maintenance of the mitotic arrest, which was 
confirmed by MAPK immunoprecipitation, treatment with a MAPK specific phosphatase 
(MKP1) (Minshull et al., 1994) and treatment with a MEK inhibitor, PD98059 (Chau and 
Shibuya, 1999). 
Another study, which linked ERK1/2 to mitotic arrest functions, was a genetics 
analysis of Drosophila’s rolled/MAPK gene (Inoue and Glover, 1998), which showed 
that loss-of-function mutations of this gene abrogate the mitotic arrest upon treatment 
with colchicine (an inhibitor of microtubule polymerization). 
It was proposed that ERK1/2 may exert its spindle checkpoint function via 
regulation of Cdc20, an activator of APC (Visintin et al., 1997) and a component of the 
anaphase-inhibitory protein complexes (Chan and Yen, 2003; Hardwick, 2005; Yu, 
2002).  It was shown that during mitotic arrest in Xenopus egg extracts ERK1/2 directly 
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phosphorylates Cdc20 at Thr-64 and Thr-68 residues (Chung and Chen, 2003).  A Cdc20 
mutant non-phosphorylatable at these (and two other) phosphorylation sites malfunctions 
during induction of the mitotic arrest: it does not form complexes with BubR1 and Mad2 
and causes a decline in Cdk1 activity under the mitotic spindle checkpoint conditions.  
The same phenotype was observed when ERK1/2 activity was blocked with MEK 
inhibitors, U0126 or PD98059, which further links these Cdc20 functions to ERK1/2 
signaling (Chung and Chen, 2003).   
Regulation of Golgi fragmentation is another function of ERK signaling during 
mitosis.  It was shown that phosphorylated MEK associates with membrane fractions in 
mitotic cells (Harding et al., 2003), localizes to Golgi during prophase (Colanzi et al., 
2003) and is necessary for Golgi disassembly (Acharya et al., 1998).  Further, a Golgi 
reassembly stacking protein of 55 kDa (GRASP55) was reported to be one possible in 
vivo target of the MEK/ERK pathway during mitosis (Jesch et al., 2001).  Interestingly, 
further studies revealed that a non-traditional ERK cascade regulates Golgi fragmentation 
during mitosis.  First, it was shown that MEK1, associated with membranes during 
mitosis, undergoes a Cdk1/cyclin B dependent cleavage (Harding et al., 2003), which 
blocks its interaction with full-length ERK (Harding et al., 2003).  Subsequent studies 
showed that a novel alternatively spliced variant of ERK1, ERK1c, is involved in the 
regulation of Golgi fragmentation during mitosis (Aebersold et al., 2004; Shaul and 
Seger, 2006).  ERK1c is regulated in an M-phase dependent manner, undergoes a 
preferential mono-tyrosine phosphorylation within the TEY activation loop and localizes 
to Golgi during early stages of mitosis (Shaul and Seger, 2006).  Two speculations can be 
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made based on these studies. First, the mechanisms of ERK1/2 pathway activation during 
mitosis may be different from those during cell cycle entry.  Second, activation of 
different functional pools of mitotic ERK may be regulated differentially.  
In summary, ERK1/2 signaling displays a variety of roles in mitotic regulation.  It 
is involved in the control of the G2/M transition, spindle formation, the mitotic 
checkpoint as well as Golgi fragmentation.  Therefore, disruption of ERK1/2 functions 
during mitosis can impair the mitotic regulation at different levels and compromise the 
fidelity and/or order of mitotic events.  Indeed, the constitutive activation of ERK1/2 
signaling in v-mos or v-ras infected 3T3 fibroblasts provokes genomic instability via 
disregulation of mitosis (Fukasawa and Vande Woude, 1997; Saavedra et al., 1999).  
Further, it is proposed that the high incidence of cancer in patients with hereditary 
tyrosinemia type I (Weinberg et al., 1976) and hepatitis B (Margolis et al., 1991) might 
be a result of genomic instability caused by non-controlled ERK1/2 activation at mitosis 
(Jorquera and Tanguay, 2001; Yun et al., 2004). 
Therefore, deciphering functions and regulation of the ERK1/2 pathway during 
mitosis is important for generation of a comprehensive vision of its role throughout the 
cell cycle.  It will also contribute to understanding biochemical mechanisms underlying 
pathologies, which is necessary for future development of efficient medical diagnostics 
and treatment approaches. 
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Regulation of ERK1/2 signaling by MEK kinases 
 
MEK kinases represent a key regulatory level in the MAPK module, where many 
different stimuli can converge to allow specific activation of a certain MEK/MAPK 
pathway (Fanger et al., 1997; Widmann et al., 1999; Xia et al., 2000; Yujiri et al., 1998), 
2000).  Consistent with this, activation of the MEK/ERK1/2 pathway under different 
cellular circumstances is regulated by different MEK kinases.  Indeed, the ERK1/2 
signaling during cell cycle entry and meiosis is activated by Raf-1 and c-Mos, 
respectively. 
The cell cycle initiation is triggered by engagement of extracellular growth 
receptors and their oligomerization (Yarden and Schlessinger, 1987).  This, in turn, 
stimulates conversion of a small GTP-ase protein Ras from an inactive GDP-bound to an 
active GTP-bound form (Kolch, 2000; Pearson et al., 2001b).  Ras-GTP mediates 
membrane translocation and activation of Raf-1, a classical MEK kinase that triggers the 
MEK/ERK/1/2 cascade during the G0-G1-S transition.  Activated MAPK directly 
phosphorylates cytoplasmic and cytoskeletal substrates or translocates into the nucleus to 
modulate transcription factors, which together promote progression into S-phase (Kolch, 
2000; Pearson et al., 2001b). 
Mechanism of ERK activation and its functions are strikingly different during 
meiosis.  It is well established that hormonal stimulation triggers oocyte maturation, at 
least partially, via induction of synthesis of c-Mos, a MEK kinase that activates the 
MEK/ERK pathway during meiosis (Castro et al., 2001).  With slight variations among 
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species, activated ERK during meiosis is involved in activation of MPF (Cdk1/cyclin B), 
maintenance of MPF activity between MI and MII of meiosis and, finally, in induction of 
the CSF (cytostatic factor) arrest of mature oocytes (Castro et al., 2001).  Thus, activation 
of the ERK pathway by different MEK kinases may condition specificity of its cellular 
functions. 
The underlying biochemical mechanisms that control activation of the MEK/ERK 
cascade during mitosis are poorly understood.  It is unclear whether Raf-1 is involved in 
the regulation of the ERK pathway during mitosis.  It was shown that Raf-1 undergoes 
hyperphosphorylation and activation in cells arrested at mitosis with nocodazole 
treatment (Laird et al., 1995; Pathan et al., 1996; Ziogas et al., 1998).  Interestingly, this 
phosphorylation and activation of Raf-1 is thought to be directly regulated by Src and 
occur in a Ras-independent (Ziogas et al., 1998), but Rac/Cdc42/Pak-dependent manner 
(Zang et al., 2001).  However, activation of Raf-1 at mitosis does not correlate with 
activation of the MEK/ERK cascade (Laird et al., 1999; Ziogas et al., 1998).  
Furthermore, none of the published works provide conclusive evidence for mitotic 
activation of Raf-1 in naturally cycling somatic cells.  As well, it has not been clearly 
demonstrated that Raf-1 in mitotic cells is linked to some of MAPK’s mitotic functions.  
A study by Yue and Ferrell detected small amounts of germ-cell specific MEK kinase, c-
Mos, in Xenopus egg extracts and provided evidence that c-Mos was important for 
activating the p42 MAPK pathway at mitosis (Yue and Ferrell, 2004).  However, earlier 
studies show that c-Mos is efficiently degraded following egg fertilization (Nishizawa et 
al., 1993; Watanabe et al., 1991; Watanabe et al., 1989) and its expression is repressed in 
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somatic tissues (Xu and Cooper, 1995; Zinkel et al., 1992).  Therefore, the involvement 
of Raf-1 and c-Mos in mitotic MAPK signaling is speculative and perhaps another MEK 
kinase is required for activation of the MAPK pathway at mitosis.   
In conclusion, a variety of MEK kinases allows activation of the MAPK pathways 
by different stimuli.  It is established that Raf-1 triggers activation of ERK1/2 signaling 
following mitogenic stimulation, whereas c-Mos activates the p42 MAPK cascade during 
meiosis.  Circumstantial evidence indicates that neither Raf-1 nor c-Mos are involved in 
the regulation of the ERK cascade during mitosis.  Thus, the identity of the mitotic MEK 
kinase remains elusive.   
 
Functions and structural organization of Raf family members 
 
Rafs are serine/threonine kinases, which are broadly implicated in regulation of 
many basic cellular processes, such as cell growth, proliferation, survival, differentiation 
and migration (Chong et al., 2001; Chong et al., 2003; Pearson et al., 2001b).  In 
mammals, the family of Raf kinases is comprised of three members, Raf-1 (Kan et al., 
1984; Rapp et al., 1983), A-Raf (Huleihel et al., 1986) and B-Raf (Calogeraki et al., 
1993; Eychene et al., 1992), which are characterized by a substantial degree of homology 
and some overlapping functions.   
Biochemical analyses demonstrate that the vast majority of intracellular Raf 
functions are exerted via MAPK signaling.  Raf regulates cell growth and proliferation 
through MEK/ERK dependent promotion of the cell cycle progression (Roovers and 
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Assoian, 2000).  It is demonstrated that at the G0/G1 border of the cell cycle the 
Raf/MEK/ERK pathway is involved in down-regulation of Cdk inhibitor p27, 
transcriptional up-regulation of cyclin D and other events that favor activation of the 
cyclin-dependent cell cycle machinery (Kerkhoff and Rapp, 1998).  The cell survival 
functions of Rafs are exerted via the MEK/ERK-mediated activation of anti-apoptotic 
kinase Akt (von Gise et al., 2001), transcriptional repression of pro-apoptotic BH3-only 
members of the Bcl2 family (for instance, Bim) (Weston et al., 2003) and up-regulation 
of IAPs (Wiese et al., 2001).  The longevity of the intracellular ERK signaling 
conditioned by kinetics of Raf activation determines the proliferation/differentiation 
decision of a cell (Brummer et al., 2002; York et al., 1998).  It is proposed that prolonged 
ERK activation, directed by B-Raf, induces cell differentiation, whereas transient ERK 
activation via Raf-1 causes their proliferation (York et al., 1998).  Raf family members as 
well are implicated in the regulation of cytoskeleton rearrangements necessary for cell 
migration, which is critical for embryogenesis, wound healing, angiogenesis, immune 
functions and tumor metastasis (Ehrenreiter et al., 2005; Pritchard et al., 2004).  
Analysis of Raf functions on an organismal level demonstrated that members of 
the Raf family are critical for life.  Indeed, A-Raf knockout mice display intestinal and 
neurological abnormalities, which can lead to postnatal death or survival with severe 
neurological defects (Wojnowski et al., 1998).  Complete Raf-1 knockout mice display 
serious embryonic aberrations: growth retardation, placenta anomalies and under-
development of the liver due to massive apoptosis of hepatocytes.  These mice die at 
midgestation (Mikula et al., 2001).  B-Raf-deficient mouse embryos are characterized by 
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massive apoptosis, causing aberrant vasculature development and vascular hemorrhage.  
These mice as well die at midgestation (Wojnowski et al., 2000; Wojnowski et al., 1997).   
All three members of the Raf kinase family, Raf-1, B-Raf, and A-Raf, share a 
common architecture of domain organization.  They all contain three large conserved 
regions: CR1, CR2, and CR3, and are functionally divided into the N-terminal regulatory 
domain and the C-terminal catalytic domain (Fig. 3) (Daum et al., 1994; Morrison and 
Cutler, 1997).  CR1 and CR2 conserved regions are located in the N-terminal regulatory 
portion of Raf protein, whereas CR3 houses the C-terminal kinase domain.  The N-
terminal CR1 and CR2 conserved regions within the regulatory domain harbor protein 
binding and regulatory phosphorylation sites.  Specifically, CR1 contains a Ras binding 
domain (RBD) and a cysteine rich domain (CRD).  These sites are critical for Raf 
interaction with up-stream regulators: small GTP-ases, such as Ras and Rap1 (Chuang et 
al., 1994) (Fig. 3).  The CR2 region contains a phosphorylation site, which is involved in 
negative regulation of Raf activity (Guan et al., 2000; Morrison et al., 1993; 
Zimmermann and Moelling, 1999) and represents a 14-3-3 binding phospho-epitope 
(Michaud et al., 1995) (Fig. 3).  The kinase domain within the C-terminal conserved CR3 
portion of Raf protein harbors two important phosphorylation regulatory sites: the N-
region (Fabian et al., 1993; King et al., 1998; Mason et al., 1999) and activation loop 
(Chong et al., 2001; Zhang and Guan, 2000) (Fig. 3).  Analogous to other kinases, it is 
thought that the phosphorylation within the activation loop of Raf induces conformational 
changes, which favor interaction of the ATP binding site with ATP (Huse and Kuriyan, 
2002; Johnson and Lewis, 2001).  Interestingly, unlike other Raf family members,  
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Figure 3.  Domain organization of Raf family members 
All members of the Raf family possess three conserved regions – CR1 and CR2, which comprise an N-terminal regulatory 
domain, and CR3, which comprises the catalytic domain.  Note that B-Raf, unlike other members of the family, contains 
as well a unique N-terminal domain (shown in shaded box). 
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B-Raf contains a unique N-terminal domain, which may be involved in B-Raf specific 
regulation or functions (Fig. 3) (Kalmes et al., 1998).   
In conclusion, Raf kinases are broadly implicated in a variety of cellular processes 
and are critical for proper organismal development and function.  Members of the Raf 
kinase family share a significant sequence homology and a similar functional domain 
organization, with some exceptions for B-Raf.   
 
Regulation of B-Raf activity by phosphorylation and protein-protein interactions 
 
It is traditionally assumed that all members of Raf family are regulated by similar 
mechanisms.  Indeed, all three Rafs have the same basic functional organization: N-
terminal regulatory domain and the N-region and activation loop in the C-terminal kinase 
domain.  It is believed that in an inactive state the N-terminal regulatory domain of Raf 
directly binds to the C-terminal kinase domain, blocking its accessibility (Heidecker et 
al., 1990).  Thus, activation of Raf can be interpreted as “opening” of Raf’s tertiary 
structure by disrupting association between the N-terminal and C-terminal domains 
(Kolch, 2000).  This is achieved by a series of coordinated regulatory phosphorylation 
and protein-protein association events.  It is proposed that active GTP-bound Ras directly 
binds to the RBD and CRD within CR1 region (Fig. 3) (Chuang et al., 1994; Morrison 
and Cutler, 1997; Nassar et al., 1995; Okada et al., 1999; Vojtek et al., 1993) and 
provokes Raf’s translocation to the plasma membrane  and removal of the inhibitory 
dephosphorylation from the CR2 (Jaumot and Hancock, 2001; Kubicek et al., 2002; 
 
 
28
Mitsuhashi et al., 2003).  These predispose Raf for positive regulatory phosphorylations 
at the catalytic domain, which finally induce the open active conformation.   
Despite the over-all similarities in regulation of Raf-1 and B-Raf activation, the 
accumulated evidence indicates that regulatory mechanisms involved in activation of 
Raf-1 and B-Raf differ in many important aspects.  First, Raf-1 and B-Raf require a 
different “dose” of the regulatory phosphorylation to achieve full activation.  Indeed, 
following Ras-mediated stimulation, activation of Raf-1 occurs as a two-set 
phosphorylation (Marais et al., 1997).  This includes Ras and Src dependent 
phosphorylation of Ser-338 and Tyr-341 residues in the N-region (Diaz et al., 1997; 
Fabian et al., 1993; Marais et al., 1995; Mason et al., 1999) and Ras dependent 
phosphorylation of Thr-491 and Ser-494 residues in the activation loop (Fig. 3) (Chong et 
al., 2003).  In contrast to this, B-Raf does not undergo regulation in the N-region: its Ser-
445 residue is constitutively phosphorylated (Mason et al., 1999) and the residue 
corresponding to Raf-1’s Tyr-341 is a phospho-mimicking Asp-448 residue (Fig. 4).  
Hence, Ras-mediated activation of B-Raf requires only phosphorylation at The-599 and 
Ser-602 residues within the activation loop (Fig. 4) (Zhang and Guan, 2000).  It is 
proposed that the constitutive presence of the negative charge in the N-region of B-Raf 
inhibits intramolecular association between the regulatory and catalytic domains(Tran et 
al., 2005), which explains the higher basal level activity of B-Raf compared to Raf-1 
(Marais et al., 1997).   
 
 
  
 
 
P PP P P P P
S750
T753
S428 
T439 
S445
D448  T599S602  S364
P 
C N 
 CR1 2 3CRCR
 
 
 
 
Figure 4.  Phosphorylation in regulation of B-Raf activity 
Activity of Human B-Raf is regulated both positively and negatively via phosphorylation.  Positive regulation by 
phosphorylation includes: 1) constitutive phosphorylation at the N-region (constitutively phosphorylated Serine-
445 and phosphorylation-mimicking Aspartic acid-448); and 2) Ras-dependent phosphorylation at the activation 
loop (Threonine-599 and Serine-602 residues).  Both regulatory units are located within the C-terminal CR3 
(catalytic) domain of B-Raf (shown in yellow).  Phosphorylation at Serine-364, Serine-428 and Threonine-439 
residues negatively regulates B-Raf and is executed by Akt.  B-Raf is also phosphorylated by ERK at the C-
terminal Serine-750 and Threonine-753 residues, but the effect of this phosphorylation on B-Raf activity is 
unknown. 
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Both B-Raf and Raf-1 undergo an inhibitory phosphorylation by Akt.  However, 
Akt targets B-Raf at three residues (Ser-364, Ser-428 and Thr-439) (Chong et al., 2001; 
Guan et al., 2000) (Fig. 4), whereas Raf-1 at only one site (Zimmermann and Moelling, 
1999).  Interestingly, one of Akt’s phosphorylation sites in B-Raf, the Ser-364 residue, 
can as well be phosphorylated by SGK, a serum and glucocorticoid inducible kinase, 
which demonstrates homology to Akt (Zhang et al., 2001).   
Recent work demonstrated that human B-Raf undergoes a feedback 
phosphorylation by ERK at Ser-750 and Thr-753 residues unique to B-Rafs C-terminal 
(Brummer et al., 2003) (Fig. 4).  The effect of this phosphorylation on B-Raf activity was 
not determined.  However, it is suggested that phosphorylation of B-Raf’s C-terminus 
may negatively affect B-Raf functions, such as cell differentiation (Brummer et al., 2003; 
Rushworth et al., 2006).   
B-Raf activity is regulated as well on the level of protein-protein interactions.  
Several B-Raf’s interactors have been identified (Fig. 5), which can be classified in two 
groups.  The first group comprises associations with the signaling and structural 
components of the MAPK module.  These include B-Raf’s direct associations with its up-
stream activators, small GTP-ases, and down-stream target, MEK, association of B-Raf 
with other components of MAPK cascade via scaffolding proteins and formation of B-
Raf/Raf-1 heterodimers.  The second group of B-Raf’s protein partners includes non-
enzymatic proteins outside of the MAPK cascade module, such as 14-3-3 protein and 
chaperone protein HSP90. 
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Figure 5.  Known partners of B-Raf protein complexes 
Proteins known to interact with B-Raf are shown and their molecular weights are 
indicated. 
 
As mentioned above, B-Raf and Raf-1 directly associate with GTP-ases Ras and 
Rap1 (Berruti, 2000; Houslay and Kolch, 2000; Papin et al., 1996; Vossler et al., 1997; 
Yamamori et al., 1995; York et al., 1998).  Interestingly, B-Raf and Raf-1 differ in their 
response to up-stream regulation by Rap1.  Notably, Rap1 activates B-Raf and B-Raf-
dependent activation of MAPK, but inhibits the Raf-1/MEK/ERK cascade (Bos et al., 
2001; Houslay and Kolch, 2000; York et al., 1998).   
B-Raf directly associates with MEK (Papin et al., 1996; Papin et al., 1995) and is 
characterized by a higher affinity to it than Raf-1 (Papin et al., 1998), which can explain 
the fact that B-Raf is a much stronger activator of MEK, compared to Raf-1 or A-Raf 
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(Mason et al., 1999; Zhang and Guan, 2000).  Interestingly, B-Raf undergoes a unique 
mode of additional regulation, alternative splicing (Barnier et al., 1995), which can 
modulate affinity of different B-Raf isoforms toward MEK (Papin et al., 1998). 
The concept of integration of all components the MAPK signaling pathway within 
one functional unit was developed through studying mating and osmosensor pathways in 
budding yeast (Faux and Scott, 1996).  Metazoan scaffolding proteins were identified by 
genetic screens in Drosophila and C.elegans.  They include KSR (kinase suppressor of 
Ras), Soc-2 (suppressor of clear homolog) and CNK (connector enhancer of KSR).  All 
of these proteins serve a structural framework for efficient interaction of Raf, MEK and 
ERK.  To accomplish this they have to fulfill three criteria: 1) accommodate 
simultaneous interaction with all components of the MAPK module (Cacace et al., 1999; 
Stewart et al., 1999); 2) facilitate activation within the module (Li et al., 2000; Roy et al., 
2002) and 3) may not possess any kinase activity (Cacace et al., 1999; Morrison, 2001; 
Stewart et al., 1999; Yu et al., 1998).  It is assumed that B-Raf signaling, like Raf-1’s, is 
facilitated by scaffolding proteins. 
Early work showed that a forced Raf oligomerization induces Ras dependent Raf 
activation (Luo et al., 1996).  Furthermore, B-Raf was purified as a component of a Ras-
dependent activator of Raf-1 (Mizutani et al., 1998).  Thus, mutual association and 
regulation among Raf members was suggested.  A more recent study directly showed that 
endogenous Raf-1 and B-Raf form heterodimers in response to Ras stimulation (Weber et 
al., 2001).  Biological significance of this interaction is not fully understood.  However, it 
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was shown that B-Raf/Raf-1 heterodimers possess a higher activity than corresponding 
monodimers (Rushworth et al., 2006).   
14-3-3 protein is important for regulation of B-Raf activity (Kolch, 2000).  
Phosphorylation of B-Raf at Ser-364 residue creates a 14-3-3 binding motif, which 
analogously to Raf-1, may be necessary for locking B-Raf in an inactive conformation 
(Morrison and Cutler, 1997).  Additionally, it is proposed that 14-3-3 protein contributes 
to activation of B-Raf signaling at least by facilitating B-Raf heterodimerization with 
Raf-1 (Garnett et al., 2005; Rushworth et al., 2006).   
B-Raf has been shown to associate with heat-shock protein 90 (HSP90) 
(Grammatikakis et al., 1999; Jaiswal et al., 1996).  It is accepted that association of 
HSP90 with B-Raf maintains B-Raf’s proper folding and functionality (Cissel and 
Beaven, 2000; Schulte et al., 1995). 
In summary, regulation of B-Raf activation and function is exerted via controlled 
coordination of B-Raf phosphorylation and its association with regulatory, structural and 
effector proteins.  Similar to other members of the Raf kinase family, activation of B-Raf 
involves unfolding of its inactive conformation.  However, B-Raf stands apart due to 
several unique regulatory features.  Unlike Raf-1, B-Raf is constitutively phosphorylated 
within the regulatory N-region, can respond differentially to an up-stream signaling by 
GTP-ases and can undergo alternative splicing, which may regulate B-Raf’s affinity 
toward MEK.  B-Raf’s association with other proteins significantly contributes to 
regulation of its activity and functions.  The most well studied interactions include: 
association with Ras and 14-3-3, formation of Raf/MEK/ERK signalosomes via 
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scaffolding proteins, B-Raf/Raf-1 heterodimerization, and stabilization of B-Raf 
molecules by association with chaperone HSP90.   
 
B-Raf as an oncogene 
 
Members of Raf kinase family were identified as proto-oncogenes (Jansen et al., 
1984; Sutrave et al., 1984).  However, extensive studies of Raf-1 mutations did not 
provide strong evidence for Raf-1 being involved in tumorogenesis.  This situation was 
drastically changed in 2002 when B-Raf was claimed to be a potential cause of a 
significant proportion of human cancers (Davies et al., 2002).  This key study, which 
performed a wide-range genomic screening of human tumors, demonstrated that B-Raf is 
mutated in 8% of all human tumors, including nearly 70% of melanomas, 14% of ovarian 
cancers, 14% of liver cancers and 12% of colorectal tumors (Davies et al., 2002).  All of 
the detected B-Raf mutations were within its kinase domain.  Interestingly, the 
overwhelming proportion of these mutations was represented by a single amino acid 
substitution: Val-600-Glu (B-RafV600E).  It accounted for 80% of all mutations and for 
more than 90% mutations in melanomas (Davies et al., 2002).  As described in the 
previous section, phosphorylation of the residues Thr-599 and Ser-602 flanking the 
mutated site is critical for full activation of B-Raf (Zhang and Guan, 2000).  Therefore, it 
is not surprising that the phospho-mimicking Val-600-Glu mutation in the activation loop 
dramatically increases B-Raf’s activity (Davies et al., 2002).  B-RafV600E induces 
transformation of NIH3T3 cells and cultured melanocytes via over-activation of the 
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MEK/ERK pathway (Davies et al., 2002; Wellbrock et al., 2004) and tumorigenicity in 
nude mice (Wellbrock et al., 2004).  Further, treatment of melanoma cell lines harboring 
B-RafV600E with Raf specific inhibitor BAY 43-9006 induces cell cycle arrest or apoptosis 
(Sharma et al., 2005).   
Since the B-RafV600E mutant displays all of major features of an oncogene and is 
expressed in a substantial percentage of melanomas, extensive studies focused on 
elucidating how it may be involved in the oncogenicity of melanoma.  The accumulated 
evidence suggests that mutation of B-Raf occurs during the early benign stages of 
melanocyte dysplasia (nevi formation) and the B-Raf mutation must be combined with 
other genetic abnormalities to become malignant.  Indeed, B-RafV600E mutation was 
detected in more than 80% of nevi, which can remain quiescent for decades without 
progressing into malignancy (Michaloglou et al., 2005).  Expression of B-RafV600E mutant 
in human melanocytes resulted in their senescence-like arrest (Michaloglou et al., 2005) 
or in formation of non-malignant nevi in transgenic animals (Patton et al., 2005).  
Importantly, transgenic zebrafish carrying the oncogenic B-Raf on a p53 deficient 
background progressively developed invasive melanomas (Patton et al., 2005).   
In conclusion, B-Raf has recently been recognized as a cellular oncogene.  Its 
most frequently mutated version, B-RafV600E, is expressed in a large proportion of human 
cancers, ranking the highest in melanomas.  This B-Raf mutant displays all the hallmarks 
of a classical oncogene: it possesses a greatly elevated kinase activity, promotes 
constitutive non-controllable ERK signaling, induces transformation of cultured cell lines 
and is required for survival of these tumors.  It is proposed that B-Raf mutation occurs at 
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the early stages of cellular dysplasia and can provoke tumorigenesis in combination with 
other mutations.  Identification of B-Raf as a critical oncogene highlights the importance 
of research focused on the elucidation of B-Raf regulatory mechanisms and B-Raf 
functions. 
 
Studying MAPK signaling in the cell-free system of Xenopus egg extracts 
 
Since the introduction of amphibian egg extracts as a research tool (Lohka and 
Masui, 1983), they have been shown to faithfully mimic many aspects of the cellular cell 
cycle and have been used to study a variety of cell cycle regulated processes.  These 
include DNA replication (Arias and Walter, 2004; Blow and Laskey, 1986; Tutter and 
Walter, 2006), nucleus formation (Chan and Forbes, 2006; Hutchison et al., 1988; Lohka, 
1998), vesicle fusion (Tuomikoski et al., 1989), cytoskeleton rearrangements (Belmont et 
al., 1990; Mandato et al., 2001), mitotic spindle formation and function (Desai et al., 
1999; Horne and Guadagno, 2003; Maresca and Heald, 2006; Tremethick, 1999), 
apoptosis (Deming and Kornbluth, 2006) and oocyte maturation (Crane and Ruderman, 
2006; Ohsumi et al., 2006). 
The main advantage of the cell-free system of Xenopus egg extracts is that it 
permits many technical manipulations not feasible in tissue culture cells.  This greatly 
increases the range of biochemical approaches which can be used for cell cycle analysis.  
Indeed, egg extracts are homogenous and synchronized for cell cycle progression, which 
is not the case for proliferating tissue culture cells.  Importantly, extracts are much more 
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suitable for biochemical fractionation, immunoprecipitation and immunodepletion, and 
morphological analysis of sub-cellular structures. 
The cell-free system of Xenopus egg extracts is a great experimental model for 
studying MAPK signaling.  It has been repeatedly shown that the MAPK cascade is 
activated throughout meiosis in Xenopus oocytes (Abrieu et al., 2001; Gotoh et al., 1995; 
Gotoh et al., 1991a; Gotoh et al., 1991b; Kosako et al., 1994) and during M-phase of the 
subsequent embryonic cycles (Guadagno and Ferrell, 1998; Hartley et al., 1994; 
Takenaka et al., 1997).  This implies that extracts prepared from Xenopus oocytes at 
different maturation stages or after fertilization can recapitulate MAPK signaling under 
different biological contexts, meiosis or mitosis respectively.   
Several standard protocols have been developed in order to prepare Xenopus egg 
extracts that represent MAPK signaling during different stages of meiosis.  Specifically, 
extracts prepared from immature oocytes arrested in prophase I of meiosis are used for 
studying MAPK regulation and functions during the G2/M transition and meiosis (Crane 
and Ruderman, 2006).  Extract preparations derived from fully developed CSF (cytostatic 
factor) arrested Xenopus oocytes (Posada et al., 1993; Sagata et al., 1989) are a valuable 
research tool for studying MAPK signaling involved in meiotic metaphase arrest (Fig. 6) 
(Lohka and Maller, 1985; Nebreda and Hunt, 1993). 
Extracts prepared from activated Xenopus eggs are routinely used for 
recapitulating the early embryonic cell cycles of S- and M-phases.  The transition of a 
Xenopus oocyte to the first mitotic cell cycle is triggered during fertilization by a 
transient increase in intracellular Ca2+ concentration (Cuthbertson and Cobbold, 1985; 
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Lorca et al., 1993).  To reproduce this biochemical trigger, mature Xenopus oocytes are 
parthenogenetically activated in vitro by a brief treatment with Ca2+ ionophore (Fig. 6) 
(Chen et al., 1998) or by subjecting them to a quick electro-shock (Murray, 1991).  Since 
extracts prepared from these eggs recapitulate embryonic cell cycling, which does not 
include G1 and G2 phases, activation of MAPK in cycling extracts is restricted to M-
phase.  Thus, mitotic MAPK activation does not overlap with MAPK activation at the 
G1/S, as it occurs in somatic cells.  Therefore, the cycling Xenopus egg extracts is an 
ideal biochemical model to study regulation of the MAPK cascade at M-phase.   
The synchronous embryonic cell cycling during the early stages of Xenopus 
embryogenesis as well as in Xenopus egg cycling extracts is conditioned primarily by 
oscillation of mitotic cyclin B levels (Murray and Kirschner, 1989a).  Since Xenopus egg 
extracts are very amenable to biochemical manipulations, it is relatively easy to arrest 
them in S- or M-phase.  Specifically, preparation of extracts from parthenogenetically 
activated oocytes in the presence of cycloheximide blocks synthesis of cyclin B and 
arrests them in S-phase (Fig. 6).  Supplementing of these extracts with recombinant non- 
degradable cyclin B (which lacks a ubiquitination D-box) (Glotzer et al., 1991) 
permanently arrests them in M-phase (Fig. 6).  This approach is routinely used to prepare 
unlimited quantities of experimental material synchronously arrested at the S- or M-
phases of the cell cycle. 
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Figure 6. Cell-free system of Xenopus egg extracts 
Mature CSF-arrested oocytes (arrested in the second metaphase of meiosis) are collected and directly processed into 
CSF extracts or parthenogenetically activated with Ca2+ ionophore A23087 prior to processing into S-, M-phase 
arrested or cycling extracts. 
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In summary, the cell-free system of Xenopus egg extracts is a powerful 
experimental model, which surpasses tissue culture cells by the scope of feasible 
biochemical manipulations.  The system is based on the natural ability of Xenopus 
oocytes to autonomously sustain the cell cycling processes.  Many different aspects of 
cell cycling and signal transduction mechanisms can be addressed by using Xenopus egg 
extracts.  Particularly, the cell-free system of Xenopus egg extracts is an optimal 
biochemical model to dissect functions and regulation of the MAPK signaling during 
mitosis. 
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Dissertation statement 
 
The MAPK cascade is an important regulator of the cell cycle (Widmann et al., 
1999).  It is evident that MAPK signaling is implicated in control of at least two stages of 
the somatic cell cycle, namely, G1/S transition (Roovers and Assoian, 2000; Widmann et 
al., 1999) and mitosis (Gotoh et al., 1991b; Guadagno and Ferrell, 1998; Harding et al., 
2003; Minshull et al., 1994; Takenaka et al., 1997; Willard and Crouch, 2001; Zecevic et 
al., 1998).  Regulatory mechanisms and functions of the MAPK pathway during cell 
cycle initiation are well understood and represent a classical dogma of molecular biology 
(Roovers and Assoian, 2000; Widmann et al., 1999).  In contrast, roles for MAPK and its 
activation during mitosis are much less defined.  Nevertheless, data from different 
experimental systems have revealed involvement of MAPK signaling in the regulation of 
a variety of mitotic functions: mitotic onset (Liu et al., 2004; Wright et al., 1999), 
formation of the mitotic spindle (Horne and Guadagno, 2003; Zhang et al., 2005), mitotic 
metaphase arrest (Chau and Shibuya, 1999; Minshull et al., 1994), Golgi fragmentation 
(Aebersold et al., 2004; Shaul and Seger, 2006) and the duration of mitosis (Guadagno 
and Ferrell, 1998; Roberts et al., 2002).  Therefore, to obtain a comprehensive 
understanding of how MAPK signaling is integrated into the cell cycle regulatory 
network, it is critical to decipher the mechanism of MAPK activation during mitosis.  
Furthermore, understanding how MAPK is controlled during mitosis may shed light on 
the biochemical mechanisms behind some pathological states, such as cancer.  Indeed, 
the MAPK pathway is constitutively activated in over 30% of human cancers (Hoshino et 
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al., 1999).  Based on the fact that MAPK plays a variety of roles throughout mitosis, it is 
plausible to suggest that disregulation of mitotic functions of the MAPK pathway may 
cause genomic instability and provoke tumorogenesis.   
The activation of the MAPK cascade under certain biological contexts is 
conditioned by specific activation of particular MEK kinases (Fanger et al., 1997; 
Widmann et al., 1999).  Therefore, I hypothesize that a specific MEK kinase is 
activated in an M-phase dependent manner and activates the MEK/MAPK pathway 
at mitosis.   To address this hypothesis I am going to use M-phase arrested Xenopus egg 
extracts to purify and identify mitotic MEK kinase activity.  Subsequently, I will utilize 
biochemical approaches to study how this MEK kinase is regulated during mitosis.  The 
results of my dissertation studies will determine the mechanism of regulating the 
activation of the MAPK cascade during mitosis and expand our understanding of how 
MAPK signaling is implicated in overall cell cycle regulation.  
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Chapter Two 
Identification of B-Raf as an M-phase MEK Kinase 
 
Introduction 
 
In order to decipher the regulatory mechanisms involved in activating the 
MEK/MAPK pathway at mitosis, the M-phase MEK kinase must be identified.  To 
achieve this, I utilized biochemical approaches in order to purify and directly identify the 
mitotic MEK kinase.  This research strategy requires an appropriate experimental model 
that fulfills several requirements.  First, it should fairly represent the biochemistry of 
mitotic activation of the MAPK cascade.  Secondly, this experimental system should be 
amenable for biochemical manipulations.  And thirdly, the experimental material should 
be available in quantities suitable for extensive biochemical purification.  The cell-free 
system of Xenopus egg extracts surpasses the tissue culture cells in all of the above-
mentioned requirements and represents an ideal biochemical experimental model for 
studying mitotic MAPK signaling.  Therefore, my biochemical studies were performed 
by using the cell-free system of Xenopus egg extracts.   
For this part of my studies, Xenopus egg extracts that are arrested in M-phase 
were utilized.  To prepare these extracts, mature (CSF-arrested) Xenopus oocytes were 
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collected and parthenogenetically activated in vitro by a brief incubation with calcium 
ionophore (Chen et al., 1998).  The activated eggs were processed into extracts and 
permanently arrested in M-phase by the addition of non-degradable recombinant cyclin B 
(Glotzer et al., 1991).  
First, I ascertained that my Xenopus extracts preparations represent an M-phase 
specific activation of the MAPK cascade.  Specifically, it was checked whether they are 
void of meiotic MEK kinase, c-Mos (Castro et al., 2001; Watanabe et al., 1989), and 
contain high levels of active MEK kinase, MEK and MAPK (Takenaka et al., 1997).   
Second, M-phase arrested Xenopus egg extracts were subjected to different 
fractionation approaches in order to isolate mitotic MEK kinase activity.  MEK kinases 
activate the down-stream MEKs by phosphorylating them at Serine and Threonine 
residues within the activation loop (Zheng and Guan, 1994).  Thus, monitoring 
phosphorylation status of these residues in recombinant MEK following its incubation in 
vitro with aliquots of samples was used as a screening tool to detect the presence of 
endogenous MEK kinase activity and visualize its redistribution among different 
fractions.   The outcome of this part of the study was the development of a purification 
scheme leading to an enrichment of mitotic MEK kinase activity.   
Up-scaled quantities of the M-phase arrested extracts were subjected to the 
developed purification protocol.  The final fractions containing active mitotic MEK 
kinase were analyzed for their composition by Western blotting and Silver staining.  
Loss-of-function approach was undertaken to validate involvement of the identified 
candidate MEK kinase into mitotic activation of the MAPK cascade.  
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Results 
 
Preparation of extracts from parthenogenetically activated Xenopus eggs, which 
are devoid of a germ-cell specific MEK kinase, c-Mos  
It is well established that activation of the MAPK pathway during Xenopus oocyte 
maturation is directed by a germ-cell specific MEK kinase, c-Mos (Castro et al., 2001).  
A temporal increase in intracellular calcium concentration induced by egg fertilization 
triggers degradation of c-Mos (Nishizawa et al., 1993; Watanabe et al., 1989) and 
inactivation of MAPK signaling (Ferrell et al., 1991), which contribute to the transition to 
the embryonic cell cycling (Castro et al., 2001). As shown in Figure 7, fertilization of 
mature Xenopus oocytes in vitro led to efficient degradation of c-Mos protein.  By 50 
min, c-Mos was undetectable by immunoblot analysis with anti-c-Mos antibodies.  
To recapitulate proper transition from CSF arrest to embryonic cycling in my 
experimental system, the time required for c-Mos degradation following Ca2+ ionophore 
treatment was determined.  To do this, mature Xenopus oocytes were parthenogenetically 
activated with Ca2+ ionophore A23187, collected at 10 min intervals and analyzed for the 
presence of c-Mos protein by Western blotting.   As shown in Figure 7, Ca2+ ionophore 
activation of Xenopus oocytes led to a complete disappearance of c-Mos within 40-50 
min after activation.  Importantly, the first mitotic cleavage, observed by 80 min post-
activation, occurred in the absence of c-Mos.  Therefore, I concluded that the activated 
eggs must be incubated at room temperature for 50-60 min before processing into 
extracts.  Using this protocol, I was able to consistently prepare Xenopus egg extracts that 
are devoid of detectable amounts of c-Mos protein and recapitulate in vitro early 
embryonic cell cycles. 
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Figure 7.  c-Mos is degraded at similar times for in vitro fertilized (upper 
panel) or Ca2+ ionophore activated (lower panel) Xenopus eggs and 
undetectable during mitosis  
Mature oocytes were fertilized or activated with Ca2+ ionophore, collected at the 
indicated time points and lysed.  Lysates were separated by SDS-PAGE and 
immunoblotted with c-Mos antibodies.  Note that the first embryonic cleavage 
occurred by 80 min in fertilized eggs.  Equal loading was verified by Coomassie 
staining.  
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Development of a protocol for purification of mitotic MEK kinase activity 
S-phase extracts were prepared from activated Xenopus eggs using the protocol 
described above.  Then, S-phase extracts were cycled into a stable M-phase state by the 
addition of non-degradable cyclin B.  Due to the absence of growth factor control, MAPK 
activation is restricted to M-phase in Xenopus egg extracts (Fig. 8).  Note that Xenopus 
oocytes and early embryos contain only one isoform of ERKs, ERK2 (Zaitsevskaya and 
Cooper, 1992).  Since it is the first identified Xenopus’s MAPK (Gotoh et al., 1991a), it is 
traditionally referred as to p42 MAPK. 
A biochemical assay for detecting MEK kinase activity in Xenopus egg extracts 
was developed in Dr Guadagno laboratory.  Aliquots of extracts were diluted in the 
kinase buffer and incubated in vitro in the presence of recombinant unactive GST-MEK.  
The products of the reaction were separated by SDS-PAGE and phosphorylation of GST-
MEK at the activation segment (Ser-217/Ser-221) was studied by Western blotting with 
phospho-MEK specific antibodies.  Despite the absence of c-Mos, MEK kinase activity 
was strongly detected in M-phase egg extracts compared to S-phase egg extracts (Fig. 8) 
implying that some other MEK kinase responsible for activation of the MAPK pathway 
at M-phase.  Several MEK kinases have been shown to directly activate MEK1/2.  This 
includes Raf family members (Hagemann and Rapp, 1999), MLK3 (Hartkamp et al., 
1999), MEKKs 1-3, c-Mos, and Tpl-2 (Fanger et al., 1997; Lewis et al., 1998).   
Unfortunately, at the time when this project was initiated, research tools 
(antibodies, siRNA technique, etc), which would enable me to specifically target a certain 
MEK kinase in order to elicit its effect on mitotic activation of the MAPK pathway, were  
 Figure 8.  M-phase arrested Xenopus egg extracts contain active MAPK and 
MEK kinase activity  
Equal amounts of S- and M-phase Xenopus egg extracts were subjected to an in vitro 
MEK kinase assay with recombinant GST-MEK as a substrate.  Phospho-MEK 
antibodies were used to analyze phosphorylation of GST-MEK.  Activation of 
endogenous MAPK was analyzed by phospho-MAPK Western blotting.  Equal sample 
loading was confirmed by immunoblotting for MAPK protein (data not shown).  
 
not readily available.  Therefore, to facilitate identification of the mitotic MEK kinase, I 
decided to purify MEK kinase activity from M-phase arrested Xenopus egg extracts.  In 
many regards, Xenopus egg extracts represent an ideal model system for purifying and 
identifying the MEK kinase responsible for mitotic activation of the MAPK cascade.  
First, Xenopus eggs provide a rich source of components of the MAPK cascade.  
Secondly, activation of the MAPK cascade is restricted to mitosis in Xenopus egg 
extracts that autonomously undergo synchronous cell cycles of S- and M-phases 
(Guadagno and Ferrell, 1998; Takenaka et al., 1997).  Finally, the Xenopus egg extracts 
are amenable to biochemical manipulations not feasible with tissue culture cells.  
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As a first purification step, the crude M-phase arrested Xenopus egg extracts were 
separated by ultracentrifugation (100, 000 g 1.5 hr, twice) into cytosolic and membrane 
fractions.  By applying equivalent amounts of crude and cytosolic fractions to an in vitro 
MEK kinase assay, I showed that the majority of the total M-phase MEK kinase activity 
is present in the cytosolic fraction (Table 1).  This suggests that the mitotic MEK kinase 
activity is cytosolic and not membrane-bound. 
As a second purification step, I fractionated the M-phase cytosol by ammonium 
sulfate (AS) precipitation.  The M-phase cytosolic fraction was supplemented with an 
appropriate volume of EB buffer containing 50% ammonium sulfate to reach a final 25% 
salt saturation.  After this, samples were rotated for 1.5 hr at 40C and precipitated proteins 
were pelleted by a high-speed centrifugation (10, 000 g 15 min at 40C).  The protein 
pellet was resuspended and proteins remaining in the supernatant were transferred to a 
new tube and subjected to sequential 50% and 75% AS precipitations as described above.  
Finally, to monitor the redistribution of the MEK kinase activity among different 
fractions, equal amounts of protein from all three AS cuts (0-25%, 25-50% and 50-75% 
saturation) as well as the final supernatant were subjected to an in vitro MEK kinase 
assay.  It was determined that the majority (>90%) of the mitotic MEK kinase activity 
from the cytosolic fraction was precipitated in the 0-25% AS cut (data not shown). Thus, 
mitotic MEK kinase activity from cytosolic fraction of M-phase arrested Xenopus egg 
extracts can be precipitated by low AS saturation, which provides a convenient 
purification step. 
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To narrow down further AS concentration necessary for precipitation of the MEK 
kinase activity, I performed the following AS cuts with M-phase cytosol: 0-10%, 10-
15%, 15-20%, 20-25% and 25-30%.  The precipitated protein fractions were resuspended 
and subjected to an in vitro MEK kinase assay.  As shown in Figure 9, the majority 
(>90%) of MEK kinase activity was precipitated in the 15-20% AS cut.  Note, that the 
20% ammonium sulfate saturation precipitated only 10% of the total proteins from the 
original M-phase cytosol fraction (Fig. 9).  Thus, 20% ammonium sulfate saturation can 
be used as an efficient step in purification of the mitotic MEK kinase activity. 
Next, a chromatography approach was utilized to further purify the MEK kinase 
activity contained within the 20% AS cut.  Several chromatography exchangers were 
screened for the ability to efficiently separate MEK kinase activity.  The following 
chromatography columns proved not to be useful in purifying the MEK kinase activity: a 
Mono S HR 5/5 column (a strong cation exchanger), a HiTrap DEAE Sepharose column 
(a weak anion exchanger), a Butyl Sepharose 4FF column (a hydrophobic interaction 
exchanger, aliphatic interactions), a Phenyl Sepharose 6FF column (a hydrophobic 
interaction exchanger, aromatic interactions).   
Fortunately, I was able to show that anionic exchange columns were effective for 
purifying the MEK kinase activity.  As shown in Figure 10, I was able to separate mitotic 
MEK kinase activity by using a HiTrap Q Sepharose HP column (a strong anion 
exchanger).  Specifically, by using a straight gradient of 0 – 1 M NaCl, the MEK kinase 
activity eluted at a range of 19-36% salt saturation.  To further focus the elution point for 
the MEK kinase activity and eliminate contamination of the MEK kinase active fractions  
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 Figure 9.  20% ammonium sulfate saturation precipitates MEK kinase activity from M-phase arrested Xenopus 
egg extracts  
Cytosolic fraction of M-phase arrested Xenopus egg extracts was sequentially subjected to protein precipitation with 
increasing concentration of ammonium sulfate.  Precipitated proteins were recovered and subjected to an in vitro MEK 
kinase assay.  Protein concentration of the obtained fractions was determined by using Bio-Rad Protein Assay kit.  Note 
that previously it was shown that concentrations of ammonium sulfate higher that 25% do not precipitate MEK kinase 
activity from M-phase cytosolic fraction.  
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Figure 10.  Partial purification of mitotic MEK kinase activity from 20% ammonium 
sulfate precipitated fraction by using HiTrap Q Sepharose HP anion-exchange 
chromatography (0 – 1.0 M NaCl elution gradient)  
1.5 mg of 20% ammonium sulfate precipitated fraction resuspended in buffer A (50 mM 
HEPES, pH 7.5, 10 mM MgCl2) was applied to a 5 ml HiTrap Q Sepharose HP column 
(Amersham Biosciences).  Proteins were eluted with a straight gradient of 1 M NaCl 
(buffer B: 50 mM HEPES, pH 7.5, 10 mM MgCl2, 1 M NaCl).  Aliquots of eluted fractions 
were subjected to an in vitro MEK kinase assay.  Note that MEK kinase activity was eluted 
at a 0.19 – 0.36 M NaCl range.  
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with irrelevant proteins with similar desalting properties, I decided to increase the elution 
resolution in the range of 0 – 30% of salt saturation.  To do this, proteins bound to a 
HiTrap Q Sepharose HP column were eluted with a step-wise gradient of 1 M NaCl: 0 – 
30% saturation (4 column volumes) and 30 – 100% saturation (1 column volume).  This 
significantly increased the efficiency of purification (Fig. 11).  The MEK kinase activity, 
eluted at 0.22 M NaCl, was concentrated in a fewer number of fractions and contained 
less total protein.   
Another anion-exchange column (Mono Q HR) also turned out to be a promising 
tool for purification of mitotic MEK kinase activity.  By applying the 20% AS 
precipitated fraction to a Mono Q HR 5/5 column and eluting bound proteins with a 
straight gradient of 0 – 1 M NaCl, I was able to collect mitotic MEK kinase activity in six 
discrete 0.5 ml fractions eluted at a 0.36 – 0.51 M NaCl (Fig. 12).  Mono Q resin is 
composed of finer beaded particles than HiTrap Q Sepharose and thus is suitable for a 
more refine protein separation.  Therefore, I decided to use a Mono Q column as a 
purification step following separation on HiTrap Q Sepharose column.  Indeed, 
application of MEK kinase active fractions eluted from a HiTrap Q Sepharose column to 
a Mono Q column further purified the MEK kinase activity (not shown).  To increase the 
efficiency of separation of eluted proteins on a Mono Q column, I modified the elution 
conditions to a step-wise gradient of 1 M NaCl: 0 – 30% (3 column volumes), 30 – 50% 
(15 column volumes) and 50 – 100% (2 column volumes).   
 
 
MEK kinase active 
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  GST-MEK-P 
 
Figure 11.  Partial purification of mitotic MEK kinase activity from 20% 
ammonium sulfate precipitated fraction by using HiTrap Q Sepharose HP 
anion-exchange chromatography (0 – 0.3 –  1.0 M NaCl elution gradient)  
3.0 mg of 20% ammonium sulfate precipitated fraction resuspended in buffer A (50 
mM HEPES, pH 7.5, 10 mM MgCl2) was applied to a 5 ml HiTrap Q Sepharose 
HP column (Amersham Biosciences).  Proteins were eluted with a step-wise 
gradient of 1 M NaCl (buffer B: 50 mM HEPES, pH 7.5, 10 mM MgCl2, 1 M 
NaCl).  Aliquots of eluted fractions were subjected to an in vitro MEK kinase assay. 
Note that MEK kinase activity was eluted at a 0.22 M NaCl range. 
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Figure 12.  Partial purification of mitotic MEK kinase activity from 20% 
ammonium sulfate precipitated fraction by using MonoQ anion-exchange 
chromatography 
1.9 mg of 20% ammonium sulfate precipitated fraction resuspended in buffer A (50 
mM HEPES, pH 7.5, 10 mM MgCl2) was applied to a 1 ml Mono Q HR column 
(Amersham Biosciences).  Proteins were eluted with a straight gradient of 1 M 
NaCl (buffer B: 50 mM HEPES, pH 7.5, 10 mM MgCl2, 1 M NaCl).  Aliquots of 
eluted fractions were subjected to an in vitro MEK kinase assay.  Note that MEK 
kinase activity was eluted at a 0.36 – 0.51 M NaCl range.  
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Thus, by subjecting M-phase arrested Xenopus egg extracts to different 
purification approaches and using an in vitro MEK kinase assay as a screening tool, I 
worked out several efficient purification techniques, which can be combined in one 
purification protocol to separate mitotic MEK kinase activity.  
 
Purification of MEK kinase activity from M-phase arrested extracts 
 
Based on results described in the previous section, I designed a four-step 
purification scheme to purify MEK kinase activity present in M-phase arrested Xenopus 
egg extracts (Fig. 13A).  Crude S-phase extracts prepared from parthenogenetically 
activated Xenopus eggs were cycled into a stable M-phase by the addition of non-
degradable recombinant cyclin B.  The M-phase state of the extracts was confirmed by 
analyzing an in vitro histone H1 kinase activity and/or observing the nuclear envelope 
breakdown and chromatin condensation under fluorescent microscopy.  Then, the crude 
M-phase extracts were separated into cytosolic and membrane fractions by 
ultracentrifugation.  The cytosolic fraction, containing nearly all of the MEK kinase 
activity (Table 1), was separated by ammonium sulfate precipitation.  Approximately 
90% of the MEK kinase activity was precipitated in the 0-20% ammonium sulfate cut and 
purified further by anion exchange chromatography on HiTrap Q Sepharose and Mono Q 
columns.  Collectively, these purification steps enriched MEK kinase activity by ~ 260-
fold (Table 1).  At the final purification step, a single protein peak eluted from the Mono 
Q column (Fig. 13B) contained MEK kinase activity as assessed by both phosphorylation  
  
 
Figure 13.  Purification of MEK kinase activity from M-phase arrested Xenopus 
egg extracts  
A. Scheme for purification of an M-phase MEK kinase activity.  B. Mono Q elution 
profile over a three-step 0 - 1.0 M NaCl gradient.  C, Mono Q fractions #10-16 contain 
an M-phase MEK kinase activity.  MEK kinase activity of Mono Q fractions # 4-60 
was measured in an in vitro MEK kinase assay.  MEK kinase activity was not detected 
in the flow through volume (not shown).  
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Table 1.  Purification of MEK kinase activity from M-phase arrested Xenopus egg 
extracts 
 
 Total 
protein, 
mg 
Total activity, 
a.u.∗ 
Specific 
activity, 
a.u./mg 
Yield, 
% 
Fold 
purification 
Crude M-phase 
extract 
1156.8 246.2 0.21 - 1 
Cytosol 
fraction 
302.0 260.0 0.86 100 4.1 
20% AS cut 28.0 236.8 8.46 91.1 40.3 
HiTrap Q 
Sepharose 
3.8 105.75 27.83 40.7 132.5 
Mono Q  0.405 22.05 54.44 8.5 259.2 
* a.u. - arbitrary units; fractions from each purification step were subjected to an in vitro 
MEK kinase assay, the levels of GST-MEK phosphorylation were determined by 
Western blotting and quantified by using ImageQuant software 
 
 
 
 
of recombinant MEK (Fig. 13C) and activation of the MAPK cascade in an in vitro 
linked kinase assay (Fig. 14).  Therefore, my results suggest that the kinase activity 
purified from M-phase arrested Xenopus egg extracts represents a bona fide MEK kinase.  
This protocol was applied at least three times and consistently led to an enrichment of the 
mitotic MEK kinase activity. 
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Fractions    8     9    10   11   12    13   14   15   16    17   18 
Figure 14.  Final Mono Q fractions contain M-phase MEK kinase activity 
Equal aliquots of Mono Q fractions # 8 – 18 were subjected to an in vitro linked 
kinase assay as described in Materials and Methods chapter.  Briefly, aliquots of 
Mono Q fractions # 8 – 18 were incubated in vitro with recombinant unactive 
GST-MEK and GST-ERK.  Next, the reaction mix was supplemented with myelin 
basic protein (MBP) as a substrate for ERK and incubation was continued.  The 
levels of ERK activation in the linked kinase reaction were determined by the 
levels of MBP phosphorylation.  To assess contribution of endogenous MAPK in 
the purified fractions to MBP phosphorylation, the aliquots of the fractions were 
incubated with MBP alone, without addition of GST-MEK and GST-ERK.  The 
levels of MEK kinase activity were represented as a difference between MBP 
phosphorylation in the cascade kinase reaction and MBP phosphorylation by the 
fractions itself.  The levels of MBP phosphorylation were visualized by 
autoradiography and quantified by using ImageQuant software. 
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B-Raf is enriched at the final stage of the mitotic MEK kinase purification 
Silver staining analysis of the final MEK kinase active fractions revealed several protein 
bands.  An example of one of the active fractions is shown (Fig. 15, lane 1).  A prominent 
protein band between 90-100 kDa correlated with M-phase MEK kinase activity 
throughout the progress of purification (see Fig. 45) and migrated at a similar molecular 
weight range as B-Raf.  Therefore, I used a polyclonal antibody raised against a highly 
conserved N-terminal portion of Human B-Raf (Fig. 16) to assess whether the protein 
band might represent B-Raf.  As shown in Figure 15 (lanes 5 and 6), this antibody readily 
recognized Xenopus B-Raf in crude S- and M-phase egg extracts as a 95 kDa doublet.  
When a purified fraction containing mitotic MEK kinase activity was immunoblotted 
with the B-Raf antibody, B-Raf was strongly detected (Fig. 15, lane 2 versus lane 6).   On 
the other hand, neither c-Mos nor Raf-1 were detected by Western blotting (Fig. 15, lanes 
3 and 4).  Similar results were observed for other fractions containing partially purified 
MEK kinase activity.  Thus, I conclude that B-Raf, not Raf-1 or c-Mos, is enriched 
during purification of the mitotic MEK kinase activity. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 15.  B-Raf is enriched at the final stage of the mitotic MEK kinase purification  
Mono Q fraction #12 (see Fig.11) was separated on 8% SDS-PAGE and analyzed by 
either silver staining (lane 1) or Western blotting with anti-B-Raf (lane 2), anti-Raf-1 
(lane 3), or anti-c-Mos (lane 4) antibodies.  Similar results were obtained with fraction 
#11.  Equal amounts of total protein from crude S-phase (lane 5), M-phase (lanes 6, 7, 
8), and CSF extracts (lane 9) were immunoblotted for B-Raf (lanes 5, 6), Raf-1 (lane 7), 
and c-Mos (lanes 8, 9).  Note that the asterisk indicates recombinant GST-cyclin B 
recognized by Santa Cruz B-Raf polyclonal antibodies, raised against a GST-conjugated 
B-Raf peptide  
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Figure 16.  Alignment of the amino acid sequences of Xenopus (AAZ06667) and 
Human (P15056) B-Raf proteins using MegAlign software  
sc9002 antibody epitope comprising an N-terminal region of Human B-Raf is shown in 
red dashed line.   
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Depletion of B-Raf, but not Raf-1, blocks activation of MAPK at mitosis 
Based on the purification results, I hypothesized that B-Raf might be required for 
activation of the MEK/MAPK pathway at mitosis.  To test this directly, endogenous B-
Raf was quantitatively removed (~99%) from S-phase extracts by two rounds of 
immunodepletion (Fig. 17A) and the depleted extracts were cycled into mitosis by the 
addition of recombinant non-degradable cyclin B.  At indicated time points, aliquots of 
egg extracts were collected to assess MAPK activation.  Entry into mitosis was monitored 
by nuclear envelope breakdown and chromatin condensation, which in control and B-
Raf-depleted extracts occurred at 20 min after cyclin B addition.  Following mitotic 
entry, MAPK became activated at 30 min in control extracts (Fig. 17B, fist and second 
lanes).  In contrast, mitotic MAPK activation was strongly inhibited in B-Raf depleted 
extracts (Fig. 17B, third lane).  The addition of recombinant B-Raf protein to B-Raf-
depleted extracts was sufficient to restore MAPK activation at levels similar to control 
extracts (Fig. 17B, fourth lane).  Thus, I conclude that B-Raf is essential for activation of 
the MAPK pathway during mitosis in Xenopus egg extracts. 
Raf-1, another member of Raf MEK kinase family, is a classical activator of the 
MAPK cascade after mitogenic stimulation.  Interestingly, studies in mammalian cells 
have implicated a possible role for Raf-1 in G2/M progression (Laird et al., 1995; Pathan 
et al., 1996; Ziogas et al., 1998).  Since Raf-1 is expressed in Xenopus egg extracts (Fig. 
18A, first lane), I decided to test whether activation of MAPK at mitosis in Xenopus egg 
extracts depends on Raf-1.  In order to do this, Raf-1 was removed from extracts by 
immunodepletion (Fig. 18A).  After this, the Raf-1 depleted extracts were driven into  
  
 
 
 
Figure 17.  B-Raf is required for activation of MAPK at mitosis 
A. B-Raf protein levels in S-phase extracts after mock- and B-Raf-depletion, and adding back of recombinant His-
tagged B-Raf.  B. MAPK activation at mitosis is blocked in B-Raf-depleted extracts and restored after addition of 
recombinant B-Raf.  Mock- and B-Raf-depleted extracts were driven into mitosis with non-degradable cyclin B and 
assessed for MAPK activation by phospho-MAPK Western blotting at indicated times.   
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Figure 18.  Raf-1 is not required for mitotic activation of MAPK pathway  
A. Raf-1 protein levels in S-phase extracts after mock- and Raf-1-immunodepletion.  B. Raf-1 is not required for 
activation of MAPK during mitosis.  Mock- and Raf-1-depleted extracts were driven into mitosis with non-degradable 
cyclin B.  1-ml aliquots of the egg extract were collected at the indicated times to monitor MAPK activation by phospho-
MAPK immunoblotting.  Equal loading of samples was confirmed by Ponceau S staining of membranes.  
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M-phase by the addition of recombinant non-degradable cyclin B.  Aliquots of the 
extracts were taken at the indicated times, and time-course of MAPK activation was 
studied by phospho-MAPK Western blot.  As it shown on Figure 18B, depletion of 
endogenous Raf-1 protein had no effect on mitotic activation of the MAPK pathway.  
Thus, I conclude that Raf-1 is not required for mitotic activation of MAPK signaling in 
Xenopus egg extracts. 
 
Conclusions 
  
The primary aim of this study was to identify the MEK kinase responsible for 
mitotic activation of the MEK/MAPK pathway in Xenopus egg extracts.  To address this, 
I developed a procedure for preparation of M-phase arrested Xenopus egg extracts devoid 
of a meiotic MEK kinase, c-Mos.  By using these extracts as a starting material, I 
developed a purification protocol leading to an enrichment of the mitotic MEK kinase 
activity.  Fractionation of M-phase arrested Xenopus egg extracts led to the purification 
of a single peak of MEK kinase activity that was identified by Western analysis as B-Raf.  
Neither c-Mos nor Raf-1 were detected in the purified MEK kinase active fraction.  The 
results from my immunodepletion experiments definitively show that B-Raf is critical for 
activating the MAPK pathway during mitosis in Xenopus egg extracts.  In contrast, the 
related Raf family member, Raf-1, is not required for M-phase activation of the MAPK 
pathway.  Thus, I conclude that B-Raf is the major MEK kinase responsible for activation 
of the MAPK signaling at mitosis (Fig. 19) 
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Figure 19.  B-Raf activates the MEK/MAPK cascade at mitosis 
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Chapter Three 
Characterization of B-Raf at Mitosis 
 
Introduction 
 
In Chapter Two, I demonstrated that B-Raf functions as a critical activator of the 
MAPK pathway during mitosis.  Presently, little is known about the cell cycle regulation 
of B-Raf at M-phase.  In this Chapter I propose to characterize the mitotic regulation of 
B-Raf activity using the cell-free system of Xenopus egg extracts.  Specifically, data 
describing possible cell cycle dependent changes in B-Raf activity, posttranslational 
modification by phosphorylation and protein interactions with its down-stream target, 
MEK, will be presented.  . 
 
Results 
 
B-Raf activity is elevated during mitosis 
To examine the regulation of the B-Raf/MEK/MAPK cascade at mitosis, I 
decided to characterize B-Raf activity in Xenopus egg extracts.  Based on the requirement 
for B-Raf in activation of the MAPK cascade during mitosis, I predicted that B-Raf 
activity would be highest during M-phase.  To measure B-Raf activity, similar amounts 
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of B-Raf protein were immunoprecipitated from S- and M-phase arrested egg extracts 
and subjected to an in vitro linked kinase assay.  The data showed that B-Raf activity is 
markedly elevated (4-6 fold) in M-phase arrested extracts compared to S-phase extracts 
(Fig. 20A).  A modest amount of B-Raf activity detected in S-phase extracts likely 
represents its high basal activity due to both constitutive phosphorylation and the 
presence of a phospho-mimicking aspartic acid residue in the positive regulatory N-
region (Mason et al., 1999).  Controls that either lack recombinant MEK and ERK or 
measure background kinase activity associated with rabbit IgG complexes demonstrated 
the specificity of the in vitro cascade reaction.   
Next, I examined B-Raf activity in Xenopus egg cycling extracts that naturally 
oscillate between S- and M-phases.  First, extracts prepared from activated Xenopus eggs 
were incubated at room temperature to initiate cycling.  At 10-min intervals, equal 
aliquots of cycling extracts were collected, snap-frozen on dry ice and stored at -80oC.  
Extracts cycling between S- and M-phase was monitored by observing nuclear envelope 
breakdown/chromatin condensation and measuring Cdk1/cyclin B activity in an in vitro 
histone H1 kinase assay.  To measure B-Raf activity throughout the cell cycle, equal 
amounts of B-Raf protein were immunoprecipitated from Xenopus egg cycling extracts, 
washed several times and subjected to an in vitro linked kinase assay.  I consistently 
observed a fluctuation of B-Raf activity during the cell cycle peaking highest during M-
phase (Fig. 20B).  Thus, my data shows that B-Raf is activated in an M-phase dependent 
manner in Xenopus egg extracts. 
 Figure 20.  B-Raf activity is elevated during mitosis  
A. B-Raf is activated in M-phase arrested extracts.  B-Raf immunoprecipitates from S-
and M-phase egg extracts were subjected to an in vitro linked kinase. Equal loading of 
immunoprecipitated B-Raf per kinase reaction was confirmed by Western analysis.   
B. B-Raf activity is up-regulated during mitosis in Xenopus cycling extracts.  B-Raf 
was immunoprecipitated from aliquots of cycling egg extract at indicated times and 
subjected to an in vitro linked kinase assay.  In vitro histone H1 kinase activity of the 
same aliquots was measured in parallel as a marker for Cdk1/cyclin B activation and 
mitotic entry.  Activation of MAPK was studied by phospho-MAPK Western blotting. 
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In a recent report, high amounts of B-Raf activity were detected in Xenopus egg 
extracts but the authors were unable to measure differences in B-Raf activity between S- 
and M-phases (Yue et al., 2006).  I speculate that the negative data could be caused by 
functional limitations of the two-component in vitro MEK kinase assay used in their 
study to measure B-Raf activity.  I utilized an in vitro B-Raf/MEK/ERK/MBP linked 
kinase assay, which allows greater signal amplification, and used at least 5-fold more 
recombinant MEK.  Thus, saturation of the reaction by purified active B-Raf complexes 
is less likely to occur under my assay conditions.  Therefore, I conclude that my cascade 
kinase reaction is more sensitive and reliable for detecting changes in B-Raf activity. 
To rule out the possibility that a MEK kinase associated with B-Raf might 
contribute to the activation of ERK in the linked kinase reaction, I decided to compare in 
vitro kinase activities of catalytically inactive and wild type B-Raf immunoprecipitates 
from S- and M-phases.  First, a site-directed technique was used to create a kinase 
inactive mutant of Xenopus B-Raf by substituting Lysine residue in the ATP-binding site 
to Methionine (Guan et al., 2000).  Next, wild type and kinase dead recombinant myc-B-
Raf proteins were expressed in Xenopus CSF extracts and introduced for incubation in S- 
and M-phase arrested extracts (see Materials and Methods for details).  Finally, the 
recombinant myc-B-Raf proteins were recovered by myc-tag immunoprecipitation and 
subjected to an in vitro linked kinase assay as described above.  My results show that the 
catalytically inactive B-Raf immunoprecipitates do not display any MEK kinase activity 
in an in vitro linked kinase assay compared to wild type B-Raf (Fig. 21).  This result  
 
  
 
 
 
 
 
 
 
 
Figure 21.  Kinase-dead B-Raf immuno-complexes from S- and M-phase 
arrested extracts do not possess MEK kinase activity  
Kinase-dead (KD) and wild-type (WT) myc-B-Raf were expressed in Xenopus egg 
extracts as described.  Aliquots containing the recombinant myc-B-Raf were 
introduced in a 1:20 ratio to S-phase arrested extracts, which after one-hour 
incubation at room temperature were driven into M-phase with non-degradable 
GST-cyclin B.  Myc-B-Raf proteins were purified by means of myc-tag antibodies 
and subjected to an in vitro linked kinase assay.  Loading of immunopurified myc-
B-Raf per kinase reaction was verified by myc-tag Western blotting.  Cdk1/cyclin 
B activity of the corresponding extracts was measured in an in vitro histone H1 
kinase assay (not shown). 
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clearly demonstrates that the activation of the MAPK cascade by B-Raf 
immunoprecipitates in the in vitro linked kinase assay reflects B-Raf activity.  
I would like to point out that my results implicating B-Raf at mitosis conflict with 
a recent study suggesting that c-Mos might regulate M-phase activation of the MAPK 
cascade in Xenopus egg extracts (Yue and Ferrell, 2004).  I speculate that the main reason 
for these conflicting results stem from differences in how the egg extracts were prepared.  
In contrast to Yue and Ferrell’s study, I do not detect any c-Mos protein in my egg extract 
preparations due to allowing the activated eggs incubating at room temperature for 50 
min prior to processing them into extracts (see Fig. 7).  Moreover, I do not detect any 
MEK kinase activity associated with c-Mos immuno-complexes isolated from M-phase 
arrested Xenopus egg extracts (Fig. 22).  Therefore, I am unable to assess any biological 
significance for c-Mos in my egg extract system.  The absence of c-Mos in my egg 
extracts closely mimics its disappearance shortly following fertilization that was 
demonstrated in earlier studies (Nishizawa et al., 1993; Watanabe et al., 1991; Watanabe 
et al., 1989) and in this study (Fig. 7).  Furthermore, the proposal that c-Mos could trigger 
the transient activation of the MAPK pathway at mitosis does not comply with its well-
established role as a cytostatic factor during ooctye maturation (Castro et al., 2001) or 
from studies showing that micro-injection of even small amounts of c-Mos can mediate a 
metaphase arrest in cleaving Xenopus embryos (Sagata et al., 1989).  Finally, gene 
knockout studies in mice argue against an essential role for c-Mos at mitosis in somatic 
tissues since mos (-/-) mice are viable without any tissue abnormalities (Colledge et al., 
1994; Hashimoto et al., 1994).  On the other hand, homozygous knockouts for B-Raf are 
embryonically lethal (Wojnowski et al., 2000; Wojnowski et al., 1997).  Thus, I propose 
that B-Raf, rather than c-Mos, is the mitotic MEK kinase that plays an essential role 
during mitosis in activating the MAPK cascade. 
 
 
 
Figure 22. c-Mos immunoprecipitates do not possess an M-phase MEK 
kinase activity   
Santa Cruz and Abcam c-Mos antibodies were used to immunoprecipitate MEK 
kinase activity from M-phase arrested extracts (c-Mos immunoprecipitates 1 
and 2 respectively).  The immunoprecipitates were washed and subjected to an 
in vitro linked kinase assay with recombinant unactive MEK and ERK.  Since 
M-phase arrested extracts have undetectable levels of c-Mos, Coomassie 
staining for IgGs was used as a loading control.  Note that equivalent amounts 
of B-Raf antibodies immunoprecipitate significantly higher levels of mitotic 
MEK kinase activity. 
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B-Raf associates with MEK in Xenopus egg extracts 
Next, I examined whether M-phase activation of B-Raf correlates with its 
ability to associate with MEK, the direct target of B-Raf.  To do this, co-
immunoprecipitation assays were performed for B-Raf and MEK.  B-Raf or MEK 
complexes were immunopurified from S- and M-phase Xenopus egg extracts and 
subjected to Western analysis for detection of both MEK and B-Raf.  As shown in Figure 
23, MEK and B-Raf were found in a complex in both S- and M-phase egg extracts 
suggesting that their association is independent of B-Raf activation at mitosis. 
 
 
 
 
 
 
Figure 23.  B-Raf associates with MEK in Xenopus egg extracts  
Aliquots of S- and M-phase arrested extracts were incubated with B-Raf, MEK, or 
rabbit IgG (mock control) antibodies.  Protein complexes purified on protein A 
beads were subjected to Western analysis for both B-Raf and MEK.  
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B-Raf does not associate with Raf-1 in mitotic Xenopus egg extracts 
Recent work suggested that B-Raf/Raf-1 heterodimerization following mitogen 
stimulation is an important mechanism that ensures proper signaling via the Raf-MEK-
ERK cascade (Rushworth et al., 2006).  However, my data indicate that Raf-1, unlike B-
Raf, is not involved in the regulation of the MAPK pathway during mitosis in Xenopus 
egg extracts.  Indeed, Raf-1 was not purified as a mitotic MEK kinase from Xenopus egg 
extracts (Fig. 15) and its immunodepletion did not affect MAPK activation at mitosis 
(Fig. 18).  These results suggest that B-Raf and Raf-1 are not implicated in the same 
signaling cascades in Xenopus egg extracts.  To obtain a direct evidence for this, I 
performed B-Raf/Raf-1 co-immunoprecipitation to analyze B-Raf/Raf-1 interactions.  
Equal amounts of M-phase arrested extracts were subjected to B-Raf, Raf-1 or mock 
immunoprecipitation.  Antibody complexes recovered on protein A beads were washed 
and analyzed for the presence of Raf-1 protein by Western blotting.  As shown in Figure 
24A, anti-Raf-1 antibody readily immunoprecipitated Raf-1 from M-phase arrested 
extracts.  Contrary, B-Raf immunoprecipitates did not show immunoreactivity with Raf-1 
antibodies, indicating that mitotic B-Raf does not interact with Raf-1 in Xenopus egg 
extracts.  Interestingly, analysis of Raf-1 and MEK interaction in Xenopus egg extracts 
showed that Raf-1 immunoprecipitates from S- and M-phase extracts failed to co-purify 
MEK, whereas B-Raf antibodies reproducibly co-immunoprecipitaed MEK (Fig. 24B and 
Fig. 23).  This further supports that Raf-1 is uncoupled from MAPK signaling during 
mitosis as shown in this (Fig. 18) and previous studies (Laird et al., 1999; Ziogas et al., 
1998).   
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Figure 24.  Raf-1 is not co-immunoprecipitated with B-Raf and MEK from 
Xenopus egg extracts  
A.  Aliquots of M-phase arrested extracts were incubated with Raf-1, B-Raf 
antibodies or rabbit IgG (mock control).  Protein complexes purified on protein A 
beads were subjected to Western analysis for Raf-1.  B.  Aliquots of S- and M-phase 
arrested extracts were incubated with B-Raf or Raf-1 antibodies or rabbit IgG (mock 
control).  Protein complexes purified on protein A beads were subjected to Western 
analysis for B-Raf/MEK and Raf-1/MEK co-immunoprecipitation.  
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B-Raf undergoes hyperphosphorylation during mitosis 
As revealed by Western blotting, B-Raf undergoes a prominent electrophoretic 
shift in M-phase arrested egg extracts (Fig. 25A) and during mitosis in cycling egg 
extracts (Fig. 25B, 60-70 and 140 min).  It is well established that phosphorylation 
comprises one of the major mechanism of post-translational regulation of B-Raf activity 
(Chong et al., 2003).  Therefore, I tested whether the electrophoretic shift of B-Raf during 
mitosis is due to phosphorylation.  To do this, B-Raf immunocomplexes isolated from S- 
and M-phase egg extracts were subjected to an in vitro treatment with lambda protein 
phosphatase.  After completion of the reaction, proteins were separated by 8% SDS-
PAGE and changes in B-Raf electrophoretic mobility were analyzed by Western blotting.  
The results show that phosphatase treatment progressively eliminated the shift of B-Raf 
isolated from M-phase extracts (Fig. 25C) demonstrating that it stemmed from 
phosphorylation.  B-Raf isolated from S-phase egg extracts was also sensitive to 
phosphatase treatment since it is constitutively phosphorylated in the positive regulatory 
N-region (Mason et al., 1999).  Therefore, I conclude that Xenopus B-Raf is 
constitutively phosphorylated in S-phase extracts and becomes hyperphosphorylated 
during mitosis. 
 
Mitotic activation of B-Raf stems from phosphorylation 
Is mitotic phosphorylation of B-Raf important for B-Raf activation?  To answer 
this question, I studied how dephosphorylation affects activity of mitotic B-Raf.  Similar 
to the above described experiment, equal amounts of S- and M-phase immunoprecipitated  
  
 
 
 
 
 
 
 
Figure 25. B-Raf undergoes hyperphosphorylation during mitosis  
A. The electrophoretic mobility of B-Raf shifts up at M-phase.  Equal aliquots of S- 
and M- phase arrested extracts were separated by 8% SDS-PAGE and subjected to 
immunoblot analysis.  Cdk1 activity was measured in an in vitro histone H1 kinase 
assay.  Coomassie blue staining was used to confirm equivalent loading of histone 
H1.  B. B-Raf undergoes an electrophoretic mobility shift during mitosis in Xenopus 
egg cycling extracts.  Aliquots of cycling egg extracts were collected at indicated 
times over two cell cycles and immunoblotted for B-Raf or MEK (loading control).  
C. B-Raf hypershift stems from phosphorylation.  B-Raf immunoprecipitated from 
S- or M-phase egg extracts was treated with lambda protein phosphatase (lambda-
PP) for indicated times, separated by SDS PAGE, and subjected to immunoblot 
analysis.  
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B-Raf were subjected to an in vitro dephosphorylation with lambda protein phosphatase.   
After the completion of the reaction, B-Raf immunoprecipitates were washed with 
copious amounts of buffer containing phosphatase inhibitors (25 mM NaF and 10 mM 
Na3VO4) and B-Raf activity was measured in an in vitro linked kinase assay.  The results 
showed that dephosphorylation of mitotic B-Raf abolished its kinase activity (Fig. 26).  
Besides this, the basal activity of B-Raf isolated from S-phase extracts was also sensitive 
to phosphatase treatment.  Thus, this data demonstrates that phosphorylation is critical for 
regulating M-phase specific activation of B-Raf. 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Mitotic activation of B-Raf stems from phosphorylation  
B-Raf immunopurified from S- or M-phase extracts was treated with lambda protein 
phosphatase (lambda-PP) and subjected to immunoblot analysis (top panel) or an in 
vitro linked kinase assay (bottom panel).  
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Xenopus B-Raf is not phosphorylated at the conserved Threonine-633 and Serine-
636 residues during mitosis 
Phosphorylation of Threonine-599 and Serine-602 located within an activation 
segment of Human B-Raf is critical for B-Raf activation, specifically for Ras-dependent 
induction of B-Raf activity (Zhang and Guan, 2000).  Since these phosphorylation sites 
are conserved to Xenopus B-Raf (Threonine-633 and Serine-636, respectively, see Fig. 
16), I asked whether phosphorylation at the indicated sites occurs during mitosis.  To 
answer this question, equal amounts of S- and M-phase extracts were probed with anti-B-
Raf phospho-Threonine-599 and phospho-Serine-602 antibodies.  The results showed that 
Xenopus 95 kDa B-Raf is not phopsphorylated at the indicated residues neither in S- nor 
in M-phases (Fig. 27).  Interestingly, the small B-Raf isoform (~68 kDa) present in 
Xenopus egg extracts and previously described in human cells (Moodie et al., 1994; 
Oshima et al., 1991; Sithanandam et al., 1990) is highly phosphorylated in an M-phase 
dependent manner at the conserved Threonine-633 and Serine-363 within the activation 
segment.  While beyond the scope of this study, it would be extremely interesting to 
determine functions and regulation of the smaller 68 kDa B-Raf isoform at mitosis by 
developing B-Raf antibodies capable of immunoprecipitation of the smaller B-Raf 
isoform. 
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Figure 27.  Xenopus 95 kDa B-Raf is not phosphorylated at the conserved 
Threonine-633 and Serine-636 residues during mitosis 
Aliquots of S- and M-phase extracts were separated by 8% SDS-PAGE and 
immunoblotted for phospho-Thr-599/Ser-602 B-Raf (1), 68 kDa B-Raf (2) and 95 kDa 
B-Raf (3).  Note that Threonine-599 and Se e activation segment 
of Human B-Raf correspond to Threonine-633 and Serine-636 in Xenopus B-Raf (see 
 
 
 
 
 
 
 
 
 
rine-602 residues in th
 
 
Fig. 16). 
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Conclusions 
In this Chapter, I provide evidence th  B-Raf is regulated in an M-phase 
dependent manner in Xenopus egg extracts.  First of all, I show that consistent with its 
requirement in mitotic activation of the MAPK pathway, B-Raf activity is remarkably 
and tran  an M-
 
itogen 
t 
 
 
 
 
at
siently increased during mitosis.  Furthermore, Xenopus B-Raf undergoes
phase specific hyperphosphorylation.  Importantly, mitotic phosphorylation of B-Raf is
critical for its activation during M-phase.  Thus, I speculate that up-stream kinase(s) 
target B-Raf at mitosis to allow for the activation of the B-Raf/MEK/MAPK pathway.  
Interestingly, 95 kDa Xenopus B-Raf is not phosphorylated at the conserved Threonine-
633 and Serine-363 within the activation loop during mitosis, contrary to its Ras-
dependent activation following mitogenic stimulation (Zhang and Guan, 2000).  This 
indicates that the mechanism of B-Raf activation at mitosis is principally different from 
that described for B-Raf during the cell cycle entry, which occurs in response to m
stimulation via activated Ras (Roovers and Assoian, 2000)).  Finally, I demonstrate tha
B-Raf does not form heterodimers with Raf-1 and associates with endogenous MEK, its 
direct target, validating that B-Raf functions as a MEK kinase in Xenopus egg extracts.   
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Chapter Four 
Regulation of Mitotic B-Raf by Cdk1/cyclin B 
In this chapte  and B-Raf 
activation in Xenopus egg extracts that cycle from S-phase to mitosis as well as a 
requirement of Cdk1/cyclin B activity f B-Raf in mitotic extracts.  Second, 
Cdk1/c
ill 
ring 
Cdk1/cyclin B triggers activation of B-Raf in Xenopus egg extracts  
From my analysis of temporal ac f Cdk1/cyclin B and B-Raf in Xenopus 
egg cycling extracts, I show that B-Raf activation during mitosis follows Cdk1/cyclin B 
activity clin B and B-
 
Introduction 
r I propose to analyze the timing of Cdk1/cyclin B
 in activation o
yclin B association with B-Raf in mitotic Xenopus egg extracts will be 
characterized based on data obtained in co-immunoprecipitaion studies.  Lastly, I w
present data that demonstrate that B-Raf is phosphorylated by Cdk1/cyclin B and that this 
phosphorylation is important for activation of B-Raf and the MAPK cascade du
mitosis in Xenopus egg extracts. 
 
Results 
 
tivation o
 (Fig. 20B).  To study the biochemical relationship between Cdk1/cy
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Raf, I a
 
tion 
r 
 
hapiro, 2004) and then analyzed B-Raf activity as outlined above.  Following 
inhibiti
activation of B-Raf could be under control 
of Cdk1/cyclin B.  Interestingly, Cdk1, recombinant GST-cyclin B, and B-Raf were all 
detecte the Chapter  
sked whether Cdk1/cyclin B could trigger B-Raf activity in Xenopus egg extracts 
cycled into a stable mitotic state.  Specifically, after the addition of recombinant non-
degradable GST-cyclin B to S-phase arrested extracts, I collected aliquots of extract at 10 
min intervals.  Cdk1/cyclin B activity was measured by an in vitro histone H1 kinase 
assay.  In parallel, B-Raf was immunoprecipitated from 5 µl of the same time-point 
aliquots and subjected to an in vitro linked kinase assay to determine its activity.  The 
data shown in Figure 28A demonstrates that activation of B-Raf follows Cdk1/cyclin B
activation suggesting that Cdk1/cyclin B directly or indirectly controls mitotic activa
of B-Raf. 
Is Cdk1/cyclin B activity necessary for B-Raf activity during mitosis?  To answe
this question, I treated M-phase arrested extracts with Flavopiridol, a Cdk specific
inhibitor (S
on of Cdk1/cyclin B, I observed a reduction in activity of mitotic B-Raf (Fig. 
28B).  This indicates that the enzymatic activity of Cdk1/cyclin B complexes is involved 
in the control of B-Raf activation during mitosis.  Therefore, the data presented here 
strengthens the idea that Cdk1/cyclin B serves as a direct or indirect activator of mitotic 
B-Raf. 
    
B-Raf associates with active Cdk1/cyclin B complexes during mitosis 
My data suggest that M-phase specific 
d in the final step of the mitotic MEK kinase purification, described in 
Cdk  acti ity 
B-R f act ity 
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Figure 28.  B-Raf activity in M-phase arrested Xenopus egg extracts depends on Cdk1/cyclin B activity 
A.  Time-course of Cdk1/cyclin B and B-Raf activation in Xenopus egg extracts after GST-cyclin B addition  
Cdk1/cyclin B activity is necessary for B-Raf activation during mitosis.  Cdk1 activity in M-phase arrested ex t s 
inhibited with Flavopiridol.  B-Raf was immuno-purified and its activity was measured in an in vitro
Equal loading of B-Raf immunoprecipitates per kinase assay was confirmed by B-Raf Western blo
activity was measured in in vitro histone H1 kinase assay.  
 + 
ol
B.  
trac s wa
 link kinase assay. 
tting.  Cdk1/cyclin B 
 
 
87
Two (Fig. 29A).  To determine whether Cdk1/
independently or within a large multi-protei mplex, a glutathione bea n 
from S- and M-phase extracts was performe s sh  in Fig. 2 1 and B-
Raf were readily detectable in GST- B complexes isolated from
extracts.  In contrast, glutathione beads pull-down from S-phase extracts, which do not 
contain GST-conjugated cyclin B, failed to precipitate either B-Raf or Cdk1.  These 
studies were extended into Xenopus egg cycling extracts to exam
Cdk1/cyclin B and B-Raf interactions during the embryonic cell cycle.  C
immunoprecipitates from t  of cycling extract were analyzed by 
Western blotting for both B-Raf and Cdk1 protein or subjected to an 
assays to measure Cdk1 activity.  Cell cycle 
nuclear formation, nuclear envelope breakdow atin condensation.  The results 
clearly show that B-Raf associates w dk1/cyclin B complexes during m
interaction parallels the activation of Cdk1 (Fig. 29C).  Analogous experim
performed by using Cdk1 antibody.  Cdk1 immunocomplexes were purified from
course aliquots of cycling extracts and analyzed for the presence of B-Raf and Cdk1 by 
Western blotting as well as for Cdk1/cy  H1 
kinase assay.   Similar to the results 
observed an increase in B-Raf co-immunoprecipitation at the beginning of
overlapped with activation of Cdk1/cyclin B complexes (Fig. 29D).  Thus, these data 
reveal that B-Raf directly associates  active Cdk1/cyclin B at m
GST-cyclin B and B-Raf were co-purified 
n co
d.  A
ds pull-dow
9B, both Cdk
 M-phase arrested 
yclin B 
in vitro H1 kinase 
acts was assessed by 
itosis and this 
ents were 
 time-
 to an in vitro
 mitosis, which 
itosis.   
own
cyclin 
ine endogenous 
ime-course aliquots
progression of the extr
n and chrom
ith C
clin B activity by applying them
obtained with Cyclin B immunoprecipitates, I 
with
 
  
 
Figure 29.  B-Raf associates with active Cdk1/cyclin B complexes during mitosis 
A. MonoQ column fraction containing partially purified mitotic MEK kinase activity 
was analyzed by B-Raf, cyclin B, and Cdk1 Western blotting.  B. Cdk1/GST-cyclin B
complexes were purified from M-phase arrested extracts by using Glutathione beads.
C. Cyclin B immuno-complexes were precipitated from aliquots of cycling
and subjected to B-Raf and Cdk1 Western blotting, and an in vitro H1 kina
 
 
 
  
 extracts 
se assay to 
measure an associated Cdk1 activity.  D. Cdk1 immuno-complexes were precipitated 
from aliquots of cycling extracts and subjected to B-Raf and Cdk1 Western blotting, 
and an in vitro H1 kinase assay. 
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Cdk1/cyclin B (and MAPK) directly phosphorylates B-Raf in M-phase arrested 
Xenopus egg extracts 
B-Raf directly associates with active Cdk1/cyclin B complexes and its activation 
occurs downstream of and depends on active Cdk1/cyclin B.  All these data suggest that 
B-Raf could be a direct target of Cdk1/cyclin B.  To clarify this, I decided to study 
whether phosphorylation of B-Raf in mitotic Xenopus egg extracts depends on 
Cdk1/cyclin B.  Specifically, I analyzed the status of B-Raf phosphorylation in M-phase 
arrested extracts where Cdk1/cyclin B activity was selectively blocked by Flavopiridol 
treatment.  Under these conditions, I observed a minor reduction in B-Raf’s mitotic 
electrophoretic mobility (Fig. 30, third lane).  To obtain further evidence that Cdk1/cyclin 
B phosphorylate B-Raf at mitosis, I decided to immunopurify B-Raf from M-phase 
arrested extracts and subject it to Western blot analysis with phospho-Cdk substrate 
antibodies.  It is well established that active Cdks phosphorylate their substrates at the 
Serine/Threonine residue within the conserved Serine/Threonine-Proline-X-
Lysine/Leucine sequence (Nigg, 1991).  I decided to take advantage of commercially 
available phospho-antibodies, which recognize both Cdk and MAPK phosphorylated 
substrates at the consensus sequences S*XK/L and PXS*P respectively.  Since these 
antibodies may recognize both Cdk and MAPK phosphorylation, I prepared M-phase 
e  
w
in
o
xtracts inhibited either for Cdk1/cyclin B (treated with Flavopiridol) or MAPK (treated
ith U0126, a MEK inhibitor) as well as M-phase extract where both kinases were 
hibited by the treatment with both inhibitors. As shown in Figure 30, phosphorylation 
f B-Raf at the PXS*P/S*PXK/L sites is dramatically increased from S- to M-phase  
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Figure 30.  Cdk1/cyclin B (and MAPK) directly phosphorylates B-Raf in M-phase 
arrested Xenopus egg extracts 
 
MEK correspondently.  B-Raf phosphorylation  was analyzed by monitoring B-Raf 
shift and reactivity of B-Raf immunoprecipitates with phospho-Cdk/MAPK substrate 
Extracts were treated with Flavopiridol and/or U0126 to inhibit Cdk1/cyclin B and 
antibodies (PXS*P/S*PXK/L). 
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(fourth lane).  Importantly, inhibition of Cdk1/cyclin B led to a reduction in B-Raf’s 
phosphrylation (Fig. 30, forth lane).  This indicates that Cdk1/cyclin B directly 
phosphorylates B-Raf at Cdks consensus phospho-site(s) during mitosis.  Interestingly, 
data presented in Figure 30, fourth lane, demonstrates also that MAPK as well directly 
targets B-Raf at mitosis.  Studies on MAPK’s involv  the regulation of mitotic B-
Raf are presented in pter . 
dk1/cyclin B directly phosphorylates Xenopus B-Raf in vitro at a conserved 
residue Serine-144  
enopus B-Raf contains two conserved SPXK sequences, which represent 
potential Cdk consensus sites (Fig. 31).  Interestingly, the first N e most 
closely resembles a sequence of a Cdk1/cyclin B preferential phosphorylation site, which 
was characterized as of K/R-S/T-P-Polar amino acid-K/L (Moreno and Nurse, 1990).  
Based on the results presented in the previous section, Serine residues within these two 
sites (namely, Serine-144 and Serine-328) are possible targets for Cdk1/cyclin B 
phosphorylation.  To address this directly, I prepared recombinant non-phosphorylatable 
X c-tagged B-Raf mutants.  Briefly, Xenopus B-raf coding sequence, cloned in 
the Guadagno lab, was sub-cloned into modified pGEM vector and subjected to site-
directed mutagenesis to produce Ser144Ala, Ser-328-Ala and Ser-144-Ala/Ser-328-Ala 
mutants.  Corresponding mRNAs were synthesized by an 
an  extracts as described under the Materials and 
M
ement in
 Cha  Five
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d translated in CSF Xenopus egg
ethods.  The mutant as well as non-mutated myc-B-Raf proteins were purified by the  
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B-Raf protein 
Figure 31.  Conserved putative Cdk1/cyclin B phosphorylation sites in Xenopus 
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means of myc-tag antibodies and used as substrates for an in vitro phosphorylation by 
active recombinant Cdk1/cyclin B in the presence of radioactive ATP.  As shown in 
Figure 32, non-mutated myc-B-Raf was readily radiolabeled by Cdk1/cyclin B, 
demonstrating that B-Raf can be directly phosphorylated by Cdk1/cyclin B.  Importantly, 
the only Ser-328-Ala mutant displayed a phosphorylation by Cdk1/cyclin B (Fig. 32).  
This data indicates that B-Raf’s Serine-144 is the main target of Cdk1/cyclin B 
phosphorylation in vitro.  This is the first evidence that B-Raf can be directly 
phosphorylated by Cdk1/cyclin B in vitro and that this phosphorylation occurs 
preferentially at the conserved Serine-144 residue within the Cdk consensus sequence.  
Note that to reduce the possibility of irrelevant myc-B-Raf radiolabeling because of B-
Raf autophosphorylation activity, all recombinant myc-B-Raf proteins used in this assay 
were kinase dead (KD) due to mutation in the ATP binding domain. 
 
Ser-144-Ala B-Raf mutant is not activated in an M-phase dependent manner 
Data described in the previous section implies that Cdk1/cyclin B mediated 
phosphorylation at Serine-144 may regulate mitotic activation of B-Raf in Xenopus egg 
extracts.  If this prediction is true, than the M-phase specific activation of non-
phosphoralatable Ser-144-Ala myc-B-Raf mutant should be blocked.  To test this, I 
directly measured activities of wild type (WT) and Ser-144-Ala myc-B-Raf proteins in S- 
and M-phase arrested extracts.  Briefly, the recombinant WT and mutant myc-B-Raf 
proteins were expressed in Xenopus CSF extracts.  Aliquots of the extracts containing the 
recombinant myc-tag B-Raf were introduced into S-phase arrested extracts.  After 1 hr  
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Figure 32.  Cdk1/cyclin B directly phosphorylates Xenopus B-Raf in vitro at a 
WT and mutant myc-B-Raf proteins were expressed in Xenopus egg extracts, purified by 
recombinant Cdk1/cyclin B.  Phosphorylation of myc-B-Raf proteins was visualized by 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
conserved Serine-144 
means of myc-tag antibodies and subjected to an in vitro phosphorylation by active 
autoradiography.  Myt-tag Western blotting was performed as a loading control. 
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incubation the extracts were driven into M-phase by the addition of recombinant non-
egradable cyclin B.  myc-B-Raf proteins were purified from S- and M-phase extracts 
with myc-tag antibodies and subjected to an in vitro linked kinase assay to assess their 
ctivities.  As expected, wild type myc-B-Raf underwent a 3-4 fold activation at M-phase 
ig. 33).  Importantly, the mutant non-phosphorylatable Ser-144-Ala myc-B-Raf was not 
ctivated and its activity remained essentially the same from S- to M-phase (Fig. 33).  
his shows that Ser-144-Ala B-Raf mutant is not responsive to an M-phase specific 
ctivation.   
Ser-144-Ala B-Raf mutant does not activate MAPK cascade during mitosis 
Is phosphorylation at Serine-144 important for B-Raf’s funct
EK kinase?  To answer this, I studied whether the mutant Ser-144-Ala myc-B-Raf can 
scue mitotic activation of the MEK/MAPK cascade in B-Raf depleted extracts.  
ndogenous B-Raf was immunodepleted form S-phase arrested extracts as described 
arlier (see Chapter Two).  Then recombinant wild type or Ser-144-Ala myc-B-Raf 
roteins were introduced into B-Raf depleted extracts (Fig. 34A) and the extracts were 
driven into M-phase by the addition of recombinant non-degradable cyclin B.  1.0 µl 
very 20 min and analyzed for MAPK activation by phospho-
dition 
f recombinant wild type myc-B-Raf reconstituted mitotic activation of MAPK at levels 
milar to those observed in control (non-depleted) extracts (Fig. 34B, first and third  
d
a
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a
T
a
 
ioning as a mitotic 
M
re
E
e
p
aliquots were collected e
MAPK Western blotting.  As expected, depletion of endogenous B-Raf abrogated 
activation of MAPK in M-phase arrested extracts (Fig. 34B, second lane).  The ad
o
si
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Figure 33.  Ser-144-Ala B-Raf mutant is not activated in an M-phase 
dependent manner 
in S- and M-phase arrested B-Raf depleted extracts, immunopurified by means 
of myc-tag antibodies and subjected to an in vitro linked kinase assay.   
Wild type (WT) and Ser-144-Ala (S144A) myc-B-Raf proteins were incubated 
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3 er-144-Ala m -Raf mutant does not activate MAPK cascade during mitosis 
el B-Raf prot ock and B-Raf depleted Xen egg extracts, and in B-Raf depleted extracts 
e  with recomb t wild-ty r Ser-1 a mu  myc-B-Raf.  B.  Ser-144-Ala myc B-Raf mutant, 
wi pe myc B- M-phase B-Raf-depleted extracts.  Mock and B-Raf 
d acts, and B-R pleted e ts supp binant wild-type or Ser-144-Ala myc-B-Raf were 
itosis with re inant non- the indicated times aliquots were collected and MAPK 
as assessed by phospho-MAPK West
 
opus 
tated
n in 
nted with recom
Figure 
A.  Lev
supplem
unlike 
deplete
driven into m
activation w
4.  S
s of 
nted
ld-ty
extr
yc-B
ein in m
inan
af de
comb
pe o
Raf, does not rescue MAPK activatio
xtrac
44-Al
leme
degradable cyclin B. At 
ern blotting. 
 
 
 
98
lanes).  Importantly, the addition of equivalent amount of non-phosphorylatable Ser-144-
Ala myc-B-Raf mutant failed to rescue MAPK activation at mitosis d 
extracts (Fig. 34B, fourth lane).  Thus, phosphorylation of Serine-144 residue within the 
Cdk phosphorylation sequence contributes to activation of B-Raf, and enables B-Raf to 
function as an M-phase MEK kinase. 
 
Ser-144-Ala B-Raf mutant exerts a dominant-negative effect o
during mitosis 
Since Ser-144-Ala myc-B-Raf does not activate MAPK cascade at m
Raf depleted extracts, I decided to study whether this mutant can com
endogenous B-Raf and interfere with mitotic activation of MAPK in non-depleted 
extracts.  Similar amounts of wild type and Ser-144-Ala myc-B-Raf proteins (Fig. 35, 
first lane), equivalent to the levels of endogenous B-Raf, were
phase arrested Xenopus egg extracts.  Following 1.0 hr incubation, extracts were analyzed 
for the levels of MAPK activation by phospho-MAPK Wester
Figure 35 (second lane), MAPK phosphorylation in M-phase ex
Ser-144-Ala myc-B-Raf mutant was significantly reduced comp
supplemented with wild type myc-B-Raf.  Note that activation of Cdk1/cyclin B 
resembled a normal pattern in both extracts (Fig. 35, third lane s the 
importance of phosphorylation at the Ser-144 for B-Raf’s ability to function as an M-
phase MEK kinase.  Furthermore, it suggests that the Ser-144-Ala m
 
in B-Raf deplete
n MAPK activation 
itosis in B-
pete with 
ented with 
yc-B-Raf mutant can  
 introduced into S- and M-
n blotting.  As shown in 
tracts supplem
ared to M-phase extracts 
).  This data reconfirm
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Cdk1 activity 
e Figure 35. Ser-144-Ala B-Raf mutant blocks MAPK activation in M-phas
extracts 
Equal amounts of wild-type and mutant Ser-144-Ala myc-B-Raf proteins were 
incubated in S- or M-phase arrested Xenopus egg extracts.  MAPK activation was 
assessed by phospho-MAPK Western blotting.  Note that addition of myc-B-Raf 
proteins did not affect activation of Cdk1/cyclin B.  
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e utilized as a potential research tool to selectively inhibit MAPK signaling at mitosis in 
enopus egg extracts and, possibly, tissue cell cultures. 
 
Conclusions 
The data ented in this Chapter rev  a novel mechanism of regulation for 
e B-Raf/MEK/MAPK cascade.  For the first time, I demonstrate that B-Raf serves as a 
irect link between the mitotic cell cycle machinery and the MAPK pathway.  Indeed, 
dk1/cyclin B associates and phosphorylates B-Raf at mitosis in Xenopus egg extracts.  
ata from an in vitro kinase reaction show that active Cdk1/cyclin B directly 
hosphorylates B-Raf at its conserved Serine-144 residue.  Biochemical analysis 
emonstrated that phosphorylation of B-Raf at this residue is critical for the M-phase 
ependent activation of B-Raf as well as a functionality c MEK 
inase.  In conclusion, I identify a new B-Raf regulatory site and provide insights into the 
echanism that regulates the activation of the MAPK pathway during mitosis (Fig. 36). 
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Figure 36.  Cdk1/cyclin B directly phosphorylates B-Raf at Serine-144 to 
trigger the B-Raf/MEK/MAPK cascade 
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Chapter Five 
Negative Feedback Regulation of Mitotic B-Raf by MAPK 
n 
The data presented in the previous chapters indicate that during mitosis B-Raf can 
e regulated by MAPK.  F ll, I repeatedly observed that the pronounced B-Raf’s 
hypershift during mitosis coincides wi activation (see Fig. 20B and Fig. 30).  A 
similar correlation was recently reported in activated Human B lymphocytes (Brummer et 
al., 2003).  More importantly, the authors showed that Human B-Raf is directly 
phosphorylated by MAPK at the conserved C-te inal sequence and that this causes B-
Raf hypershift (Brummer et al., 2003).  Since the C-terminal MAPK phosphorylation site 
is conserved in Xenopus B-Raf, it is important to elucidate whether the same mechanism 
operates during mitosis.  Indeed, blocking of MAPK activation in M-phase arrested 
Xeno K inhibitor U0126 reduces the levels of 
B-Raf’s mitotic hyperphosphorylation (see Fig. 30).  In addition, the treatment with a 
MEK inhibitor U0126 reduces B-Raf’s reacti ity with Cdk/MAPK phospho-substrate 
antibodies (see Fig. 30).  Thus, the goal of the studies presented in this Chapter is to 
further explore the MAPK-dependent phosphorylation of B-Raf in Xenopus egg extracts 
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during mitosis and characterize its role in regulating activity of mitotic B-Raf.  
Specifically, data that describe interactions between endogenous B-Raf and MAPK 
during M-phase and phosphorylation of Xenopus B-Raf by MAPK will be presented.  
Finally, by observing changes in B-R  conditions when the MAPK-
mediated feed ylation on 
-Raf activity will be characterized. 
 
Results 
xtracts is 
 
af activity under
back is blocked or enhanced, the effect of this MAPK phosphor
B
 
Mitotic hyperphosphorylation of B-Raf depends on active MAPK 
B-Raf was previously reported to undergo an electrophoretic mobility shift during 
B lymphocyte activation through feedback phosphorylation by ERK (Brummer et al., 
2003).  Therefore, I asked whether B-Raf‘s hyper-shift in mitotic Xenopus egg e
dependent on MAPK.  To answer this, Xenopus egg extracts were treated with a MEK-
specific inhibitor U0126 prior to cycling them into mitosis.  The immunoblot analysis 
confirmed inhibition of MAPK, which led to blocking M-phase specific 
hyperphosphorylation of B-Raf (Fig. 37A, see as well Fig. 30).  Similar results were 
observed in Xenopus cycling extracts treated with the MEK inhibitor U0126 (Fig. 37B).  
Note that the MEK inhibitor U0126 does not affect Cdk1 activation in Xenopus egg 
extracts, as assessed both by microscopic analysis of nuclear envelope 
breakdown/chromatin condensation and by measuring Cdk1 activity in an in vitro H1
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e mitotic kinase assay (see Fig. 30).  Thus, MAPK feedback substantially contributes to th
hypershift of B-Raf. 
 
 
 
 
 
 
 
 
 
 
 
Figure 37.  Mitotic hyperphosphorylation of B-Raf depends on activ
S-phase extracts were cycled into M-phase with recombinant GST-cyclin B in the 
 
e MAPK 
A.  Mitotic hyper-shift of B-Raf is blocked in the presence of the MEK inhibitor U0126. 
presence of 50 mkM U0126 or DMSO.  Equal aliquots of the egg extracts were 
blotting.   
Raf 
during mitosis. Aliquots of cycling extracts were separated by 8% SDS-PAGE and 
separated by 8% SDS-PAGE and analyzed by B-Raf and phospho-MAPK Western 
B.  Treatment of Xenopus cycling egg extracts with U0126 blocks hyper-shift of B-
analyzed by Western blotting.   
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ctly phosphorylates B-Raf at mitosis, then it might be possible to 
detect the association between these two proteins.  To test this possibility, equivalent 
amounts of MAPK were immunoprecipitated from S- and M-phase egg extracts and 
subjected to Western analysis with B-Raf antibodies.  The levels of B-Raf co-
immunoprecipiated with MAPK were much higher in the MAPK complexes isolated 
from M-phase arrested extracts compared to S-phase extracts (Fig. 38A).  
To analyze dynamics of B-Raf/MAPK interaction during mitosis, I studied how 
B-Raf/MAPK association is changing in Xenopus egg cycling extracts.  MAPK was 
immunoprecipitated from frozen time-course aliquots and obtained immunoprecipitates 
were subjected to B-Raf Western blotting.  Interestingly, I detected a two-phase B-
Raf/MAPK association throughout mitotic progression (Fig. 38B).  First, B-Raf was 
associated with MAPK at the on-set of mitosis, which overlapped with Cdk1/cyclin B 
activation.  Secondly, B-Raf was bound to MAPK during middle-late mitosis, which 
coincided with robust MAPK activity.  Since I repeatedly observe the appearance of B-
R  is 
te PK 
m
b
Mitotic B-Raf associates with MAPK 
If MAPK dire
af’s mitotic hyper-shift during middle-late stages of mitosis (Fig. 20B, Fig. 25B), it
mpting to speculate that during the second phase of B-Raf/MAPK interaction, MA
ay exert a direct B-Raf  phosphorylation.  Taken together, my data show that B-Raf 
ecomes associated with MAPK in egg extracts specifically during M-phase.   
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Figure 38.  Mitotic B-Raf associates with MAPK 
ntrol 
immunoprecipitates from S- and M-phase extracts were separated on 10% SDS-PAGE 
and analyzed by B-Raf and MAPK Western blotting.  B.  B-Raf associates with 
MAPK twice throughout mitosis in cycling extracts.  MAPK immunoprecipitates from 
aliquo  of cycling extracts collected at the indicated time-points were separated on 
10% SDS-PAGE and analyzed by B-Raf and MAPK Western blotting.  Cdk1 activity 
of the corresponding aliquots was assessed in an in vitro histone H1 kinase assay.  
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 directly phosphorylates Xenopus B-Raf in vitro and causes B-Raf’s 
electrophoretic mobility shift 
he association APK h B- ugge at it might contribute directly to 
B-Raf hyperphosphorylation.  To study this, I perfor an in vitro kinase assay using 
endogenous Xenopus B-Raf isolated from S-phase extracts as a potential substrate for 
active recombinant ERK2.  The results show that active ERK2 readily phosphorylated B-
Raf in vitro (Fig. 39A).  Moreover, phosphorylation of B-Raf by ERK2 caused a 
reduction in the electrophoretic mobility of B-Raf (Fig. 39B, forth and fifth lanes).  
Therefore, I conclude that MAPK can directly phosphorylate Xenopus B-Raf and 
contrib e -Raf’s mitotic shift. 
 directly phosphorylates Xenopus B-Raf in vitro at the conserved C-
terminal SPKTP motif  
uman B-Raf is phosphorylated directly by ERK2 at both MAPK consensus 
S/TP sites within the C-terminal SPKTP motif (Brummer et al., 2003).  However, the 
effect of this phosphorylation on B-Raf activity has not been described.  Since the 
SPKTP motif is conserved between Human and Xenopus B-Raf (Fig. 40A), I asked 
whether the same phosphorylation sites in Xenopus B-Raf protein are targeted by MAPK.  
T
r inal 
S ild 
ty sted  
MAPK
T  of M  wit Raf s sts th
med 
ut  to B
 
MAPK
H
o do this, I utilized a site-directed mutagenesis technique and introduced alanine 
esidues at the two phospho-acceptor sites (serine and threonine) within the C-term
PKTP motif to created a B-Raf non-phosphorylatable APKAP mutant.  mRNAs of w
pe (WT) and mutant (MT) myc-tagged Xenopus B-Raf were translated in CSF-arre
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immunoprecipitated from S-phase arrested  egg extracts and subjected 
 B-Raf IP S-phase 
 
 
 
 
 
 
 
B-Raf-P 
ERK2 - + 
32-P-ATP + + A 
 
 
 
 
 
 
 
 
 
Figure 39.  MAPK directly phosphorylates Xenopus B-Raf in vitro and 
causes B-Raf’s electrophoretic mobility shift 
A.  MAPK directly phosphorylate immunopurified B-Raf in vitro.  B-Raf was 
Xenopus
to an in vitro phosphorylation by active recombinant ERK2 in the presence of 
radioactive ATP.  Radiolabeling of B-Raf protein was visualized by 
autoradiography.  B.  Phosphorylation of B-Raf by MAPK causes B-Raf 
hypershift.  B-Raf was immunopurified from S-phase arrested extracts and 
incubated in vitro with active recombinant ERK2 in the presence or absence of 
ATP.  Reaction mixer was separated by 8% SDS-PAGE and B-Raf was analyzed 
by B-Raf immunoblotting.  
B 
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xtracts (see Materials and Methods for details).  Then, the recombinant myc-tagged B-
af proteins were re-isolated by ipitati
bje  to an in vitro phosphor on ctive r K2 in the presence of 
dioactive ATP.  As shown in Figure 40B, radio-labeling of the Xenopus myc-tagged B-
af mutant in the presence of active ERK2 was strongly suppressed compared to wild 
pe myc-B-Raf demonstrating that these conserved sites are targeted by ERK2. 
 
-terminal APKAP B-Raf mutant displays a reduced MAPK-dependent shift at 
itosis 
To study whether MAPK-mediated phosphorylation at B-Raf’s C-terminal 
PKTP motif occurs during mitosis, I analyzed the phosphorylation status of the C-
rminal B-Raf mutant in M-phase arrested Xenopus egg extracts.  The non-
hosphorylatable myc-B-Raf APKAP mutant introduced to M-phase arrested extracts.  
fter 1.0 hr incubation, the electrophoretic mobility of mutant B-Raf was analyzed by 
% SDS-PAGE.  The data showed that the mitotic hypershift of B-Raf (APKAP) mutant 
as m ourth 
nes g 
xtra as 
igh (Fig. 40C, 
ird
hos
 
e
R immunoprec on with myc-tag antibodies and 
su cted ylati by a ecombinant ER
ra
R
ty
C
m
S
te
p
A
8
w arkedly reduced compared to that of wild type B-Raf (Fig. 40C, third and f
la ) suggesting that these MAPK sites are phosphorylated in Xenopus M-phase eg
cts.  Interestingly, the electrophoretic mobility of the B-Raf (APKAP) mutant w
tly increased following inhibition of MAPK with a MEK inhibitor U0126 
 and sixth lanes).  This indicates that perhaps some other B-Raf site(s) are 
phorylated in an MAPK-dependent manner during mitosis.   
e
sl
th
p
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Figure 40.  MAPK directly phosphorylates Xenopus B-Raf at the conserved 
A. Amino acid alignment of the C-terminal Human (P15056) and Xenopus 
and phosphorylation sites are indicated.  B. The conserved C-terminal SPKTP 
wild type (WT) and the C-terminal APKAP mutant (MT) myc-B-Raf proteins 
epitope antibodies and subjected to an in vitro kinase reaction with recombinant 
by autoradiography (top panel).  Levels of myc-B-Raf per reaction were estimated 
Mutant (MT) B-Raf displays a reduced M-phase electrophoretic mobility.  
ere 
incubated in S-, M-phase extracts, or M-phase extracts pre-treated with U0126.  
analyzed by 
Western analysis.   
C-terminal SPKTP motif 
(AAZ06667) B-Raf regions using MegAlign software.  Putative MAPK binding 
motif in Xenopus B-Raf is phosphorylated by ERK2.  Recombinant full-length 
were expressed in Xenopus egg extracts as described, immunopurified by myc-
active Erk2 and gamma-32P-ATP.  Phosphorylation of myc-B-Raf was detected 
by Western analysis using myc epitope antibodies (bottom panel).  C.  APKAP 
Recombinant wild type (WT) or APKAP mutant (MT) myc-B-Raf proteins w
Phosphorylation status of the recombinant B-Raf proteins was 
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C-terminal APKAP B-Raf mutant possesses an elevated MEK kinase activity 
Currently, it is unknown whether the MAPK-mediated feedback phosphorylation 
of B-Raf at the conserved C-terminal SPKTP motif plays a role in regulating its kinase 
activity.  Therefore, I analyzed the activity of the myc-tagged B-Raf (APKAP) mutant in 
Xenopus egg extracts.  Myc-tagged B-Raf wild type and (APKAP) mutant proteins were 
incubated in either S- or M-phase egg extracts, re-isolated by means of myc-tag 
antibodies, and subjected to an in vitro linked kinase assay.  As expected, wild type B-
Raf kinase activity was 2-4-fold higher in M-phase egg extracts than in S-phase extracts 
(Fig. 41, bars 1 and 3).  Interestingly, the kinase activity of the non-phosphorylatable B-
Raf APKAP mutant isolated from M-phase egg extracts was 2-3 fold higher than activity 
of wild type B-Raf (Fig. 41, bars 3 and 4).  This suggests that phosphorylation of the C-
terminal SPKTP motif renders a negative effect on B-Raf activity.  Importantly, the C-
terminal APKAP B-Raf mutant was still activated in an M-phase specific manner (Fig. 
41, bars 2 and 4).  This implies that the C-terminal mutation does not interfere with the 
abi ed 
as  in S-
pha ing 
the k 
reg y an 
ele
pho ack 
phosphorylation at these sites negatively regulates B-Raf during mitosis. 
lity of the mutant B-Raf to respond to activation mitotic signaling inputs.  I observ
well that the C-terminal APKAP B-Raf mutant possesses a higher kinase activity
se extracts compared to wild type B-Raf (Fig. 41, bars 1 and 2).  Since it is miss
 MAPK phosphorylation sites, which potentially are involved in negative feed bac
ulation, this B-Raf mutant may be more resistant to inactivation and, thus, displa
vated kinase activity at S-phase.  Collectively, these results show that MAPK 
sphorylates B-Raf at the C-terminal SPKTP sequence and suggest that feedb
  
 
 
 
 
 
Figure 41.  Phosphorylation-defective C-terminal APKAP B-Raf mutant 
possesses an elevated MEK kinase activity 
Xenopus wild-type (WT) or APKAP mutant (MT) full-length myc-B-Raf proteins 
epitope antibodies and subjected to an in vitro linked kinase assay.  Levels of 
were incubated either in S- or M-phase extracts, immunopurified by means of myc-
myc-B-
Raf per reaction were estimated by Western blotting.   
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Inhibition of MAPK activity with a MEK inhibitor U0126 activates B-Raf in M-
phase arrested extracts 
If MAPK feedback negatively regulates B-Raf activity in Xenopus mitotic egg 
extracts, then I predict that blocking MAPK activity would lead to an increase in B-Raf 
activity at mitosis.  To test this prediction, I pretreated Xenopus egg extracts with a MEK 
specific inhibitor U0126 before driving them into M-phase.  Inhibition of MEK blocks 
activation of MAPK and, thus, eliminates the MAPK-mediated feedback loop.  Then 
endogenous B-Raf was immunopurified from control (treated with DMSO) and U0126 
treated extracts and subjected to an in vitro linked kinase assay.  The results show that B-
Raf activity is enhanced in the absence of MAPK feedback compared to non-treated 
extracts (Fig. 42).   
 
Over-activation of MAPK with constitutively active recombinant MEK inhibits B-
Raf activity in M-phase arrested extracts 
Likewise, I tested whether B-Raf activity would decrease under conditions of 
constant MAPK feedback.  Indeed, the addition of a constitutively active recombinant 
MEK to M-phase arrested egg extracts maintained high levels of MAPK activity and led 
to a ate 
MA -
Raf
 substantial decrease in B-Raf activity (Fig. 43). Together, these results implic
PK in a feedback loop, which phosphorylates the C-terminal SPKTP sequence of B
 to negatively regulate its activity. 
 
 Figure 42. Inhibition of MAPK activity with a MEK inhibitor U0126 activates 
To inhibit MAPK activation during mitosis, S-phase arrested extracts were 
M-phase with recombinant non-degradable cyclin B. After 1.0 hr incubation at 
B-Raf in M-phase arrested extracts  
supplemented with a MEK inhibitor, U0126, concomitantly with driving them into 
room temperature extracts were quick frozen.  MAPK activation was assessed by 
phospho-MAPK Western blotting and activity of B-Raf was measured in an in 
vitro linked kinase assay.  Loading of immunopurified B-Raf per kinase reaction 
was verified by B-Raf Western blotting.  Note that the addition of the MEK 
inhibitor did not affect Cdk1/cyclin B activity (not shown). 
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Figure 43.  Over-activation of MAPK with constitutively active recombinant 
MEK inhibits B-Raf activity in M-phase arrested extracts  
To over-activate MAPK during mitosis, M-phase arrested extracts were 
supplemented with recombinant constitutively active MEK.  After 1.0 hr incubation
at room temperature extracts were quick frozen.  MAPK activation was assessed b
phospho-MAPK Western blotting and activity of B-Raf was measured in an in vitr
linked kinase asssay.  Loading of immunopurified B-Raf per kinase reaction was 
verified by B-Raf Western blotting.  Note that the addition of constitutively active 
MEK did not affect Cdk1/cyclin B activity. 
o 
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Conclusions 
 
The experiments presented in this Chapter demonstrate that mitotic B-Raf in 
Xenopus egg extracts undergoes a direct regulation by MAPK.  First, B-Raf associates 
with MAPK specifically during M-phase and its mitotic hyperphosphorylation depends 
on active MAPK.  Secondly, active MAPK can directly phosphorylate Xenopus B-Raf in 
vitro and induce its electrophoretic mobility shift at levels similar to that of mitotic B-
Raf.  Interestingly, the in vitro phosphorylation of B-Raf by MAPK as well as MAPK-
dependent phosphorylation of B-Raf in mitotic extracts occurs predominantly at the C-
terminal conserved SPKTP motif.  Elimination of this phosphorylation site enhances 
activity of mitotic B-Raf.  Further, inhibition or over-activation of MAPK in M-phase 
arrested Xenopus egg extracts oppositely affects B-Raf activity: enhances or diminishes 
it, respectively.  These results together demonstrate that the MAPK-mediated feedback 
phosphorylation at the C-terminus negatively regulates B-Raf activity during mitosis.  
Thus, I propose the negative MAPK-mediated feedback loop contributes to down-
regulation of the B-Raf/MEK/MAPK at the late mitosis (Fig. 44).   
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M-phase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 44.  MAPK directly phosphorylates mitotic B-Raf at Serine-784 
and Threonine-787 to inhibit B-Raf activity 
B-Raf S784
T787
PP
MEK 
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Chapter Six 
Characterization of large multi-protein c mplexes containing active mitotic B-Raf  
 
Introduction 
B-Raf is known to be regulated l of protein-protein interaction.  
Identification of proteins interacting with B-Raf under different biological contexts is 
important for deciphering how B-Raf erse cellular processes.  The majority 
of known B-Raf interacting proteins were identified by co-immunoprecipitation 
technique or the yeast two-hybrid system (Berruti, 2000; Papin et al., 1996).  On the other 
hand, some studies report that B-Raf can be purified within large multi-protein 
comple
implies that regula bly may be much more complex 
than currently understood.  Proteomics is a powerful approach for analyzing multi-protein 
complexes.  The goal of research presented on this Chapter is to characterize the partially 
purified large molecular weight multi-protein complexes that contain active mitotic B-
Raf.  In addition, proteomics data obtained by using mass spectrometry analysis will be 
presented to describe the candidate components of the mitotic B-Raf complexes. 
 
 
 
 
o
 
at the leve
 regulates div
xes (Jaiswal et al., 1996; Mizutani et al., 2001; Mizutani et al., 1998).  This 
tion of B-Raf by protein-protein assem
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Results 
 
Purification of mitotic MEK kinase a ity as B-Raf containing large multi-
protein complexes 
ig.13A), which leads to an enrichment of MEK kinase activity present in M-phase 
arrested Xenopus egg extracts.  Briefly s M-phase egg extracts were 
subjected to two rounds of ultracentrifugation (100,000 g for 1.5 hr) to obtain the 
cytosol
vations 
eins are 
 of 
 
ivity 
ay be represented by multi-protein complex(s) containing B-Raf.  To obtain a direct  
ctiv
As described in Chapter Two, I have developed a purification protocol (see 
F
, crude Xenopu
ic fraction.  The M-phase cytosol was fractionated by ammonium sulfate 
precipitation.  A 0-20% ammonium sulfate cut, containing 90% of the MEK kinase 
activity, was sequentially subjected to separation on two anion-exchange columns, 
HiTrap Q Sepharose HP and Mono Q HR 5/5.  During this purification two obser
relevant to this Chapter were made.  First, the MEK kinase activity elutes as a single peak 
from the final Mono Q column (Fig. 13B), which may imply that the eluted prot
purified within one large complex.  Secondly, Silver stain analysis of equal amounts
protein (5 µg) at each of the purification step detected several protein bands, some of 
which are increased in intensity at each successive purification step (Fig. 45) indicating 
that they may be associated with the purified MEK kinase activity.  Western analysis 
shows that B-Raf (95 kDa) is enriched in the final purified fraction (see Fig. 15, second
lane) and most likely represents one on these protein bands.  Thus, there are at least two 
indirect observations indicating that the partially purified mitotic MEK kinase act
m
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progression of the M-phase MEK kinase purification  
GE 
and their protein compositions were visualized by Silver staining. 
 
Figure 45.  Protein profiles of mitotic MEK kinase active fraction throughout 
Equal amounts (5 µg) of MEK kinase active fractions were separated by 8% SDS-PA
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evidence whether th iv  p u  separately or together in a 
comple  at the final (  Q m a ra g of proteins of the purified MEK 
kinase active fraction on a 5-20% gradient native polyacrylamide gel under non-
denatur onditions to allow protein complexes to remain together.  After completion 
of the run, I visualized a pattern of protein separation by Silver staining.   A single strong 
broad band was detected (with a few weak minor bands below) suggesting that most of 
the pro ins in  mitotic MEK kinase active fraction are togethe complex 
(Fig. 46, first lane).  Is B-Raf a part of this large protein complex? er this, 
Western analysis was performed on the same sample.  The results show that the majority 
of B-Raf resided in the major higher molecular weight band (Fig. 46, second lane).  
Collectively, these results suggest that the purified mitotic MEK kinase activity 
represents large molecular weight complex(s), which include B-Raf and several other 
unknown proteins.  
entifi on of potential components of large multi-protein complexes 
containing active mitotic B-Raf 
I postulate that components of the purified mitotic MEK kinase active complex(s) 
mig , it 
is i
that both Cdk1 and cyclin B are present in the purified MEK kinase active fraction (see 
Fig. 29A) and show that they associate with B-Raf at mitosis in Xenopus egg extracts (see 
Fig. 29B, C and D).  To further characterize this protein complex, I used a proteomics  
ese ind
Mono
idual
 colu
rotei
n) st
ns co-p
ge, I 
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ing c
te  the r in a large 
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Id cati
ht serve a role in regulating B-Raf activation or function during mitosis.  Therefore
mportant to identify these proteins.  Fortuitously, I determined by Western analysis 
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Figure 46.  Mitotic MEK kinase activity purified from M-phase arrested 
Xenopus egg extracts resembles a large B-Raf-containing protein complex  
Final MEK kinase active fraction was run on a gradient non-denaturing PAGE and 
analyzed by Silver staining and B-Raf Western blotting.   
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pproach to identify the other proteins purified with the mitotic MEK kinase activity.  To 
o this, I performed a large-scale purification of the MEK kinase activity from Xenopus 
itotic egg extracts using an established four-step protocol (Fig. 13A).  50 µg of purified 
EK kinase activity wa tained with colloidal blue 
nvitrogen).  Fourteen protein bands detected by colloidal blue were carefully excised 
om the gel and pooled into three groups for Mass spectrometric (MS) analysis.  
equence analysis of trypsin-digested peptides was performed at the Harvard 
icrochemistry Facility by microcapillary reverse-phase HPLC nano-electrospray 
ndem mass spectrometry on a Finnigan quadrupole ion trap mass spectrometer.  The 
dividual MS/MS peptide spectra were then correlated with known protein sequences.  
 addition to B-Raf, Cdk1, and cyclin B, over 25 new proteins were identified (Table 2).   
Many of the proteins identified in the plex have 
stablished roles in actin cytoskeleton regulation (actin, filamin, talin 2, gelsolin), 
ceptor-mediated endocytosis (Adaptin, Epsin1, beta-adaptin 1 subunit, clathrin heavy 
hain, HABP1, and AP-2), nuclear transport and nuclear pore complex formation 
(CAS/Cse1, Nup93, importin beta 3, Nup 155), mitotic regulation (CAS/Cse1, APACD) 
and c t 
PA28
was identified by MS as a potential component of the B-Raf containing mitotic MEK 
inase active protein complex(s).  The identification of PA28 proteasome subunit 
pports the validity of my approach for discovering novel proteins that comprise a large 
multipr tein complex containing B-Raf.      
a
d
m
M s separated by SDS PAGE and s
(I
fr
S
M
ta
in
In
purified MEK kinase active com
e
re
c
hromatin-related functions (RPA, ATR).  The proteosome activator alpha subuni
, previously shown to be a B-Raf-specific interacting protein (Kalmes et al., 1998), 
k
su
o
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Name MW MS/MS Comments 
Table 2.  Proteins identified by Mass spectrometry in the final mitotic MEK kinase active 
fraction  
spectra 
Cytoskeletal proteins 
Beta-Actin  42 kD 53 Structural component of cytoskeleton 
Nup93 93 kD 35 Nucleoporin, a nuclear pore complex protein 
Filamin 280 kD 28 Non-muscle actin-binding scaffold protein 
Gelsolin  86 kD 17 Actin-binding de-polymerizing factor 
Nup155 155 kD 14 Nuclear pore complex protein 
Talin 2 220 kD 2 Adaptor between integrin and actin cytoskeleton 
Cellular Trafficking proteins 
Adaptin 90 kD 42 Mediator of intracellular Golgi trafficking  
Importin 120 kD 37 Mediator of nuclear transport 
beta 3 
CAS/CSE1 110 kD 27 Regulator of nuclear/cytosolic reshuffling of 
importin alpha 
AP-2 48 kD 9 Adaptor protein required for uptake of cargo 
proteins 
Beta-
Adaptin 1 
105 kD 7 A subunit of AP-1 complex involved in clathrin 
assembly in Golgi 
Clathrin, 184 kD 4 Structural component of Golgi trafficking 
heavy chain  vesicles  
HABP1 57 kD 4 Nucleus/mitochondria and extracellular 
trafficking agent  
Tom1 54 kD 2 Sorts ubiquitinated proteins into multivesicular 
bodies 
SNAP 32 kD 2 Golgi protein 
Epsin1 90 kD 2 Regulator of endocytosis 
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ontinued) 
 
Name MW  
spe
Comments 
Table 2.  Proteins identified by Mass spectrometry in purified mitotic MEK kinase active 
fraction (c
MS/MS
ctra 
Mitotic proteins 
CAS/CSE1   110 kD 27 Mitotic spindle checkpoint protein 
Apacd 29 kD 10 to Microtubule dynamics regulator; localizes 
centrosomes and midbody 
Epsin1 90 kD 2 Endocytosis; Cdk1/cyclin B substrate during 
mitosis 
DNA Metabolism proteins 
Replication   n 
Factor A 
70 kD 22 Assists T-antigen in initiating the replicatio
system 
Wellcome  4 Nucleotide metabolism  
CRC pSK 
ATR 292 kD 3 heckpoint regulator DNA damage c
Protein Stability Regulatory factors 
CCt8 60 kD 66 of the Cct chaperonin complex Subunit 
HSP70  70 kD 24 Chaperone protein 
PA-28-beta 28 kD 3 tor subunit Proteosome activa
Tom1 54 kD 2 cular Sorts ubiquitinated proteins into multivesi
bodies 
Intr llulace ar Metabolism Proteins 
Ndrg20 40 kD 16 lase Alpha/beta hydro
Aldolase   40 kD 10 Glucose metabolism 
Cn2 52 kD 9 lic dipeptidase  Cytoso
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Described above approaches for characterization of mitotic MEK kinase active 
co ) do not pr n n ular weight.  To get some insights 
into the size of the B-Raf cont itotic MEK kinase active complex(s), I used gel 
filt atog hich ws  on their sizes 
under native conditions.  First, th ten 00 
HR 10/30) was pre-calibrated with a mix cular weights.  After 
this, 2.6 mg of 20% ammonium sulfate p ed fraction containing B-Raf activity 
was applied to the column and s e conditions.  Aliquots of 
the ction subj  to
Western blotting to analyze size-wise distribution 
B-Raf protein respectively.  As shown in Figure 47, both mitotic MEK kinase activity 
an f were loca high 00- actions (# 
28-38).  This data is consistent with the idea that active mitotic B-Raf exists in large 
pro plexes.  ngly Raf  middle-range molecular 
we  (90- ), bu tal M actions was 
signif tly lower.  Sinc itotic MEK kinase a
represented by B-Raf (Fig. tic B-Raf functions in 
hig lar weig in co exe
Purification of mitotic B-Raf within large multi-protein complexes 
mplex(s ovide a estimatio
aining m
 of its molec
ration chrom raphy, w  allo  for the separation of proteins based
e re tion capacity of the column in use (Superdex 2
 of proteins of known mole
recipitat
eparated under the same nativ
 collected fra s were ected  an in vitro MEK kinase assay and B-Raf 
of the mitotic MEK kinase activity and 
d B-Ra ted in a er 4 700 kD molecular weight range of fr
tein com Interesti , B-  was also detected in
ight fractions 300 kD t to EK kinase activity of these fr
ican e m ctivity in Xenopus egg extracts is 
17), this may indicate that active mito
h molecu ht prote mpl s. 
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Figure 47.  Active mitotic B-Raf is a large 700-400 kD
2.6 mg of 20% am iu S d 0  0 fi o
colum for levels of MEK kinase activity by an in vitro M k e y f
the presence of B-R y st c si f t n 
capacity was calibr
 purified by gel filtration as a protein complex 
mon m sulfate precipitated fraction was separated on a uper ex 2 0 HR 10/3  gel ltrati n 
n.  Collected fractions were analyzed EK inas assa and 
af b  We ern blotting.  To determine mole ular zes o  the eluted proteins the column re entio
ated with a mix of proteins with known molecular weights. 
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If protein-protein interactions are important for B-Raf signaling at mitosis in 
Xenopus egg extracts, than I would speculate that formation of these hig lecular B-
Raf containing protein complex(s) should be dynamic throughout the .  To 
obtain some preliminary evidence for this, I decided to compare protein p
immunopurified with B-Raf antibodies from S-phase (inactive B-Raf) and M-phase 
(active B-Raf) Xenopus egg extracts.  Equal amounts of B-Raf protein were 
immunoprecipitated from S and M-phase arrested Xenopus egg extracts, separated by a 
10% SDS PAGE, and co-immunoprecipitated proteins were visualized taining. 
As shown in Figure 48, there is a significant difference in a set of proteins, which interact 
with B-Raf at S- and M-phases.  Specifically, 120 kD and 45 kD prot
B-Raf preferentially during S-phase, whereas 65 kD and 77 kD proteins interacted 
exclusively with mitotic B-Raf.  This preliminary data indicates tha  
complexes changes from S- to M-phases. 
 
Conclusions 
 
In this Chapter, I show that mitotic MEK kinase activity p  egg 
extracts is purified as B-Raf containing multi-protein complex(s).  Gel f timates 
the size of these active mitotic B-Raf protein complex(s) to be in the range of 400-700 
kDa.  Protein composition of B-Raf immunoprecipitated complexes 
extracts changes from S- to M-phase, indicating that formation of B-Raf protein 
associations is controlled in the cell cycle dependent manner and may be important for  
her mo
 cell cycle
rofiles co-
by Silver s
eins associated with 
mbly of B-Raf
Xenopus
iltration es
Xenopus egg 
t asse
resent in 
in 
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Figure 48.  Protein profile co-immunoprecipitated with B-Raf is changing 
B-Raf immuno-complexes precipitated from equal amounts of S- and M-phase 
o-
from S- to M-phases 
arrested extracts were washed and separated on 10% SDS-PAGE. Proteins c
purified with B-Raf antibodies were visualized by Silver staining. 
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gulation of B-Raf functions.   To generate a broader view of regulation of B-Raf during 
M-phase, proteins potentially comprising the mitotic B-Raf containing MEK kinase 
active protein complex(s) were id ass spectrometry.  These include 25 
protein with known functions invo d i tin cytoskeleton regulation, receptor-
mediated endocytosis, nuclear/cytosol trafficking and nuclear pore complex formation, 
mitotic regulation and proteins with chromatin-related functions.  Future studies are 
necessa  to validate interac  these proteins within B ing multi-protein 
complex(s) and disclose their involvement in regulation of B-Raf functions. 
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The central discovery of this dissertation is the demonstration that B-Raf is the 
ajor MEK kinase required for activation of the MAPK pathway at mitosis.  This work 
rovides the first evidence that B-Raf functions at mitosis and expands our understanding 
f B-Raf’s involvement in the regulation of the cell cycle.  In particular, it is proposed 
at B-Raf signaling controls progression through the cell cycle at two different stages: 
uring the G1/S transition and at mitosis. 
MAPK signaling has several roles at mitosis, including regulation of the G2/M 
ansition (Liu et al., 2004; Wright et al., 1999), control of the spindle formation (Horne 
nd Guadagno, 2003; Zhang et al., 2005), maintenance of the spindle assembly arrest 
hau and Shibuya, 1999; Minshull et al., 1994), regulation of Golgi fragmentation 
ebersold et al., 2004; Shaul and Seger, 2006) and the duration of mitosis (Guadagno 
nd Ferrell, 1998; Roberts et al., 2002).  I speculate that at least some of these MAPK 
nctions at mitosis are regulated by B-Raf.  Indeed, a number of recent studies by the 
uadagno laboratory have extended my work of B-Raf to human somatic cells.  First, B-
 
 
 
Chapter Seven 
General Discussion 
 
A novel role for B-Raf in cell cycle regulation 
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Raf was shown to localize to the mitotic app tus in HFF (human foreskin fibroblasts) 
cells in a pattern similar to one observed for active MEK and ERK (Shapiro et al., 1998; 
Willard and Crouch, 2001; Zecevic et al., 1998).  Specifically, it was shown that B-Raf 
localizes to the centrosomes through indle microtubule and kinetochores 
during metaphase.  Further, phosp  Ser-602) B-Raf was detected in 
the areas of condensed chromatin during prophase, at the centrosomes, kinetochores and 
chromosomes during aphase and at the 
midbody during cytokinesis (Borysova MK, Guadagno TM, 2006, manuscript 
submitt
he 
mplicated in the regulation of mitotic spindle 
checkp
.  
 
ara
out mitosis and sp
horylated (Thr-599 and
 metaphase, at the spindle midzone during late an
ed).  Loss-of-function studies showed that reduction of endogenous B-Raf by 
RNA interference treatment led to the accumulation of abnormal mitotic spindles 
(Borysova MK, Guadagno TM, 2006, manuscript submitted).  Thus, these data support 
the idea that B-Raf directs MAPK signaling during mitosis in somatic cells to regulate t
mitotic spindle. 
In addition, B-Raf may as well be i
oint signaling.  Specifically, it was shown that expression of the human mitotic 
checkpoint kinase Mps1 (Weiss and Winey, 1996) is dependent on B-Raf/MEK/ERK 
signaling (Cui Y, Guadagno TM, manuscript in preparation).  Thus, Mps1 may be an 
important target of B-Raf signaling during mitosis to regulate the spindle checkpoint
Further studies are required to explore the possible implication of B-Raf in the 
mechanism of spindle checkpoint.   
Based on the data presented in my dissertation, I speculate that mitotic B-Raf is 
not involved in the regulation of Golgi fragmentation during mitosis.  In the experimental
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h 
tation 
 is shown to be dependent on MAPK signaling in somatic cells, is 
discuss
 
d that B-
 was attributed to its pro-survival functions 
(Wojno  
system used in my studies the vast majority of mitotic MEK kinase (B-Raf) activity was 
detected in the cytosol fraction void of membranes.  Thus, it is unlikely that mitotic B-
Raf localizes to Golgi apparatus.  However, this was not specifically addressed in my 
experiments.  A recent study proposed that Raf-1 activates Golgi-associated pools of 
MEK during mitosis thereby regulating Golgi fragmentation at the mitotic onset (Colanzi 
et al., 2003).  However, this conclusion is based on the data obtained by inhibition of Raf-
1 activity with the autoinhibitory domain of Raf-1 (Bruder et al., 1992) or Raf kinase 
inhibitory protein (RKIP) (Yeung et al., 2000), both of which may interfere wit
activation of the other members of the Raf family, A-Raf and B-Raf.  Thus, the 
involvement of a particular Raf family member in the regulation of Golgi fragmen
during mitosis is not conclusively defined yet. 
The potential implication of mitotic B-Raf in the regulation of the G2/M 
transition, which
ed in the next section (B-Raf directly links Cdk1/cyclin B and MAPK signaling 
during mitosis). 
Identifying a role for B-Raf at mitosis further expands our understanding of the
prominent role that B-Raf has in mediating cell proliferation during embryogenesis.  
Gene knockout of B-Raf in mice demonstrated that B-Raf is critical for proper fetal 
development (Wojnowski et al., 2000; Wojnowski et al., 1997).  It was suggeste
Raf’s involvement in embryogenesis
wski et al., 2000; Wojnowski et al., 1997).  However, my new data indicates that
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-
which 
 
g of B-Raf’s involvement in the 
regulat af will 
r of 
Raf in Xenopus egg extracts occurs subsequent to the activation of Cdk1/cyclin B (Fig. 
regulation of cell division during early embryogenesis could be another important role for
B-Raf.   
B-Raf is an important oncogene which is mutated and activated in 8% of all 
human tumors and in nearly 70% of melanomas (Davies et al., 2002).  Activating 
mutations in the B-Raf gene lead to constitutive B-Raf signaling and elevated ERK 
activity.  It is tempting to speculate that constitutive B-Raf signaling could promote 
mitotic errors that contribute to B-Raf-driven tumorigenesis.  In fact, deregulation of B
Raf’s mitotic functions may provoke the formation of aberrant mitotic structures, 
can lead to genomic instability.   
In summary, identification of B-Raf as the mitotic MEK kinase is a novel finding,
which expands our comprehensive understandin
ion of the cell cycle.  Further exploration of potential mitotic roles for B-R
shed insights into the mechanisms of B-Raf’s biological functions, such as its 
involvement in embryogenesis, cell proliferation and oncogenesis. 
 
B-Raf directly links Cdk1/cyclin B and MAPK signaling during mitosis 
 
The data in my dissertation demonstrate that Cdk1/cyclin B, a major regulato
mitotic entry, directly phosphorylates B-Raf and that this phosphorylation contributes to 
the activation of B-Raf at mitosis. Several lines of evidence support this novel 
mechanism as a regulator of mitotic B-Raf activity.  First, activation of endogenous B-
 
 
135
dependent manner (Fig. 29) and undergoes a Cdk-dependent phosphorylation at 
some o lin B 
e-144 
ot 
he 
 
dk1/cyclin B directly phosphorylates and activates 
mitotic
r 
ing cell 
n extracellular 
signals trigger activation of B-Raf.  Binding of mitogen proteins to the appropriate 
growth e 
plasma membrane and induces its activation.  At mitosis an intrinsic mechanism 
involvi
hat B-Raf 
t 
28).  Second, endogenous B-Raf associates with active Cdk1/cyclin B complexes in an 
M-phase 
f its Cdk-phosphorylation consensus site(s) (Fig. 30).  Third, active Cdk1/cyc
directly phosphorylates in vitro recombinant Xenopus B-Raf at its conserved Serin
residue (Fig. 32).  Finally, a non-phosphorylatable Ser-144-Ala B-Raf mutant does n
undergo activation in an M-phase dependent manner (Fig. 33) and does not activate t
MAPK pathway at mitosis (Fig. 34); furthermore, the mutant exerts a dominant-negative
effect by blocking mitotic activation of MAPK in Xenopus egg extracts (Fig. 35).  
Together, these data suggest that C
 B-Raf.   
A role for Cdk1/cyclin as an activator of B-Raf opens new perspectives fo
understanding how B-Raf is regulated during the cell cycle.  The mechanism of B-Raf 
activation at M-phase appears to be distinct from its activation mechanism dur
cycle entry (Roovers and Assoian, 2000).  During cell cycle initiatio
-factor receptors induces activation of Ras, which in turn recruits B-Raf to th
ng the mitotic machinery leads to B-Raf activation.  B-Raf accommodates mitotic 
signals from Cdk1/cyclin B that promote activation of the MAPK pathway.  Based on 
what is known about B-Raf regulation by phosphorylation, it can be proposed t
is receptive to two distinctive regulatory phosphorylations.  Specifically, following 
extracellular mitogenic stimulation B-Raf undergoes a Ras dependent phosphorylation a
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e 
 
dies are necessary to elucidate the molecular basis for how 
phosph ding 
at 
erine-
-Raf 
t if 
ortion of 
yclin 
its Threonine-599 and Serine-602 residues within the activation loop (Zhang and Guan, 
2000).  Interestingly, my data show that mitotic 95 kDa B-Raf is not phosphorylated at 
these sites in mitotic Xenopus egg extracts (Fig. 27).  However, the activation of mitotic 
B-Raf in the Xenopus egg extract system requires phosphorylation at its Cdk/cyclin B 
phosphorylation site.  Further analysis in somatic cells will need to determine whether th
same Serine-144 site is phosphorylated at mitosis.  This could be analyzed by developing
phospho-site specific antibodies and performing immunofluorescent studies.  Thus, 
during cell cycle entry and mitosis B-Raf can be subjected to two different sets of 
phosphorylation, both of which contribute to B-Raf’s activation. 
Future stu
orylation at the Serine-144 residue induces B-Raf into an active state.  Accor
to the existing dogma, activation of Raf kinases results from conformational changes th
open the C-terminal kinase domain from the inhibitory N-terminal regulatory domain 
(Kolch, 2000).  Therefore, I speculate that the presence of a negative charge at the S
144 residue can promote the aforementioned intramolecular changes necessary for B
activation, similar to other known regulatory phosphorylations.  It should be noted tha
this prediction is correct, this would be the first identified site in the N-terminal p
B-Raf protein that undergoes a positive regulatory phosphorylation.  Alternatively, my 
data do not exclude that the phosphorylation of B-Raf at the Ser-144 residue creates a 
binding site for a B-Raf interactor, which in turn mediates B-Raf activation.  
The proposed biochemical mechanism of B-Raf activation by a direct Cdk1/c
B phosphorylation helps explain how MAPK signaling and the cell cycle regulatory 
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was 
cell 
 MAPK activities 
during ay be under 
tic 
gs 
tic 
machin
machinery are coordinated during M-phase.  From the present study, it appears that 
activation of the MAPK pathway during M-phase occurs down-stream of Cdk1/cyclin B
and that B-Raf serves a direct link that integrates activation of MAPK signaling to the 
initiation of M-phase.   Therefore, it can be proposed that activation of mitotic B-Raf is
coordinated to the completion of DNA replication and occurs after commitment to 
mitosis.   
The role for B-Raf as a link between Cdk1/cyclin B and the MAPK pathway 
described by using the Xenopus egg extracts, which represent the early embryonic 
cycle.  It is likely that a similar mechanism coordinates Cdk1 and
the somatic cell cycle.  Circumstantial evidence indicates that B-Raf m
the regulation of Cdk1/cyclin B in tissue culture cells.  Indeed, both B-Raf and active 
Cdk1/cyclin B localize to the same mitotic structures.  Similar to B-Raf, at the early M-
phase Cdk1/cyclin B is found at the centrosomes (Jackman et al., 2003) and at the mito
spindle and condensed chromatin at metaphase (Huo et al., 2005; Lee et al., 2003; Stiffler 
et al., 1999). 
In conclusion, I demonstrate that Cdk1/cyclin B phosphorylation of B-Raf is 
required for its activation at mitosis.  The M-phase activation of B-Raf via Cdk1/cyclin B 
phosphorylation provides a novel mechanism of B-Raf regulation.  It expands our 
understanding of how B-Raf signaling is controlled throughout the cell cycle and begin
to elucidate how activation of the MAPK cascade is coordinated with the mito
ery. 
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ed in 
ion of MAPK signaling during mitosis.  In fact, immunodepletion of Raf-1, 
unlike B
 
 
t 
xtracts, whereas the B-Raf/MEK interactions were reproducibly detected.  
Next, B se 
f B-
her, 
monstrate that B-Raf, but not Raf-1, functions as the mitotic MEK kinase. 
B-Raf, but not Raf-1, regulates MAPK activation at mitosis 
 
The studies herein provide evidence that the role of mitotic MEK kinase is 
specific to B-Raf within the Raf kinase family.  My data demonstrate that another 
member of the Raf family, Raf-1, does not display features of a MEK kinase involv
the regulat
-Raf, from Xenopus egg extracts does not affect MAPK activation at M-phase, 
indicating that that the presence of Raf-1 is irrelevant for triggering the MAPK pathway
during mitosis (this study and Yue and Ferrell, 2004).  This is consistent with the 
previously published data showing that activation of Raf-1 in nocodazole-arrested mitotic 
cells does not lead to activation of the down-stream components of the MAPK cascade
(Laird et al., 1999; Ziogas et al., 1998).  The present study provides further evidence tha
Raf-1 is uncoupled from mitotic MAPK signaling.  Co-immunoprecipitation analyses 
showed that Raf-1 does not associate with its classical down-stream target, MEK, in 
Xenopus egg e
-Raf, but not Raf-1, was enriched during purification of the mitotic MEK kina
activity, demonstrating that B-Raf is the major MEK kinase present in M-phase arrested 
Xenopus egg extracts.  Finally, a recent study demonstrated that down-regulation o
Raf, but not Raf-1, via RNA interference (RNAi) abrogates normal spindle formation in 
somatic cells (Borysova MK, Guadagno TM, 2006, manuscript submitted).  Toget
these data de
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Recen ers is 
important for activation of the MAPK pathway following mitogenic stimulation (Weber 
et al., 2 itotic 
ediated 
f-
-
-1 
fic 
he 
 
11S regulator with the 20S proteasome core complex affects the specificity of the  
tly it has been proposed that formation of B-Raf/Raf-1 heterodim
001).  However, I did not detect interactions between B-Raf and Raf-1 in m
Xenopus egg extracts.  Therefore, I conclude that Raf-1 is not involved in B-Raf m
activation of the MAPK cascade at M-phase. 
Several biochemical mechanisms may ensure the specificity of B-Raf versus Ra
1 as the mitotic MEK kinase.  As mentioned above, specificity can be controlled by a 
mechanism that favors the preferential association of mitotic MEK with B-Raf versus 
Raf-1.  Secondly, Raf-1, unlike B-Raf, may be unreceptive to mitotic up-stream 
regulatory inputs necessary to trigger its activation as a MEK kinase.  My work revealed 
that phosphorylation of Xenopus B-Raf at its Cdk1/cyclin B phosphorylation site (Serine
144 residue) is critical for activation of B-Raf and for B-Raf’s capacity to trigger the 
MAPK cascade at M-phase.  Interestingly, this Cdk1/cyclin B phosphorylation site is 
conserved only among B-Raf members of the Raf kinase family (Fig. 49).  Thus, Raf
may not be implicated into the Cdk1/cyclin B – MAPK pathway due to the absence of 
this regulatory site. The Serine-144 residue, targeted by Cdk1/cyclin B, is located in the 
N-proximal portion of B-Raf, which does not resemble homology to other members of 
the Raf family.  It is intriguing that regulation of this domain may enable B-Raf’s speci
functions.  This idea is supported as well by another study which showed that the N-
terminal domain of B-Raf is critical for B-Raf, but not Raf-1, specific interaction with t
alpha-subunit of the 11S proteasome regulator (Kalmes et al., 1998).  Association of the
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Figure 49.  The N-terminal Cdk1/cyclin B hos hory atio site  con erved am ng B Raf 
family 
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ubiquitin directed proteolysis (Dick et al., 1996; Groettrup et al., 1996).  However, 
whether B-Raf regulates the 11S proteasome subunit is not clear 
subunit is not phosphorylated by B-Raf (Kalmes et
at B-Raf and Raf-1 can respond differently 
P-ase, Rap1, activates B-Raf, but does not 
y and Kolch, 2000; York et al., 1998).  The 
/cyclin B proposed herein further highlights the 
nase family. 
 im
tracellular stimulation by growth factors, it is 
 cascade from
 components of the m
h Cdk1 in nocodazole-arrested mitotic cells and 
tion.  Impor
ted nocodazole
stitutively active H-Ras or Raf-1 (Dangi and 
e evidence
specific to B-Raf within the Raf family.  Unlike B-Raf, Raf-1 is not required for MAPK 
activation in mitotic Xenopus egg extracts.  Further, Raf- urified as the M-
since the 11S alpha-
pacity to activate the MAPK 
receptors to MAPK 
itogen-dependent 
dk1/cyclin B activity inhibits 
-arrested cells as well as in 
 mitotic MEK kinase is 
1 was neither p
 al., 1998). 
ulation by growth factors.  Since cells 
 growth-factor 
tantly, C
 that the role of
Notably, it has already been reported th
te R
to up-stream signaling inputs.  A sm
1 (
all GT
slaactiva af- Bos et al., 2001; Hou
mechanism of B-Raf activation by Cdk1
regulatory differences within the Raf ki
It appears that throughout the cell cycle, Raf-1’s ca
pathway is triggered only following mitogenic st
undergoing mitosis do not respond to ex
proposed that during G2/M the signaling
via Raf-1 is blocked by Cdk1/cyclin B activity (Dangi and Shapiro, 2005).  Specifically, 
it was shown that Raf-1 and its up-stream
pathway, Sos-1 and Grb2, associate wit
undergo a Cdk1-dependent phosphoryla
activation of MAPK in growth-factor trea
nocodazole-arrested cells expressing con
Shapiro, 2005). 
In conclusion, my results provid
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 and a Cdk1/cyclin B 
mediate
 
.  
 
ts of my dissertation demonstrated that B-Raf undergoes negative 
feedbac
phase MEK kinase or shown to associate with MEK.  I propose that the B-Raf speci
terminal domain may enable B-Raf to be receptive for mitotic regulatory inputs via 
Cdk1/cyclin B.  Uncoupling Raf-1 from association with MEK
d inhibition of the growth-factor receptor pathway may as well ensure B-Raf’s 
specificity in functioning as the mitotic MEK kinase.   
 
Mitotic B-Raf undergoes a negative feedback regulation by MAPK 
 
Feedback loop phosphorylation is broadly implicated in the regulation of MAPK
signaling.  The guanine nucleotide exchange factor, Sos-1, is phosphorylated by MAPK 
following EGF receptor stimulation (Corbalan-Garcia et al., 1996; Waters et al., 1996)
This phosphorylation is thought to represent a negative regulatory feedback loop that 
desensitizes the receptor-mediated signaling by inhibiting Sos-1 interactions with adaptor
proteins, such as Grb2 (Corbalan-Garcia et al., 1996; Waters et al., 1996).  The 
phosphorylation feedback loop operates within the MAPK module itself.  MEK was 
shown to exert a positive feedback regulation on Raf-1 (Zimmermann et al., 1997).  Raf-
1 was demonstrated to undergo both negative (Dougherty et al., 2005) and positive 
(Balan et al., 2006) feedback regulations by MAPK.    
The resul
k regulation by MAPK during mitosis.  My data showed that the 
hyperphosphorylation of mitotic B-Raf is primarily caused by a MAPK-mediated 
phosphorylation at Serine784 and Threonine787 residues within the conserved C-
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mics 
e B-Raf mutant enhances PC12 
differentiation (Rushworth et al., 2006).  This suggests that phosphorylation of the C-
terminal 
My study is the first to address the eff ct of C-terminal phosphorylation on B-Raf 
kinase 
 
y 
ates 
 
of B-Raf/Raf-1 heterodimers 
(Rushw  
rrested Xenopus 
 
 the 
terminal SPKTP motif of B-Raf.  A similar situation was reported for B-Raf in activated 
human B lymphocytes (Brummer et al., 2003).  Furthermore, a B-Raf mutant that mi
constitutive phosphorylation at the C-terminal MAPK phosphorylation sites is 
characterized by a decreased efficiency in promoting differentiation of PC12 cells 
(Brummer et al., 2003), whereas a non-phosphorylatabl
SPKTP motif negatively affects B-Raf biological functions. 
e
activity.  I showed that kinase activity of a non-phosphorylatable B-Raf mutant 
following incubation in M-phase extracts is significantly higher compared to wild-type 
B-Raf.  Further, inhibition and over-activation of endogenous MAPK in M-phase arrested
Xenopus egg extracts enhances or diminishes B-Raf activity, respectively.  Together, m
data support the proposal that B-Raf activity during mitosis is negatively regulated by a 
feedback loop mediated by MAPK phosphorylation. 
The mechanism by which phosphorylation of the C-terminal sites down-regul
activity of B-Raf requires further studies.  It was proposed that MAPK-mediated 
phosphorylation at the Threonine residue within the C-terminal phosphorylation site
abrogates B-Raf signaling by promoting disassociation 
orth et al., 2006).  However, it is unlikely that the same mechanism operates
during mitosis, since B-Raf/Raf-1 heterodimers do not form in M-phase a
egg extracts.  The C-terminal MAPK phosphorylation sites are located within close
proximity to a 14-3-3 binding site (Brummer et al., 2003).  Thus, it is possible that
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phosph
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nism 
MAPK phosphorylation modulates B-Raf association with 14-3-3 protein and thereby 
induces down-regulation of its activity. 
Why is a B-Raf activity in M-phase arrested Xenopus egg extracts eleva
S-phase levels despite its hyperphosphorylation and the presence of active MAPK?
speculate that mitotic B-Raf in these extracts is represented by two different species:  
active B-Raf, which is not phosphorylated at the C-terminus, and inactive 
hyperphosphorylated B-Raf.  Another explanation is that the MAPK-m
orylation of B-Raf is not sufficient to completely inhibit B-Raf activity and needs 
to be combined with other regulatory events, for instance inactivation of Cdk1/cyclin B
Analysis of temporal fluctuations of Cdk1/cyclin B, B-Raf and MAPK activities 
and B-Raf hyperphosphorylation in cycling Xenopus egg extracts shows that inactivation 
and hyperphosphorylation of B-Raf during mitosis overlaps with inactivation of 
Cdk1/cyclin B and activation of MAPK (Fig. 20).  Based on these data, I speculate that 
the negative feedback phosphorylation of B-Raf by M
 and contributes to inactivation of B-Raf at times of cyclin B degradation and 
inactivation of B-Raf’s activator, Cdk1/cyclin B.  It is plausible to suggest that this 
mechanism of B-Raf inhibition via a MAPK-mediated feedback loop ensures a transie
activation of the B-Raf/MEK/MAPK pathway necessary to accommodate M-phase 
progression and exit from mitosis. 
In summary, mitotic B-Raf undergoes feedback phosphorylation via activated 
MAPK that appears to negatively regulate B-Raf activity.  I postulate that this mecha
ensures a transient activation of the B-Raf/MEK/MAPK pathway during mitosis.  
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ingle peak of MEK kinase activity eluted from a 
Mono Q
Together, my work describes a comprehensive mechanism for the regulation of B-Raf 
activity during mitosis.  I propose that ac
 triggers activation of B-Raf, perhaps at the spindle apparatus, which directs 
activation of the MAPK cascade.  At the latter stages of mitosis, probably after cyclin 
degradation and inactivation of Cdk1, MAPK feeds back to B-Raf to down-regulate its
activity (Fig. 50).  Together, these regulatory mechanisms control transient activation
the B-Raf/MEK/MAPK cascade during mitosis. 
 
Mitotic B-Raf functions in multi-protein complexes 
 
Active B-Raf was reportedly purified within large protein complexes (Jaiswal et 
al., 1996; Mizutani et al., 2001; Mizutani et al., 1998).  Specifically, purification 
Ras-dependent Raf-1 activator from a rat brain homogenate led to isolation of a 400 kDa
B-Raf containing protein complex (Jaiswal et al., 1996; Mizutani et al., 2001; Mizutani e
al., 1998) and B-Raf from PC12 cell lysates was isolated within large (>300 kDa) pro
complexes (Jaiswal et al., 1996; Mizutani et al., 2001; Mizutani et al., 1998).  The w
from my dissertation suggests that active mitotic B-Raf exists as well in large multi-
protein complexes.  Purification of M-phase MEK kinase activity from M-phase arre
Xenopus egg extracts resulted in a s
 chromatography column.  Separation of the final MEK kinase active fraction 
under native non-denaturizing conditions showed that B-Raf was present in a large 
protein complex.  Analysis of the protein composition of this complex by SDS- 
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PAGE revealed that it consists of many proteins, many of which were enriched 
throughout the purific sing gel filtration, it was estima e molecular 
weigth range of the active mitotic B-Raf containing complex is between 400-700 kDa.  
Preliminary studies demonstrate that a set of proteins that a
immunoprecipitates in  e tracts rs sligh
48).  Thus, the formation of B-Raf complexes in Xenopus s to be 
dynam ay be an important mechanism that controls B
proper functioning at M-phase.  The biochemical analysis of the purified B-Raf complex 
described several proteins that may associate with B-Raf ity and 
signaling during mitosis.  My work demonstrated that B-Raf associates w
Cdk1/cyclin B comple d M n an
association between  B-R s detected at the beginning of mitosis in 
Xenopus ion with MAPK was visualized twice 
throughout mitosis, at the beginning and during middle-late M-phase.  B
shown that B-Raf forms complexes with MEK both at S- 
Additionally, over 25 proteins were identified as potential com
Raf containing protein comp Table 2).  Several of the identified proteins have 
already been linked to the re ce, 
beta-actin was identified as one of the predominant com itotic 
MEK kinase active complexes.  It has been shown that B-Raf (P
MEK (Pawlak and Helfman, 2002) and MAPK (Barros and 
in the regulation of actin cytoskeleton functions.  Future stud lucidate 
ation.  By u ted that th
ssociate with B-Raf 
 from S- to M-phases (Fig. 
-Raf’s regulation and/or 
ctiv
ith active 
anner.  Interestingly, 
esides this, it was 
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whether the B-Raf/MEK/MAPK dependent reorganization of actin cytoskeleton
M-phase.  This can be addressed by studying how reduction in B-Raf, MEK and MAPK
levels following specific siRNA treatments affects the actin cytoskeleton structures in 
 cells. 
Some of the identified candidate proteins are known substrates and/or interactor
of B-Raf, MEK, MAPK or Cdk1/cyclin B.  Specifically, PA-28-beta, a proteasome 
activator subunit, is shown to be a B-Raf interactor (Kalmes et al., 1998).  CAS/CSE1,
protein essential for proper chromosome segregation in yeast (Brinkmann et al., 1995; 
Xiao et al., 1993), which localizes to mitotic spindle in somatic cells (Scherf et al., 1
is thought to be a non-traditional substrate for MEK1 (Scherf et al., 1998).  HABP1,
regulator of intracellular traffic, is a substrate for MAPK (Majumdar et al., 2002).  
Finally, Epsin1, a protein that regulates endocytosis (Rosse et al., 2003) and replication 
factor A (Dutta and Stillman, 1992) are substrates for Cdk1/cyclin B.   
Other proteins identified by Mass spectrometry are linked to MAPK signaling.  It 
is proposed that importin 3 beta is involved in the intracellular translocatio
ollowing injury of neurons (Perlson et al., 2005).  Filamin A, an actin-binding 
protein, has been implicated in the regulation of MAPK activation following stimulat
of extracellular receptors (He et al., 2003; Scott et al., 2006).  ATR’s nuclear 
translocation upon DNA damage was shown to be regulated by ERK (Wu et al., 2006). 
Future studies are necessary to validate association of the identified proteins within the 
mitotic B-Raf complexes and directly assess their involvement in the regulation of B-Raf 
activity or functions at mitosis.   
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f B-Raf regulation and function.  This work provides some insights into the 
nature o  
nd 
es the 
tions for 
s.  
In conclusion, the data presented in this study demonstrate that mitotic active B-
Raf exists in large protein complexes.  Identification of proteins associated with a large 
molecular weight complex with B-Raf during M-phase will aid in deciphering the mito
mechanisms o
f B-Raf protein-protein interactions that may contribute to B-Raf signaling during
mitosis.  I showed that mitotic B-Raf directly associates with Cdk1/cyclin B, MEK a
MAPK.  Additionally, a proteomics approach was utilized to identify other candidate B-
Raf interactors at mitosis.  Over 25 proteins, which are structural or regulatory 
components of the cytoskeleton and cellular trafficking or implicated in mitosis, DNA 
metabolism or regulation of protein stability, were identified.  Some of these proteins 
have been already linked to MAPK or Cdk1/cyclin B signaling.  This fact encourag
use of the candidate protein list as a good starting point for future investigations that 
elucidate the regulation and functions of the mitotic B-Raf complexes. 
 
Future research directions 
 
Identification of B-Raf as a mitotic MEK kinase is a novel finding that opens a 
broad spectrum of new research interests.  I propose three main research direc
future studies of B-Raf signaling at mitosis.  First is the elucidation of biochemical 
mechanisms that regulate mitotic B-Raf.  Second is defining B-Raf’s roles during mitosi
And third is investigating the effects of oncogenic B-Raf at mitosis. 
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lished by 
 
ons 
APK 
phosphorylations oppositely affect activity of mitotic B-Raf, it will be interesting to 
understand how these two pho nated throughout mitosis.  
To address this, phospho-specific antibodies need to be prepared and then used to analyze 
a time-  
 
atory phospho-sites 
will be important to study.  This can be done by analyzing B-Raf activity and 
There are several aspects of B-Raf regulation at mitosis that can be addressed in 
future studies.  In this dissertation I show that phosphorylation is the major mode of 
regulation of mitotic B-Raf.  Further studies are required to completely decipher how 
phosphorylation regulates B-Raf at M-phase.  Specifically, it will be interesting to 
elucidate the mechanism by which phosphorylation of the Cdk1/cyclin B phosphorylation 
site (Serine-151 residue in Human B-Raf) contributes to activation of B-Raf, as well as a
mechanism of inhibitory phosphorylation at the C-terminal MAPK phosphorylation sites
(Serine-750and Threonine 753 residues in Human B-Raf).  This can be accomp
analyzing activities of corresponding phospho-mimicking and non-phosphorylatable 
mutants as well as their associations with regulatory and effector proteins of the MAPK
cascade at mitosis.  Analysis of the B-Raf tertiary structure by X-ray crystallography and 
virtual molecular 3D modeling could provide detailed information how phosphorylati
of these sites affect B-Raf’s conformation.  Since Cdk1/cyclin B and M
sphorylation events are coordi
course of B-Raf phosphorylation throughout mitosis.  Furthermore, it needs to be
addressed whether mitotic B-Raf undergoes regulatory phosphorylation at other sites.  A
broad analysis of B-Raf phospho-modifications can be performed by phospho-
microsequencing of B-Raf immunopurified from mitotic Xenopus egg extracts.  Finally, 
on the flip side, the phosphatases that dephosphorylate B-Raf’s regul
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an be 
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re this 
orylation during mitosis following treatment with specific phosphatase inhibitors 
or in in vitro phosphatase assays. 
Analysis of the protein complexes that form with B-Raf during mitosis is anoth
important area of biochemical studies.  The proteomics data provided in this study c
used as a good starting point for this research.  Co-immunoprecipitation studies and 
biochemical purification approaches could be used to validate interaction of the identified 
proteins with B-Raf at mitosis.  Validation of particular B-Raf mitotic interactors will 
refine and focus future studies of B-Raf regulation and functions at mitosis. 
B-Raf is known to undergo alternative splicing, which can modulate its activit
(Papin et al., 1998).  My data indicate that a small 68 kDa isoform of B-Raf is 
phosphorylated within the activation loop in M-phase arrested extracts, indicating that the 
68 kDa B-Raf may function during mitosis along with the 95 kDa B-Raf studied in this 
work.  Interestingly, my data showed that immunodepletion of 95 kDa B-Raf 
Xenopus egg extracts does not affect the levels of 68 kDa (not shown) suggesting tha
smaller B-Raf isoform is not required for activation of the MAPK cascade at mitosis.  
However, the contribution of 68 kDa B-Raf in MAPK activation in mitotic extracts was 
not addressed directly.  Thus, it still needs to be determined whether 68 kDa B-Raf 
regulates MAPK-independent functions at mitosis or cooperates with 95 kDa B-Raf in 
the regulation of mitotic MAPK signaling.  It would be very interesting to explo
possibility further in future studies by raising antibodies that can immunoprecipitate the 
smaller B-Raf isoform. 
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tern analysis I have reproducibly observed an 
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 dissertation research suggest that B-Raf can be activated twice 
throughout the cell cycle: at the G1/S following mitogenic stimulation and during 
It needs to be addressed whether B-Raf protein levels are regulated in an M-phase
dependent manner.  By using Wes
ent of B-Raf during mitosis and decrease of its levels at the subsequent S-phase 
(Fig. 20B, 25B, 37B).  This implies that B-Raf protein levels may be up-regulated during 
M-phase and down-regulated at the mitotic exit.  The possibility that B-Raf expressio
regulated in an M-phase dependent manner needs to be addressed directly in the future 
studies.  Studying stability of B-Raf throughout the cell cycle will be used to elucidate 
this question.  However, B-Raf protein does not possess classical D- or KEN
ces for ubiquitination, which targets mitotic proteins for proteasome-directed 
degradation (Pfleger and Kirschner, 2000).  Thus, it is unlikely that mitotic B-R
undergoes APC-directed proteolysis.   
Recent work revealed that B-Raf localizes to mitotic structures, such as the 
mitotic spindle, centrosomes, condensed chromatin, kinetochores and midbody 
(Borysova MK, Guadagno TM, 2006, manuscript submitted).  Proper intracellular 
localization of B-Raf can play an important role in ensuring specificity of B-Raf’s 
regulation and functions during mitosis.  Thus, studying biochemical mechanisms that 
control intracellular distribution of mitotic B-Raf will contribute to understanding 
regulation of B-Raf signaling.  To study this, the domains necessary for B-Raf’s 
localization to certain sub-cellular structures need to be defined.  This can be 
accomplished by analyzing sub-cellular localization of different B-Raf truncated mutants
The results of my
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d to 
.  To generate a comprehensive picture of B-Raf’s regulation during cell cycle, it 
would be interesting to elucidate how these two different B-Raf regulatory mecha
are coordinated.  This can be accomplished by studying a time-course of B-Raf’s 
phosphorylation at the Cdk1/cyclin B-dependent and Ras-dependent residues throughout 
the cell cycle in a synchronized population of tissue culture cells. 
Therefore, several aspects of B-Raf regulation during mitosis require further 
study.  These include further exploration of phosphorylation and protein complex 
formation as modes of regulation of mitotic B-Raf, elucidation whether B-Raf prot
levels are regulated in an M-phase dependent manner and whether alternative isoform
B-Raf are involved at mitosis and, finally, the characterization of mechanisms of B
intracellular localization.   
The second direction for future research is studying B-Raf’s mitotic function
First of all, it should be addressed whether the known MAPK’s functions at mito
mediated by B-Raf.  A recent study demonstrated that B-Raf localizes to the mitotic
apparatus and is required for proper spindle formation in somatic cells (Borysova M
Guadagno TM, 2006, manuscript submitted), a mitotic role which already has been 
defined for MAPK (Horne and Guadagno, 2003).  To further understand the mecha
by which B-Raf regulates the mitotic spindle, it will be necessary to identify wha
substrates are targeted by the B-Raf/MEK/MAPK cascade to promote proper f
of the mitotic spindle.  Among other MAPK functions that may be mediated by B-Raf are 
otic spindle checkpoint, regulation of M-phase entry, and Golgi fragmentation.  B-
Raf loss-of-function and gain-of-function studies will reveal whether B-Raf is linke
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ation of B-Raf mitotic functions may result from expression 
of the B
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n 
some of the abovementioned mitotic events.  There is a possibility as well that B-Raf may 
have mitotic roles, which are not dependent on MAPK.  Tissue cell lines and the cell-free
system of Xenopus egg extracts could be utilized to explore B-Raf’s functions dur
mitosis. 
The third research direction is to study whether disregulatio
ns can provoke tumorigenesis.  Recently B-Raf was recognized as a prominen
oncogene, which is mutated and activated in a large proportion of human cancers, 
particularly, melanoma (Davies et al., 2002).  Since I have shown that B-Raf activates 
MAPK signaling at mitosis and is implicated in the regulation of the mitotic spindle in 
somatic cells (Borysova MK, Guadagno TM, 2006, manuscript submitted), it is plausible
to hypothesize that disregul
-Raf oncogene.  This may lead to improper chromosome segregation and 
genomic instability, thereby provoking tumorogenesis.  Analysis of mitotic abnormalitie
and the rate of accumulated chromosomal aberrations in somatic cell lines ectopically
expressing the oncogenic form of B-Raf will clarify its role in tumorigenesis. 
In conclusion, my dissertation research describes B-Raf as the mitotic MEK 
kinase critical for activation of the MAPK cascade.  I demonstrate that B-Raf activation 
at mitosis is coupled to the mitotic regulatory machinery, namely Cdk1/cyclin B.  I
addition, recent studies have demonstrated a role for B-Raf in regulating the mitotic 
spindle in human somatic cells.  Therefore, I propose that B-Raf is an essential regulator 
of mitosis.  Future research is necessary to define and characterize B-Raf’s regulation and 
functions at mitosis in normal cells and in cancer. 
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Chapter Eight 
S-phase arrested Xenopus egg extracts were prepared essentially as described 
(Chen et al., 1998).  Briefly, mature Xenopus oocytes were dejellied in 2% L-cysteine 
solution (pH 7.8), washed in MMR buffer (5 mM HEPES, pH 7.8, 100 mM NaCl, 2 mM 
KCl, 1 mM MgCl2, 2 mM CaCl2, 0.1 mM EDTA) and parthenogenetically activated with 
the Ca  ionophore A23187 (0.2 µg/ml) for 2.5 minutes.  After Ca  ionophore 
withdrawal, the activated eggs were incubated in egg lysis buffer (10 mM HEPES, pH 
7.8, 250 mM sucrose, 50 mM KCl, 2.5 mM MgCl2, 1 mM DTT, 50 µg/ml 
cyclohexamide) for another 50-60 min at room temperature before processing into 
extracts by a high-speed centrifugation (10, 000 g 15 min at 4ºC).  This method closely 
mimics the degradation of c-Mos, a meiosis specific MEK kinase, which is observed 
following fertilization (Chen et al., 1998; Nishizawa et al., 1993; Watanabe et al., 1991; 
Watanabe et al., 1989).  M-phase arrested extracts were prepared by supplementing crude 
S-phase egg extracts with recombinant non-degradable sea urchin ∆90 cyclin B1 (75-100 
nM final) and incubating at room temperature for 60 min.  Expression and purification of 
GST-∆90 cyclin B was performed as described (Horne and Guadagno, 2003).  Note that 
 
 
 
Materials and Methods 
 
Preparation of Xenopus egg extracts  
2+ 2+
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all preparations of M-phase extracts were checked for the activation of MAPK and the 
absence of c-Mos protein by immunoblot analysis.   
Cycling extracts were prepared in a procedure similar to described above, except 
that eggs activated with the calcium 87 were incubated in XB buffer (10 
mM HEPES, pH 7.7, 50 mM su  MgCl2, 0.1 mM CaCl2) for 45 
min before processing them into extracts.  Cytostatic factor (CSF) arrested Xenopus egg 
extracts were prepared as described (Murray, 1991).   
 
 Studying c-Mos degradation in fertilized and Ca2+ ionophore activated Xenopus 
oocytes 
Mature Xenopus oocytes were fertilized with sperms freshly isolated from male 
Xenopus frogs (Heasman et al., 1991) or activated with Ca2+ ionophore A23187 as 
mentioned above.  Fertilized and Ca2+ ionophore activated eggs were incubated at room 
temperature in 0.25X MMR solution. (1.25 mM HEPES, pH 7.8, 25 mM NaCl, 0.5 mM 
KCl, 0.25 mM MgCl , 0.5 mM CaCl , 0.025 mM EDTA).  10 eggs were collected at 10-
minute intervals and frozen on dry ice.  Frozen eggs were thawed on ice and resuspended 
in 100 µl of extraction buffer (20 mM HEPES, pH 7.2, 0.25 M sucrose, 0.1 M NaCl, 50 
mM β-glycerol phosphate, 2.5 mM MgCl , 1 mM Na VO , 25 mM NaF) supplemented 
with 10 µg/ml of each leupeptin, pepstatin, and aprotinin.  Lysates were subjected to 
centrifugation for 12 min at 4oC in an eppendorf centrifuge.  The levels of c-Mos protein 
in the clarified extracts were visualized by Western analysis with c-Mos antibodies. 
 
ionophore A231
crose, 100 mM KCl, 1 mM
2 2
2 3 4
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clonal anti-phospho (T202/Y204) 
ERK (1
was purchased from Calbiochem, 
rabbit anti-MEK (1:1000) was prepared by Zymed Laboratories (South San Francisco, 
1:1000) were provided by Jim Ferrel (Stanford University) and rabbit anti-cyclin 
B were
ated 
mM 
 
ammonium sulfate to reach final 20% saturation.  Samples were rotated for 2.0 hrs at 4ºC 
Immunoblot analysis  
Primary antibodies used include: mouse mono
:2000), rabbit polyclonal anti-phospho (S217/S221) MEK (1:1000), and mouse 
monoclonal myc-tag (1:1000) were purchased from Cell Signaling; rabbit polyclonal 
anti-B-Raf (sc9002; 0.02 µg/ml), anti-Raf-1 (0.4 µg/ml), anti-c-Mos (0.4 µg/ml), anti-
ERK2 (0.2 µg/ml) and anti-phospho (T599/S602) B-Raf (0.2 µg/ml) were purchased from 
Santa Cruz; mouse monoclonal anti-Cdk1 (0.2 µg/ml) 
CA) against an N-terminal 16 amino acid sequence of Xenopus MEK1, rabbit anti-
MAPK (
 provided by James Maller (University of Colorado). 
Secondary antibodies included species-specific alkaline phosphatase-conjug
anti-mouse (Jackson ImmunoResearch Laboratories) and anti-rabbit (Sigma) IgG that 
were detected with the CDP-Star chemiluminescence substrate (Roche Diagnostic). 
 
Purification of mitotic MEK kinase activity from Xenopus egg extracts 
Crude M-phase arrested extracts prepared as described above were 
ultracentrifugated twice at 100,000 g for 1.5 hr to isolate cytosolic fraction.  Mitotic 
cytosol fraction was diluted in ice-cold egg lysis buffer (10 mM HEPES, pH 7.8, 250 
sucrose, 50 mM KCl, 2.5 mM MgCl2, 1 mM DTT) supplemented with 10 µg/ml of each 
leupeptin, pepstatin, and aprotinin and mixed 3:2 with the same buffer containing 50%
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and precipitated proteins were pelleted by a high-speed centrifugation (10, 000g 15 min 
at 4ºC) ) 
C-
 a 
 step-
l) were collected and 
analyze
ed 
f kinase 
-
.  The pellet was resuspended in buffer A (50 mM HEPES, pH 7.5, 10 mM MgCl2
supplemented with 25 mM NaF and 1 mM Na3VO4, and 10 µg/ml of each pepstatin, 
leupeptin and chymostatin, and subjected to chromatography separation by using FPL
AKTA (Amersham Biosciences).  First, the pellet was applied to a 10-ml HiTrap Q 
Sepharose HP column (Amersham Biosciences).  The proteins were eluted with a step-
wise NaCl gradient in buffer A: 0-0.3 M (40 ml), 0.3-1 M (10 ml).  Fractions that 
contained MEK kinase activity (0.17-0.25 M NaCl) were pooled together and applied to
Mono Q HR 5/5 column (Amersham Biosciences).  The proteins were eluted with a
wise NaCl gradient in buffer A: 0-0.35 M (3 ml), 0.35 0.50 M (15 ml), 0.5-1 M (3 ml).  
Fractions containing MEK kinase activity (0.37-0.42 M NaC
d for protein composition by Western blotting and Silver Staining with GelCode 
SilverSNAP Stain Kit (Pierce).  All purification steps were performed at 4oC and assay
for MEK kinase activity. 
 
MEK kinase assays 
To measure MEK kinase activity, samples were incubated in 30 µl o
buffer (50 mM HEPES, pH 7.5, 10 mM MgCl2, 0.1 mM ATP, 25 mM NaF, 1 mM 
Na3VO4, 1 mM DTT) containing 0.5 µg of recombinant unactive GST-MEK1 (Upstate) 
for 20 min at 25oC.  The kinase reaction was stopped with SDS sample buffer and 
reaction products were separated by SDS-PAGE.  Phosphorylation of recombinant GST
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.1 mM 
0 µl 
DS-PAGE, and transferred to a PVDF membrane.  The levels 
of MBP phosphorylation was visualized by autoradiography and quantified by using 
ImageQ
 
protein (Upstate) and 2 µCi 32PγATP for 20 min at 30ºC.   Reactions were stopped by the 
MEK1 at serine residues 217 and 221 was analyzed by immunoblotting with phospho-
S217/S221 MEK antibodies (Cell Signaling).   
Alternatively, MEK kinase activity was measured in an in vitro linked kinase 
assay as described (Guan et al., 2000).  Briefly, aliquots of purified fractions or protein A
beads immunocomplexes were incubated with 1.0 µg of recombinant unactive GST-
MEK1 (Upstate) in 25 µl of reaction buffer (25 mM HEPES, pH 7.5, 10 mM MgCl2, 25
mM β-glycerophosphate, 5 mM EGTA, 1 mM DTT, 5 mM NaF, 1 mM Na3VO4, 0
ATP) for 20 min at room temperature.  The reaction mix was briefly centrifugated to 
pellet immunocomplexes.  Next, 20 µl of the supernatant was mixed with 10 µl of the 
reaction buffer containing 9.0 µg of recombinant unactive GST-ERK and reaction was 
continued for another 15 min. Finally, 3 µl aliquot of the reaction was mixed with 3
of reaction buffer containing 50 µg of MPB and 5 µCi of 32Pγ-ATP and incubated for 
another 10 min at room temperature.  The kinase reaction was stopped with SDS sample 
buffer, separated on 15% S
uant software.  
 
In vitro histone H1 kinase assay 
To measure Cdk1/cyclin B activity, 1 µl aliquots of Xenopus egg extracts were 
incubated in 50 µl of kinase buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM
EGTA, 2 mM DTT, 0.1 mM ATP, 10 µM PKI, 0.01% Brij 35) containing 20 µg H1 
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ion levels of histone H1 were determined 
by auto
 
-
 
 
 
recipitations were performed by adding 4 µg of rabbit polyclonal 
B-Raf antibodies (Santa Cruz) to 10 µl of Xenopus egg extracts diluted in 40 µl of buffer 
A (50 m l2, 25 mM NaF, 1 mM Na3VO4) supplemented 
with 10
anta 
addition of SDS sample buffer and heating at 95ºC for 5 min.  Reaction products were 
separated by 10% SDS PAGE and phosphorylat
radiography. 
 
Immunodepletion  
To immunodeplete B-Raf from S-phase extracts, 50 µl of extracts were incubated
under gently rotation for 1-1.5 hr at 4ºC with 15 µg of rabbit polyclonal B-Raf antibodies 
(Santa Cruz) pre-bound to 5 µl of protein A sepharose 4B Fast Flow beads (Sigma).  B
Raf immuno-complexes were pelleted by a quick centrifugation, and a second round of
immunodepletion was performed.  As a control, extracts were mock depleted in parallel
using an equivalent amount of rabbit IgG (Sigma).  In a similar procedure, Raf-1 was 
immunodepleted from S-phase extracts with 5 µg of rabbit polyclonal Raf-1 antibodies
(Santa Cruz). 
 
Immunoprecipitation 
B-Raf immunop
M HEPES, pH 7.5, 10 mM MgC
 µg/ml of each pepstatin, leupeptin and chymostatin.  To immunoprecipitate c-
Mos-associated MEK kinase activity from M-phase arrested extracts, 5 µg of either S
Cruz c-Mos antibodies or Abcam c-Mos antibodies were added to 10 µl of extracts 
diluted in 40 µl of buffer A.  Following a 2 hr incubation on ice, immunocomplexes were 
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 directly in in vitro linked kinase or phosphatase assays or 
resuspended in SDS sample buffer and analyzed by immunoblotting. 
 
chymostatin.  The immune complexes were recovered on protein A agarose 
beads (Sigma) and washed three times with EB buffer containing 0.1% Triton X-100.   
03 
nd 
recovered on protein A agarose beads (Sigma), washed twice with the same buffer 
containing 0.1% Triton X-100, and 3 times with buffer A alone.  Washed B-Raf immune 
complexes were used
 
Co-immunoprecipitation analysis 
For co-immunoprecipitation studies 20 µl of Xenopus egg extracts were mixed 
with 6.5 µg of anti-B-Raf (Santa Cruz), 6.5 µg of anti-Raf-1 (SantaCruz), 4 µg of anti-
MEK (customer-designed, Zymed Laboratories), 4 µg of anti-MAPK, 4 µg of anti-Cdk1
(Calbiochem) or 6 µg of anti-cyclin B1.  Extracts were diluted 1:1 in EB buffer (80 mM 
β-glycerol phosphate, pH 7.3, 15 mM MgCl2, 20 mM EGTA, 25 mM NaF, 1 mM 
Na3VO4) supplemented with 0.1% Triton X-100 and 10 µg/ml of each pepstatin, 
leupeptin and 
 
Generation of wild-type and mutant Xenopus B-Raf constructs  
A Xenopus B-Raf cDNA clone was obtained from ATCC (Image Clone I.D. 
6860469).  DNA sequencing analysis, performed at H. Lee Moffitt Cancer Center DNA 
facility, confirmed a full-length Xenopus cDNA containing an open reading frame of 8
amino acids.  The sequence data of Xenopus B-Raf has been submitted to the Genbank 
database under accession No DQ097958.  The B-raf coding region was excised at Hi
III sites and sub-cloned into a modified pGEM transcription vector (kindly provided by 
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yc-
 
 prepared and 
verified by DNA sequencing (H. Lee Moffitt Cancer Center DNA facility): Ser-144-Ala, 
Ser-329-Ala, Ser-144-Ala/Ser-329-Ala, Ser-784-Ala/Thr-787-Ala, Lys-517-Met, Lys-
517-M
y as 
f 
CSF-arrested egg extracts supplemented with 2.5 µl of rabbit reticulocyte lysate 
(Ambio tle mixing every 
15 min  
in 
Dr. Rey-Huei Chen from the University of Cornell) down-stream of an N-terminal m
tag.   
Mutant constructs were generated by using the QuikChange site-directed
mutagenesis kit (Stratagene).  The following myc-B-Raf mutants were
et/Ser-144-Ala, Lys-517-Met/Ser-329-Ala, Lys-517-Met/Ser-144-Ala/Ser-329-
Ala. 
 
Expression of recombinant myc-B-Raf proteins in CSF Xenopus egg extracts 
Expression of wild-type and mutant B-Raf proteins was performed similarl
described (Sharp-Baker and Chen, 2001).  Briefly, wild type and mutant myc-B-ra
transcripts were generated using the mMESSAGE mMACHINE T7 transcription kit 
(Ambion).   4 µg of purified mRNA transcripts were introduced into 21 µl of Xenopus 
n).  Protein expression was carried out at 23ºC for 5 hr with gen
.  Expression of recombinant proteins was confirmed by Western blotting with
myc epitope antibodies.  In order to reproduce the S-phase phosphorylation status of the 
recombinant B-Raf proteins, aliquots of translated WT or mutant myc-B-Raf proteins 
were introduced into S-phase arrested extracts in a 1:20 ratio and incubated for 30-60 m
at room temperature.  To induce M-phase phosphorylation of the recombinant proteins, 
aliquots of S-phase extracts containing myc-B-Raf protein were driven into M-phase by 
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binant myc-B-Raf proteins undergo dephosphorylation during incubation in S-
phase e tracts. 
in 
r (25 mM HEPES, pH 7.5, 150 mM NaCl, 25 mM β-glycerophosphate, 10 mM 
MgCl2, 10% glycerol, 5 mM EGTA, 1 mM DTT, 1 mM Na2VO4, 5 mM NaF, 0.1% 
Triton ed 
on ice w
h 
 and 
 
ing to in 
d 
adding recombinant non-degradable cyclin B.  Western blot analysis revealed that 
recom
xtracts and acquire hyperphosphorylation during incubation in M-phase ex
 
Purification of recombinant myc-B-Raf proteins from Xenopus egg extracts 
Myc-B-Raf recombinant proteins were purified by immunoprecipitation using 
myc-tag antibodies.  Aliquots of egg extracts containing myc-B-Raf were diluted 1:20 
buffe
X-100 and 10 µg/ml of each pepstatin, leupeptin and chymostatin) and incubat
ith myc-tag monoclonal antibodies (Cell Signaling) for 2 hrs. Protein A 
Sepharose beads were added and incubation was continued for another 12-16 hrs wit
gentle inversion at 4ºC.  Immuno-complexes were washed twice with the same buffer
twice with the reaction buffer (25 mM HEPES, pH 7.5, 25 mM β-glycerophosphate, 10
mM MgCl2, 5 mM EGTA, 1 mM DTT, 1 mM Na2VO4, 5 mM NaF) before apply
vitro kinase assays. 
 
Phosphatase Treatment 
B-Raf immunoprecipitates from S- and M-phase arrested extracts were incubate
with 50 units of recombinant lambda protein phosphatase (Upstate Biotech) in 50 µl of 
phosphatase buffer (50 mM HEPES, pH 7.5, 0.1 % BSA, 100 µM EDTA, 2 mM MnCl2, 
and 5 mM DTT) for 30 min at 37ºC.  To stop reactions, precipitates were washed with 
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 7.5, 
 vitro Cdk1/cyclin B kinase assay 
clin 
B (New
 of 
ed by the addition of SDS sample buffer and heating at 950C for 5 
min. 
 
copious amount of the buffer containing phosphatase inhibitors (50 mM HEPES, pH
10 mM MgCl2, 25 mM NaF, 1 mM Na3VO4). 
 
In
Myc-B-Raf IPs were incubated with 100 units of recombinant active Cdk1/cy
 England Biolabs) in 30 µl of kinase buffer (50 mM Tris-HCl, pH 7.5, 10 mM 
MgCl2, 1 mM EGTA, 2 mM DTT, 0.1 mM ATP, 0.01% Brij 35) with radioactive 
32PγATP (5 µCi/reaction) for 30 min at 30ºC.  Reactions were stopped by the addition
SDS sample buffer and heating at 95ºC for 5 min. 
 
In vitro ERK2 kinase assay 
Endogenous B-Raf or myc-B-Raf immunoprecipitates were incubated with 20 
units of recombinant active ERK2 (New England Biolabs) in 30 µl of kinase buffer (50 
mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT, 0.1 mM ATP, 0.01% 
Brij 35) with or without radioactive 32PγATP (5 µCi/reaction) for 30 min at 300C.  
Reactions were stopp
 
Native gel electrophoresis and transfer 
Samples were run in a 4-25% gradient gel (BioRad) in SDS-free buffer (250 mM
Tris, 200 mM glycine) for 12-14 hrs at 4ºC.  Transferring of separated proteins to PVDF 
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S, pH 
00 µl. 
 
 
 
 
 
 
 
 
 
 
membrane was performed in the transfer buffer supplemented with 0.5% SDS (20 mM 
Tris, 150 mM glycine, 0.5% SDS). 
 
Gel filtration 
Size exclusion chromatography was performed at 4ºC using Superdex 200 HP 
10/30 column (bed volume ~24 ml; Amersham Biosciences) with a FPLC-AKTA 
(Amersham Biosciences) purification system in the buffer containing 50 mM HEPE
7.5, 10 mM MgCl2 and 10 µg/ml of each pepstatin, leupeptin and chymostatin.  The flow 
rate was 0.25 ml/min and the sample volume was 1
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